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1General introduction
1.1 Upper limb function
Our arms and hands are unique. Hardly any other living organism has such a pair
of tools that can grasp, hold, move and manipulate objects like humans have. The
arms, including the shoulder, upper arm, elbow, forearm and wrist connect the hands
to our body. The arms enable us to position and rotate our hands in such a way that
we can use them for whatever we want to do. Our arms and hands play a crucial
role in the way we manifest and express ourselves. We use them not only to perform
heavy labour but also to carry out gentle actions such as using a computer, playing
piano or making friendly gestures to others. Our arms and hands are also important
for supporting our communication. It is with good reason that the expression ’talking
with one’s hands’ exists. The arm and hand together are also called the upper limb,
or the upper extremity. These terms are often used in this thesis, when both the arm
and hand are meant. Upper limb movements play a fundamental role in everyday life.
Imagine you would have limited upper limb function, what a tremendous impact this
would have on almost all areas of daily life.
1.2 Upper limb function in neuromuscular
disorders
Several neuromuscular conditions can substantially impair the ability to use the arms
and hands, due to muscle weakness or impaired muscle control, such as myopathies,
neuropathies, mitochondrial disorders, motor neuron diseases and neuromuscular
transmission diseases [1]. Diﬀerent patterns exist with regards to the muscles that are
involved in neuromuscular disorders (NMD). Some NMD mainly aﬀect limb, axial and
facial muscles, whereas in other types, respiratory, cardiac, and swallowing muscles
may (also) be aﬀected [2]. At present, there is no cure available for any form of genetic
NMD that can completely stop (or reverse) the symptoms. Existing treatments including
allied health care interventions such as occupational therapy, physical therapy and
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speech therapy, focus on symptom relief and strategies to compensate for loss of
functions. Because of the fundamental role that arm and hand movements play in
everyday life, NMD may have a huge impact on the ability to perform daily activities
and fulﬁl roles in life, which may inﬂuence the quality of life of the aﬀected persons.
Among types of NMD that have a signiﬁcant impact on the ability to use the arm and
hand in daily living are Facioscapulohumeral Dystrophy (FSHD), Limb-girdle Muscular
Dystrophy (LGMD), DuchenneMuscular Dystrophy (DMD) and Spinal Muscular Atrophy
(SMA) [3, 4]. Little is known about upper limb function in these diseases. The natural
course of various types of NMD, including FSHD, LGMD, SMA, and DMD, has been
described in the past [4]. This description was however mainly on the level of muscle
function and structure in general. The level of activities, upper limb activities in
particular, was hardly studied. More recently, the role of upper limb functions and
their relation to activity limitations in children and adolescents with DMD has been
investigated [5, 6]. Little is known, however, about impairments and their eﬀects on
upper limb activities and the participation in daily life in diﬀerent types of NMD, including
DMD, SMA, LGMD, and FSHD. Hence, these neuromuscular diseases are described
below starting with DMD, which was the target group of the expert meeting described
in chapter 2. The rest of this thesis mainly focuses on FSHD. In chapters 3 and 7, the
two other neuromuscular diseases (SMA and LGMD) are addressed as well.
DMD
DMD is the most common form of muscular dystrophy in children. It is an X-linked
recessive disorder, with an incidence of one in 6,000 male births [7]. Life expectancy
in young men with DMD has increased from 14 years of age in the 1960s to about 30
years of age nowadays [8]. Although there is large variability in function [9], people
with DMD generally have severely impaired motor functions. The ability to walk is
impaired at ﬁrst, but eventually also upper limb functions become severely impaired.
Despite the limited distal motor functions, adult persons with DMD are often still able to
perform certain daily hand activities. At later stages, when muscle strength diminishes
further, people tend to lose this capacity [10]. In the teen years, upper limb impairments
become more severe. The patterns of decline in upper limb functions of boys and men
with DMD have been studied in detail by a member of our research group [5].
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SMA
SMA is caused by degeneration of the spinal cord motor neurons, resulting in muscular
atrophy and weakness. SMA is an autosomal recessive inherited type of NMD, and
it is one of the most common NMDs in children with an incidence of about one in
12,000 live births [11]. SMA can be divided into four subtypes (type 1: severe, onset
0-6 months; type 2: intermediate, onset 7-18 months; type 3: mild, onset above 18
months; type 4: adult onset), based on the age of onset and the maximally achievable
motor function. The clinical spectrum ranges from early infant death (type 1) to normal
adult life with only mild weakness (type 4) [12]. Accept from SMA type 1, the disorder
is slowly progressive. The upper limbs are usually stronger than the lower limbs [13].
Non-ambulant SMA patients tend to increase in upper limb strength until the age of
14 and tend to deteriorate afterwards [14]. It has been demonstrated that there is a
gradual loss of muscle strength and physical functions in the upper limbs [15]. There
is a broad range of functional capacities among people with SMA, from not being able
to feed oneself to almost completely preservation of upper limb functions [16].
LGMD
LGMD comprises a group of autosomal dominant and autosomal recessive muscular
dystrophies that primarily involve the pelvic and shoulder girdle muscles. There are
many diﬀerent types of LGMDs, with a variable clinical course, ranging from severe
forms with rapid onset and progression to very mild forms. The prevalence of subtypes
of LGMD in the population is also highly variable, depending on geographical and
ethnic factors [17]. In LGMD, there is usually more weakness in the proximal muscles
than in the distal muscles and in most people with LGMD, upper limb function is usually
mildly impaired [18].
FSHD
FSHD is an autosomal-dominant, slowly progressive form of muscular dystrophy
and the most common inherited muscular dystrophies in adults with an estimated
prevalence in the general population of one in 8,000 [19]. FSHD causes mainly facial
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weakness, clavicular ﬂattening, scapula winging, and proximal muscle weakness in the
upper limbs. In addition, many trunk and leg muscles may become involved, of which
the abdominal muscles and foot elevators are aﬀected relatively early in the course
of the disease. Myopathic changes are seen in muscle biopsies, and recent studies
showed muscle inﬂammatory pathology [20] and fat inﬁltration [21]. Because of the
proximal muscle weakness, people experience diﬃculties while positioning their upper
limbs in space. The severity of involvement is variable, ranging from facial weakness
to generalized weakness, with eventually wheelchair conﬁnement in about 20% of the
people [22].
1.3 Upper limb interventions in NMD
Although no cure is available yet for any form of genetic NMD, life expectancy in for
instance DMD has increased due to better healthcare and respiratory support. In
combination with the many ICT solutions that have been developed in the last decade,
people with NMD have potentially much better possibilities to participate in scholarly
or work activities than ever before. Hence, interventions focusing on quality of life
become more and more necessary. So far, current intervention programs have focused
mainly on improving ambulation and less on improving or supporting arm function.
While the possible harm of training interventions in NMD has been communicated
for a long time, it has recently been shown that interventions like moderate-intensity
resistance or aerobic training can be applied safely in NMD [23, 24]. In a recent
study, it was demonstrated that the activity level, measured by the Motor Function
Measure (MFM), did not decrease during a exercise training of six months in contrast
to a control group receiving no speciﬁc training [6]. To improve the quality of life of
people living with NMD who experience severe upper limb impairments, it is important
to facilitate the performance of activities of daily living (ADL). One way to do that is to
use assistive devices that augment arm function. In the past, various devices have
been developed. These devices usually support the user by compensating part of the
weight of the user’s arm [25]. This type of device is called ’dynamic arm support’ and
can be subdivided into non-powered and powered devices [26]. Powered devices are
meant for people with very limited to no muscle strength. Non-powered devices require
a certain amount of residual muscle strength for accelerating and decelerating the
upper limb to overcome friction and balancing errors [27]. Despite all developments
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in designs, the number of users of dynamic arm supports is still low [28]. Various
reasons have been mentioned for this situation: interfaces are too complex, supported
range of motion is limited, device dimensions are too large, and support is insuﬃcient
due to clinical deterioration or the mere fact that a person prefers not to use supportive
aids [28, 29]. Various initiatives aim to develop new devices that better suit the needs
of the users. Examples of such developments are the McArm project (Box 1) and the
Flextension A-Gear project (Box 2).
1.4 Upper limb measurement
To understand how exercise interventions or the prescription and use of devices could
be improved, a good understanding of whether and how an intervention works is
necessary. Systematic analysis of movements is required to investigate people’s
capacity to move the upper limbs. It is not only important to understand movement
patterns from a biomechanical point of view, but also to relate this to activity limitations
that people experience during daily life activities.
Movement capacity in controlled setting
Already in the 15th century, Leonardo da Vinci studied the structure of the human
body, and he described the mechanical aspects during various movements [30]. Since
then, many theories and experimental techniques have been developed to study the
mechanical factors that play a role in the musculoskeletal system. These mechanical
factors can be quantiﬁed using kinematic analysis [31]. Kinematics is the part of
mechanics that describes the motion of points, objects, and systems of objects, without
considering the masses of the objects or the forces acting on it [32]. The goal of any
kinematic analysis is to develop a model that describes the motion of real-world
objects. In human movement studies, kinematic examinations can be performed to
model the functional performance of the limbs in normal and abnormal conditions
[31]. The development of 3D motion tracking techniques (e.g. by using optoelectronic
or accelerometric methods) has made digitally tracking of objects during movement
accessible for widespread use. To analyze human movement kinematics, a lot of
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Box 1: McArm project
The studies performed in this thesis were part of the McArm (Motion Controlled
Arm support) project. This project was initiated by Focal Meditech BV, with the
aim to develop a robotic arm support that can be controlled intuitively. Such arm
support works on the basis of robot technology and is controlled by measuring
minimal forces that the user still can generate in certain directions. Target users
are mainly people with NMD or with stroke. The project had two main goals. The
ﬁrst one was to build two prototypes of a motion controlled ’dynamic arm support
for use in daily life, and a training version to be used in virtual environments.
A secondary goal was to investigate implementation of lightweight materials in
the fabrication of new devices, such as carbon ﬁber. The development cycle
began with the collection of usage and user requirements. In addition, previous
developments and products have been closely reviewed. In a later stage of
the project, it was attempted to convert the user requirements into technical
speciﬁcations.
Figure 1: Prototype of motion control arm
support
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Box 2: Flextension A-Gear project
The objective of Flextension was to develop new support aids for the upper
limbs that improve the quality of life for people with DMD. The initiative started
in 2007 as a result of questions from the Duchenne Parent Project about what
engineering and technology could do to improve the quality of life for boys
with DMD. In 2009, an explorative study was performed to identify needs and
requirements for a discrete, body-connected support aid that can be worn under
the clothing and that can support an independent operation of the arm during
primary daily activities (Figure 2) [29].
Since then, a group of researchers and developers have been working on the
development of this device, in the A(bility)-Gear project. The focus of this project
was to develop a passive arm support - controlled by the user, without motors
- as well as an active arm support - powered by motors that are controlled by
the user [33]. This project resulted in a new prototype that is a step towards
inconspicuous and therefore well-received dynamic arm supports for people
with muscular weakness (Figure 3).
Figure 2: Concept of wearable arm support Figure 3: New prototype
of wearable arm support
kinematic variables are needed to describe all the movements of the diﬀerent segments
and joints of the body. To specify these variables, a kinematic model is required that
simulates movement in the various types of anatomical joints and how these are
connected by bony segments [31]. For the upper limb, a standard deﬁnition of such a
model for the shoulder, elbow, wrist, and hand was proposed by Wu et al. in 2005 [34].
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With the techniques that are available, the movement capacity of people with NMD
can be investigated systematically under laboratory conditions.
To analyze neuromuscular control of movement in individuals with NMD, studying solely
movement by kinematics is insuﬃcient. It would also be helpful to know how diﬀerent
muscles are involved in performing the movements. Analysis of muscle involvement
can be done by recording the electrical activity of the muscles that are formed by
physiological variations in the state of muscle ﬁbre membranes. These recordings
are named electromyography (EMG). When EMG is used to record muscular patterns
and coordination between muscles, it is called kinesiological EMG [35]. Clinical use
of kinesiological EMG techniques has been focused primarily on lower extremity
interventions, but potential applications for the upper extremities are indicated as
well [36]. With kinesiological EMG, timing parameters such as the onset of muscle
activity can be derived, as well as the magnitude of the EMG signal. The magnitude is
regarded as an indicator of the contraction level of a muscle [36]. The combination of
the use of kinematic and EMG analysis tools can, thus, help to assess the eﬃcacy of
training interventions and supportive devices.
Self-reported capacity in daily life
While investigating human movement and muscle involvement is useful to determine
the physical function of a person, it provides only little insight into people’s upper limb
capacities and performance of daily life activities. Daily life activities involve a broad
spectrum, from very basic activities such as reaching, grasping, and lifting, to more
complex activities such as grooming, opening a door, preparing food, using a cell
phone, etc. So far, basic upper limb activities have been assessed with, for example,
the Brooke scale. This scale classiﬁes activity limitations into six categories, varying
from ‘being able to lift both arms sideways in a full circle until they touch above the head,
starting with the arms at the sides’ to ‘not being able to raise the hands to the mouth
and not having useful function of the hands’ [37]. However, there is little accurate
information about limitations in activities that require more complex movements of the
upper limbs. To investigate how capable people are to perform ADL, measures like
the Capabilities of Upper Extremity (CUE) or the ABILHAND questionnaires may be
more suitable. The CUE assesses basic upper limb capacities and the ABILHAND
evaluates the ability to perform daily activities [38, 39]. The CUE contains 32 items
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(30 items right/left arm, two items both arms) that can be scored on a 7-point scale (1
= unable to perform, 7 = can perform without diﬃculty). The ABILHAND questionnaire
contains 22 items that can be scored on a 3-point scale (0 = impossible, 1 = diﬃcult,
2 = easy). It is conceivable that upper limb activity limitations in patients with NMD
will be related to lack of muscle strength, but limitations can also be inﬂuenced by
pain and muscle or joint stiﬀness. The use of self-report measures like the CUE and
ABILHAND can help to identify upper limb activity limitations that individuals with NMD
experience in daily life. In combination with questions about pain and stiﬀness, for
example, as used in the ’University of Michigan Upper Extremity Questionnaire’ [40],
activity limitations and participation restrictions related to pain and stiﬀness complaints
can be identiﬁed.
1.5 Thesis outline
In the current thesis, the focus is on upper limb function in people with FSHD, one of
the most common muscular diseases in adults characterized by signiﬁcant problems
in the positioning of the upper limbs in space. The conducted studies constitute part
of a larger research line, in which upper limb function is also investigated in DMD and
comparable NMD such as SMA and LGMD. In this thesis, upper limb function, activities,
and participation of people with FSHD were compared to upper limb functioning in
people with LGMD, SMA, and DMD. The aim is to ﬁnd answers to the following research
questions:
• What is known about upper limb function in patients with FSHD and how can
upper limb function be measured?
• What activity limitations and participation restrictions do patients with FSHD
experience in daily life, and are these comparable to those in DMD, LGMD and
SMA?
• What is the inﬂuence of an arm support on upper limb use in patients with FSHD
in daily life activities?
Because research on arm support in NMD is limited, an expert meeting was organized
to discuss the necessities regarding arm function research in DMD and state-of-the-art
requirements for assistive devices that can be used to support arm function. In this
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workshop, the focus was on DMD because most research concerning arm function
analysis and use of devices, so far, has been done in people with DMD. The outcomes
are, however, also relevant for other types of NMD and are therefore described in
Chapter 2.
Chapter 3 presents a literature review on arm function in people with FSHD and LGMD.
In this chapter, the natural course upper limb function and measures to study such
function in these two groups is presented.
Chapter 4 investigates which upper limb activity limitations people with FSHD expe-
rience in daily life. These limitations are investigated using self-reported outcome
measures at the level of body functions (pain and stiﬀness), daily life activities and
societal participation.
Chapter 5 describes the results of a study in which arm movements and the involve-
ment of speciﬁc muscles are investigated with kinematic and EMG tools in a group of
people with FSHD and in healthy people during the performance of motor tasks in a
movement laboratory.
While the use of arm supportive devices has been investigated before, in for example
healthy elderly and people who have had a stroke, the changes induced by arm
supports in person with FSHD are unknown. In Chapter 6, the eﬀect of an arm
support on arm kinematics and EMG activity is explored in individuals with FSHD as
well as in healthy individuals.
To investigate whether comparable proﬁles of upper limb function can be identiﬁed in
various types of NMD (i.e. FSHD, LGMD, DMD, and SMA), the same self-reported
questionnaires are used. Chapter 7 describes the reported upper limb impairments
and activity limitations in people with FSHD compared to those with LGMD, DMD, and
SMA.
Chapter 8 contains a summary and general discussion, including clinical implications,
based on the studies reported in this thesis. In addition, future perspectives will be
contemplated.
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2.1 Introduction
Workshop theme and participants
The 1st workshop on Assistive Technology for people with Duchenne Muscular Dys-
trophy (DMD) was held in London (United Kingdom), on April 27th 2015. The primary
goal was to bring people from diﬀerent disciplines together and discuss opportunities
to accelerate the development of upper-extremity assistive technology for enhancing
the functional abilities of non-ambulant men with DMD. The topics of the workshop
included the state of the art, emerging avenues and challenges of upper-extremity
assistive technology. Twenty-four participants representing parents, experts in user
requirements, human-machine research, electrical and mechanical engineering, and
clinicians involved in the care of children with Duchenne muscular dystrophy from
Denmark, the Netherlands, the UK and the USA, participated in the workshop. Key re-
sults included the identiﬁcation of the need for comparative studies based on standard
requirements and outcome measures, and the low acceptance rate of commercially
available devices. Advanced robotic arm supports are still in experimental phase.
Finally, focus groups were initiated on (1) evidence based user requirements and
acceptance, (2) assessment protocols, (3) modular technology, and (4) accessibility
and reimbursement.
DMD and assistive technology
DMD is a progressive muscle disorder, characterized by muscle wasting and weakness.
The ﬁrst signs of the disease is ambulatory delay, with 50% of DMD boys starting to
walk after 18 months [1]. DMD leads to full time use of a wheelchair in the mid-teens,
loss of upper-extremity (UE) function in the late-teens followed by the development of
cardiomyopathies and respiratory failure [1, 2]. Currently, there is no cure for DMD, and
treatment is mainly aimed at delaying disease progression and preserving functional
abilities. Due to these new treatments (including nocturnal ventilation), life expectancy
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in boys with DMD has increased from 14 years of age in the 1960s to 25 years of
age in the 1990s [3, 4]. Currently, the median survival of boys with DMD is estimated
to be over 30 years [5, 6] and it is expected that the life expectancy will continue to
increase. Because of the prolonged life expectancy, the number of individuals living
with DMD is increasing. This group of young men live with impaired UE function
for more than 15 years, which severely limits the performance of basic activities of
daily living (like self-feeding and personal care) and restrict social participation. It is
generally accepted in the DMD community that early and combined eﬀorts of steroids
and bracing to preserve leg strength are rewarded by a longer ambulatory period.
There is also evidence that suggests that certain assisted arm training delays the
progression of muscle weakness in the arms [7]. The use of assistive devices has
the potential to improve the quality of life for people with DMD, by enabling them to
continue performing activities of daily living and participate in social activities. Between
1936 and 2011 [8], more than 100 UE assistive devices have been developed. Most
of them are intended for rehabilitation to regain strength and motor control, and few
are designed to assist during activities of daily living. UE assistive devices for daily
use are also known as dynamic arm supports. Despite all the developmental eﬀorts,
few devices are commercially available. Van der Heide et al. [9] concluded that only
a few number of dynamic arm supports that have been developed have also been
evaluated. Most of the studies that they found examined the eﬀects of dynamic arm
supports on body functions, activities, and participation under laboratory conditions.
Although, in general, these studies report positive outcomes, the number of users
of dynamic arm supports appears to be low. Researchers have mentioned various
possible reasons that could be the cause of the low number of users: preference of
compensatory movements over using an assistive device, large dimensions of the
devices that stigmatize the user, diﬃculties in adjusting the device, clinical deterioration
and expense. Besides eﬃcacy evaluation under laboratory conditions, a much better
understanding of eﬀectiveness of using dynamic arm supports in daily life is needed
[9].
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2.2 User requirements
Patients perspective
Elizabeth Vroom presented what the highest priorities are for young men with DMD.
In order to improve quality of life for those living with Duchenne, independence and
participation must be facilitated. For young men, it is important to be able to participate
in work and social activities. While privacy is indicated as being important, socialization
and employment are priorities as well. In 2007, the Dutch Duchenne Parent Project
organized a workshop to determine whether improving arm or leg function should
be prioritized. The outcomes of this workshop were that young men considered
arm function as the highest priority. The loss of lower extremity function, can be
compensated fairly well by using a wheelchair, but compensating the loss of arm
function is less evident [10]. Although complete loss of arm function arises at the
late-teens, it has been shown that performing activities with the arms is already limited
in the late ambulatory stage and that participating in school activities is also restricted
because of these limitations [10]. When young men with Duchenne were asked what
a new drug should gain in terms of daily activities, the responses were related to the
activities that can be achieved with the arms: touch face, self-feed, personal care
such as brushing teeth, toileting, use of computer, ability to maneuver wheelchair are
considered of high value. Individuals with DMD expressed an urgent need for privacy,
which becomes impossible as weakness increases. Two user requirements studies
have been performed to determine what activities are considered to be most important.
Annie Kennedy presented the results from a study performed by the PPMD in the USA.
The results from focus groups sessions were combined with an online survey that was
distributed in the USA (N=19), to determine priorities of ambulant and non-ambulant
people with DMD. The priority activities for the ambulant group were stand up, pick up
objects from the ﬂoor and walk upstairs. The priority activities for the non-ambulant
group were repositioning at night, bring hands to mouth, shift while seated, using
joystick and using the keyboard of a computer.
Imelda de Groot presented the results from a World-wide survey. In this survey, 213
individuals (age ranging from 1.5 to 35.2 years old) with DMD participated, of which 95
were ambulant and 118 non-ambulant. From this survey, there was concluded that the
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main priority is to eat independently and prepare food. Subsequently, activities that
were indicated to be important by the ambulant respondents were get dressed, reach
to objects or lift objects and writing. Activities that were indicated being important by
the non-ambulant respondents were personal hygiene, drinking and using a computer
[10].
Discussion and Future Actions
• Arm function is highly important. More insight in ADLs that should be supported
and what people require from an arm support is needed. Current surveys address
what young men value (e.g., use of computer). It is important to reach out more
broadly in getting input into device design—it might just be that we are currently
sampling a small portion of the population who is willing to test a novel device. It
is also important to consider potential users in the full range of the progression,
from early through late loss of ambulation.
• Studies on technical requirements are needed (e.g. required movement speed,
number of degrees of freedom, range of motion of each joint). While there is a
considerable variety of upper-extremity assistive devices, there are few studies
that investigate the user requirements. One example is the study by Ramanathan
et al. [11], which analyzes the arm trajectories of healthy subjects during ADL to
ﬁnd what are the movements that an arm support device should assist.
• The use of two arms may be preferred over one arm, since a lot of ADL are
bimanual tasks. Current devices are essentially for one arm, therefore bimanual
application doubles the price. Insurance companies typically reimburse at most
one arm support.
• Patient organizations have a crucial role in putting patients ﬁrst, encourage
collaborations, recognize unmet needs, determine which initiative has the highest
priority, leverage research funding, stimulate regulatory approval, improve the
access of technology and advocacy in the reimbursement of devices.
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2.3 Evaluation of Arm function
In order to optimize devices and assess eﬀectiveness of devices, quantitative and
objective evaluation methods are needed. Quantitative data comprises kinematic
parameters, such as the range of motion of supported arm movements and the muscle
eﬀort that is needed to using a particular type of arm support. Individuals with DMD
need relatively more eﬀort in all directions in order to perform the same movements as
healthy controls. Also, they recruit more muscles simultaneously for all motions. One
key question is whether muscle activation requirements or the amount of energy is
required to perform a speciﬁc activity will become lower by using the assistive device.
Disease Progression and Training Eﬀects
In the same World-wide survey (N=213) that was presented by Imelda de Groot,
changing patterns of arm function during the course of DMD were investigated. The
questionnaire included the domains of pain and stiﬀness in the arms, activity limitations
and restrictions in social participation. In general, pain, stiﬀness, and activity limitations
increased with disease stage. The researchers found that activity limitations in the arms
already occurred in the early ambulatory stage, and that these limitations aﬀected
their social participation. About 70% of the respondents experienced limitations
when performing social activities. Only 9% of the respondents on the other hand
used supportive aids [10]. Progressive muscle weakness results in reduction of
physical activity and disuse of the musculoskeletal and cardiorespiratory systems,
because performing activities cost more and more energy [12]. In addition, the use
of a motorized wheelchair and a sedentary lifestyle further restricts the arm function,
resulting in secondary physical deterioration and disuse. To decrease the deterioration
due to disuse, arm training is considered [13]. There is evidence that assisted bicycle-
like motion training of the legs and arms is feasible and safe for both ambulant and
wheelchair-dependent children [7]. Recently, a training study in DMD was conducted,
in which participants received a training program with a dynamic arm support. The
training was based on a virtual reality computer game, in which participants had to
perform several ADL while using dynamic arm support. Six boys ﬁnished the study
and in four of these six boys, the trained arm retained more motor function than the
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untrained arm. These preliminary ﬁndings may indicate that boys with DMD can safely
train their arms with dynamic arm support [14].
Range of Motion
Jay Han presented part of his work on measuring reaching workspace. In order to
quantify the reachable workspace, various methods can be used. One promising
method is the Kinect-acquired reachable workspace measure, developed at the Uni-
versity of California. This method comprises a scalable and aﬀordable sensor-based
upper extremity reachable workspace assessment system using a Kinect sensor [15,
16]. This quantitative reachable workspace outcome measure has demonstrated ap-
plicability as a novel surrogate marker of upper extremity function in DMD and Becker
Muscular Dystrophy (BMD) [17]. In a series of preliminary studies, the reachable
workspace outcome measure has shown its validity, reliability, and sensitivity, as well
as clinical-meaningfulness by correlating strongly with person-reported activities of
daily living (ADL) function. Additionally, the Kinect-acquired reachable workspace
measure demonstrated its utility in both ambulatory and non-ambulatory individuals
as well as pediatric and adult populations with DMD/BMD, providing for the ﬁrst time,
a means to follow progression of the disease through important clinically-meaningful
functional milestones, such as both the loss of ambulation and ability to self-feed,
through the lifespan of an individual with DMD or BMD. The impact of the novel upper
extremity assessment tool and outcome measure will be most directly felt in clinical tri-
als where it will facilitate: 1) access to clinical studies for non-ambulatory individuals, 2)
reduction of study participant burden, 3) improvement in eﬃciency through automation,
4) home-based data collection via internet-connected sensor, and 5) better evaluation
of eﬃcacy for interventions; all contributing to potentially transform the way clinical trials
are conducted in DMD/BMD. However, improved quantitative measurements of upper
extremity with its correlative clinical data will also have implications for intervention
development in the robotics ﬁeld. The kinematic and dynamic parameters obtained
across a large cohort with a spectrum of disease severity and functional levels can be
used to inform design of assistive devices, robots, and exoskeletons. The data will also
be informative in general model building as well as reﬁning models of upper extremity
function. Identiﬁcation of individual requirements/needs and functional parameters
will contribute to a more ‘personalized’ and prescriptive robotic system that will be
optimized and tailored to individual functional needs.
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Discussion and Future Actions
• Arm function progression studies: Monitoring the disease progression is needed
so that engineers know what level of assistance is needed as a function of time
(per day, per year) in arm supports. To this end modeling may be useful to
estimate individual muscle function.
• How much support is needed: A current problem is that the arms are often
disused, which results in deterioration of muscle capacity. Once people with
DMD lose ambulation, the arm use is reduced. The general consensus was to
keep using the arms, but also that overuse should be avoided. There is a need
to address upper extremity function, with titrating how much assistance is given.
Although it is not scientiﬁcally clear when there is overuse, fatigue, pain and no
functional return the next day are associated with upper extremity overuse and
can be used to help titrate the amount of assistance required.
• There is a need for outcome measures to evaluate arm function in a daily life
setting: Currently insuﬃcient objective data is available to evaluate how much the
arms are used/burdened during the day. Also longitudinal studies are missing.
• Therapeutic eﬀects: Pilot studies suggest that there may be a therapeutic eﬀect
when a person regularly uses an arm support. How does this therapeutic eﬀect
relate with the quality of life of the users? Is it necessary to prevent overuse of
the arms?
2.4 State of the art and current research
Commercial Arm Supports
The ﬁrst arm supports were developed in the 1960’s [8]. While the ﬁrst designs only
supported eating movements, current devices assist a wide range of ADL. Up to
date, there is a large number of UE assistive devices that have been developed,
but only few are intended for daily use, commercially available and used by people
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with DMD. Extensive reviews can be found in [8] and [18]. Dynamic arm supports
can be divided into two subcategories, non-powered (also called passive, or body-
powered devices) and powered devices (also known as active or externally-powered
devices). Non-powered arm supports use elastic elements (i.e. springs) to compensate
the weight of the arm. Tariq Rahman, Paul Verstegen and Blake Mathie presented
the developments of the WREX, the arm supports of Focal Meditech and the X-Ar
respectively. The WREX (JAECO Orthopedic, USA) [19] and the TOP (Focal Meditech
BV, the Netherlands [20]) arm supports are non-powered arm supports that have been
in the market for more than 20 years. The WREX (JAECO Orthopedics, USA) is
now available in two versions: the metal version that attaches to the wheelchair or
to a table, and a wearable version that combines 3D printed plastic parts and metal
parts, known as Baby WREX, for ambulatory children [21]. More recent commercially-
available non-powered arm supports include the SLING, the Dowing and the Balancer
(Focal Meditech BV, the Netherlands [20]), the VERTICAL M.A.G (Proteor, France), the
Nitzbon Mobility Arm (Nitzbon, Germany), the Saebo MAS (Saebo Inc., USA) and the
X-Ar (Talem Technologies, USA [22]). Powered arm supports use motors to change
the settings of the gravity compensation mechanism or to move the arm in the vertical
or horizontal plane using a joystick or buttons. The TOP arm support can be extended
with an actuator, called HELP, to provide active support in the vertical direction to assist
persons with more severe muscle weakness. Beside the TOP/HELP, Focal Meditech
has developed the active version of the Sling, Darwing and the GoWing. Other powered
arm supports include the Armon (Microgravity Products, NL) [23], the Zonco Mobile
Arm Valet (ZoncoArm, USA) [24], the DAS (Exact Dynamics, the Netherlands) [25]
and the Neater Arm support (Neater Solutions, UK) [26]. A recent systematic review
on the eﬀect, eﬀectiveness and usability of arm supports concluded from the results
of 47 evaluation studies that there was an increased ability to perform activities of
daily living and user satisfaction when using an arm support, but that the use of
dynamic arm supports at home was low [9]. A recent study of a questionnaire-based
evaluation of the WREX concluded that the WREX made a signiﬁcant improvement in
arm function for users while performing everyday tasks. Sixty percent of the 55 users
included in the study continued to use the WREX at the time of the survey. Sixty-nine
percent of wheelchair-mounted WREX users continue to use it, and 48% of body-
mounted continue to use it. Reasons for abandonment included weight, interference
with other activities, joint contractures, and imprecise gravity compensation. Users
showed more improvement of arm function with the wheelchair-mounted WREX than
the body-mounted model. Aesthetics, ﬁtting, and reimbursement were identiﬁed as
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areas for improvement [27]. Furthermore, a user evaluation study with the Neater arm
support concluded that the use of the Neater arm support by adults and teenagers
with neuromuscular disorders could greatly improve their independence, conﬁdence,
and ability to engage in social situations [28].
Current Research on Arm Supports
In addition to currently available devices there are several initiatives that aim to develop
solutions that better suit the needs of young men with DMD. Among these initiatives
are: the A-Gear project (DPP-Flextension, The Netherlands), the ReachABLE project
(New Jersey Institute of Technology, USA) and the Patient@Home project (Aalborg
University, Denmark). Micha Paalman and Joan Lobo-Prat presented the work done
in the Flextension A-Gear project. The Flextension A-Gear project started in 2011 with
the goal of developing an inconspicuous arm support that could adapt to the growing
needs of people with DMD. The development towards the ultimate arm support was
divided in two separate functional prototypes: the Passive A-Gear and the Active
A-Gear, which are directly related to two levels of assistance. The Passive A-Gear is
intended for younger individuals that are still able to perform activities of daily living
when the weight of the arms is compensated. The Passive A-Gear, in contrast to the
existing arm supports, has a mechanical structure that closely follows the biomechanics
of the arm and trunk, uses a novel spring conﬁguration to balance the weight of the
arm, and has a hip joint incorporated to allow ﬂexion/extension movements of the
trunk [29]. When the support provided by the Passive A-Gear becomes insuﬃcient,
the Active A-Gear will provide the extra assistance in weaker individuals with DMD
using motorized joints. In order to operate active arm supports the user needs to
communicate his motion intention to the device through a control interface. The
selection of the control interface in response to speciﬁc user needs and capabilities
is a crucial determinant of the usability of the arm support. In previous studies, we
have shown that the use of electrical activity of arm muscles (known as surface
electromyography, sEMG) or the measurement of small forces that are still generated
by the muscles, are both suitable signals to derive the motion intention of the adults
with DMD with very limited arm function and control active arm supports [30]. When
using force-based control it is crucial to accurately distinguish the voluntary forces from
the intrinsic forces of the arm such as gravity, inertia or stiﬀness forces. Especially
for persons with a severe muscle weakness the intrinsic forces of the arm have to
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be compensated. An alternative method is EMG-based control. Although the use
of muscle activity is less intuitive, the EMG signals are not aﬀected by the intrinsic
properties of the arm such as stiﬀness, and therefore directly represent the motion
intention of the user. On the other hand, disadvantages of EMG-based control include
the poor long-term signal. In [30] we found that while movements with the force-based
control were smoother and faster, EMG based-control was perceived as less fatiguing.
Madeline Corrigan gave an overview of the ReachABLE project, which is carried out
by the New Jersey Institute of Technology (NJIT). This project aims at developing a
wheelchair mountable admittance controlled arm support to increase independence
for activities of daily living for individuals with DMD. A proof-of-concept prototype has
been developed to demonstrate the feasibility of implementing force-based control with
motorized antigravity assistance to provided intuitive, compliant, and inherently safe
user control [31]. Force-based admittance control allows the minimization of the friction
and inertia that opposes the user’s movements, which decreases the overall force
required to control the device. Admittance control allows the intuitive use of residual
muscle strength to operate the device. The use of residual muscle strength has the
potential to reduce disuse atrophy and the development of contractures. Because
admittance control involves modelling the device as a small point mass, the device
can be tailored to the functional status of each individual. The mass can be decreased
as the strength of the user decreases over time to continue to allow control of the
device despite the change in muscle capacity. Conversely, the mass can be marginally
increased, as needed, to promote use of the muscle strength that remains in order
to promote use of residual strength that can potentially reduce disuse atrophy [31].
Musculoskeletal models have been widely used to investigate the upper-extremity
biomechanics. Musculoskeletal models can be implemented to objectively analyze
the interaction between the user and the arm support. The manufacturing of an upper-
extremity assistive device is an expensive process and patient-speciﬁc musculoskeletal
models hold a large potential for design optimization of such devices. By co-simulating
musculoskeletal model and orthosis dynamics, the properties of the orthosis can be
adjusted to obtain an optimal design to augment the residual capabilities of a speciﬁc
patient. However, to achieve this, a patient-speciﬁc model that takes into account the
properties of the musculoskeletal system, including the pathology, must be developed
and validated. Miguel Nobre Castro presented part of his work in which he modeled
the upper-extremity of a patient with idealized brachial plexus injuries (BPI), from which
paralyzed/atrophied muscles were known. This model contains 10 joints and 134
muscle-tendon units and by using inverse dynamic analysis internal forces (muscles
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and joint reactions) were estimated [32]. The co-simulation of the patient model with a
passive orthosis model was performed taking advantage of patient’s residual muscles
function during a ‘pick a cup and drink’ task. This study suggested that a BPI patient
with an idealized C7 nerve root lesion could be assisted by an orthosis whose set of
springs’ stiﬀness was optimized. Design optimization promotes experimentation and
design maturation before the manufacturing stage as long as the subject and orthosis
models are accurate. Clinical validation of these prototypes is mandatory to assess
the function of the orthosis under operating conditions.
Discussion and Future Actions
• The adoption rate of commercially available arm supports is low: There are
several potential reasons that limit the user’s acceptance of arm supports: current
devices have large dimensions, which compromises their attractiveness and they
do not provide enough support for the weaker users. It is important to determine
the variables behind the adoption or rejection of arm supports and how to weigh
those variables in the design and deployment process. There is a need of studies
that investigate which user requirements are not met. There is also a need to
incentivize the use of arm supports to preserve arm function.
• There is a need for evaluation of current arm supports. There are several arm
supports on the market and it is not clear what are the capabilities and limitations
of each of them. A quantitative and objective evaluation of the performance of
each arm support and their working principles could result in a set of guidelines
for choosing which arm support is the most suitable for a speciﬁc user.
• It is not clear whether users prefer wearable devices or devices that require
wheelchair attachment: Both wearable and wheelchair based devices present
advantages and limitations. Most of the commercially available devices are
wheelchair bound and new developments are focusing on wearable arm supports.
• A clear image of certiﬁcation and reimbursement in various countries is needed:
To get devices reimbursed, cost-beneﬁt studies are needed. Although it is
diﬃcult, quality of life and costs need to be justiﬁed. Such cost-beneﬁt studies
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are needed from both the individual using the device and their caregiver. One of
the challenges is to progress from anecdotal feedback to reliable statistics.
2.5 Emerging Avenues
Soft Robotics
Conor Walsh presented his vision on the next generation wearable robots, in which
he foresees use of soft materials such as textiles and elastomers to provide a more
conformal, unobtrusive and compliant means to interface to the human body [33–36].
These robots will augment the capabilities of healthy individuals (e.g. improved walking
eﬃciency, increased grip strength) in addition to assisting patients who suﬀer from
physical or neurological disorders. Various projects focus on the design, fabrication
and control principles that are required to realize these systems. An example is a
soft exosuit that can apply assistive joint torques to restore mobility of those with
physical disability [33, 34]. Advantages of this suit over traditional exoskeletons are
that the wearer’s joints are unconstrained by external rigid structures, and that the
worn part of the suit is light, which minimizes the suit’s unintentional interference with
the body’s natural biomechanics. There has been demonstrated that healthy subjects
required 7% less muscle activation when the used the exosuit. A second example
is the development of a soft robotic glove for hand rehabilitation that consists of a
wearable textile with attached elastomeric ﬂuid-powered actuators specially designed
to match the natural movements of the ﬁngers and thumb [35, 36]. A similar glove
is also being tested at usability in persons with muscular dystrophies. Part of the
technology is open source available via a Soft Robotics Toolkit.
Shell-based mechanisms
Just Herder shared his vision on the possibilities of compliant shell-based mechanisms
(or shell mechanisms for short), a class of mechanism between conventional linkage
based exo-robotic systems and soft robotics, in body support devices. Shell mecha-
nisms is the extension of the idea of statically balanced compliant mechanisms [37–39]
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into the third dimension in the form of spatially curved shells that are to be designed
for speciﬁed stiﬀness. This technology bears the promise of true exoskeletons that
could be wearable underneath regular clothing. This means that the functionality
of exo-robotic systems, which tend to be bulky and stigmatizing, needs to be ﬁtted
into a design space of around 10 mm around the body contour. Statically balanced
shell mechanisms are excellent candidates for achieving this challenging goal. Herder
his team is currently working in this direction by developing dimensional optimization
methods based on isogeometric analysis, and semi-automated graphical synthesis
methods. The initial results are promising although there are still challenges to be
overcome. Future developments include extension of shell-mechanisms to distributed
mechatronic systems where motion, actuation and sensing are distributed over the
surface of the shells.
Control modalities
Aldo Faisal gave an overview of the possibilities of eyetracking as control modality
for assistive devices. He explained that the pursuit of an eﬀective brain machine
interface holds the hope to enable patients with severe motor disorders to interact with
their surroundings. Diﬀerent approaches can be categorized as non-invasive cortical
interfaces (e.g. EEG), invasive cortical interfaces, e.g. implanted multi-electrode
arrays (MEA), or non-invasive and non-cortical interfaces (e.g. EMG). The clinical
aim, however, remains the same: to extract an intention signal from a patient, for
which conventional approaches such as joystick, mouse movement or sip and puﬀ
control are not possible. Present ‘assistive technology’ interfaces can serve most of its
possible users. Operating however is still as slow as 10-15 years ago (e.g. abundant
use of scan systems that almost always solve the problem, but inhibit speedy task
performance), not intuitive or too complex. The use of a combination of intention
signals for example eye movements and muscle activity has the potential to realize
fast and easy to learn control interfaces with a very little latency. Based on the idea
‘Seeing is moving’, Faisal and his collaborators applied an eye-tracking based control
interface into the control of a wheelchair. In the European project ENHANCE, similar
approaches are used to develop control interfaces for active arm and hand support
devices.
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Trunk, head and hand support
Bart Koopman and Arno Stienen presented some of the latest developments in trunk,
head and hand support devices. Persons with DMD often have instability of the trunk
and head leading to balance problems while sitting. Scoliosis is often present and
negatively aﬀects trunk posture. Control of trunk posture is not only essential for
respiration and to avoid swallowing problems, but also for optimal function of the arm
and for positioning of the head to make visual control of the arms possible. Arm support
enables persons with DMD to continue use of the arms and hand by being able to
position the hand in a larger area around the body. However, bringing the arm further
away from the body destabilizes trunk posture, which limits use of the arm support.
Given these problems, stabilization of the trunk is often necessary. However, this
currently involves restriction of the degrees of freedom of the trunk and hence arm/hand
function. In addition, current trunk stabilizing braces and supportive devices are often
uncomfortable, cause pain and induce respiratory problems, feeding problems, and
potentially pressure sores. New solutions are required that stabilize trunk and head
postures while allowing the user to choose postures that support optimal performance
of hand/arm activities. It is crucial that the assistance provided by devices is adapted
to actual needs of those with Duchenne. Too much help may have the price of adding
to muscle loss, so has to be titrated carefully. Beside the importance of adaptive trunk
and head support, adaptive support of hand function may be essential for persons
with DMD in late non-ambulatory. In order to realize such adaptive supports, control
of the device and minimal dimensions are important factors. A good understanding of
the progression of the weakness in diﬀerent muscle groups is needed to build better
devices. Biomechanical models may also be useful. It is however diﬃcult to develop a
kinematic model, so it is important to collect lots of date which is made available for
the community.
Discussion and Future Actions
• Are the expectations from robotic solutions realistic?: While emerging technolo-
gies are very attractive from a technical point of view, it is important to keep in
mind that there is a need for functional, robust and aﬀordable assistive devices.
The high rate at which these emerging technologies are advancing is a clear
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indication that there is global interest in developing better assistive devices that
can improve the quality of life of people with DMD.
• Share best practices, and things that did not work: A mailing list involving the
workshop participants and others interested, that is updated (with a résumé)
regularly, including new publications and products.
2.6 Conclusion
At the end of the workshop, John Porter and Just Herder gave a summary of the
workshop’s contents and chaired the discussion between the workshop’s participants.
The workshop addressed the user requirements, the current methods for the evaluation
of arm function, the commercially available arm supports, the current research projects
towards active arm supports, and emerging technologies that could be useful for the
future development of assistive technology for people with DMD. Based on these
discussions, six clusters of action points were identiﬁed. These are (a) identifying user
and caregiver needs and acceptance, (b) assess performance of user and caregiver
before and after ﬁtting of a device, (c) develop lab and ambulant testing metrics
and protocols, (d) gather data on use of device, (e) develop modular technology
and (f) work on accessibility and reimbursement in diﬀerent countries. These action
points were distributed over four focus groups, namely on (1) evidence based user
requirements and acceptance, (2) assessment protocols, (3) modular technology, and
(4) accessibility and reimbursement. The ambition of these groups is to accelerate
progress in these focus areas by coordinating cross-border research and development
eﬀorts and identify opportunities for governmental and industrial funding.
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Abstract
Objective: The aims of this review were 1) to provide insight into the natural course
of upper-extremity (UE) impairments and UE activity limitations associated with fa-
cioscapulohumeral dystrophy (FSHD) and limb-girdle muscular dystrophies (LGMD),
and 2) to provide an overview of outcome measures used to evaluate UE function and
activity in patients with FSHD and LGMD.
Methods: Scientiﬁc literature databases (PubMed, MEDLINE, EMBASE, CINAHL and
Cochrane) were searched for relevant publications. Inclusion criteria: 1) studies that
included persons with a diagnosis of FSHD or LGMD; and 2) studies that reported the
natural course of the UE functions and/or activity with outcome measures at these
levels.
Results: 247 publications were screened, of which 16 fulﬁlled the selection criteria.
Most studies used manual muscle testing (MMT) to evaluate UE function and the
Brooke Scale to evaluate UE mobility activities. The clinical picture of UE impairments
and limitations of UE activities in FSHD and LGMD patients was highly variable. In gen-
eral, FSHD and LGMD patients experience diﬃculty elevating their upper extremities
and the execution of tasks takes considerably longer time.
Conclusions: The clinical course of UE impairments and activity limitations associated
with FSHD and LGMD is diﬃcult to predict due to its high variability. Although measures
like MMT and the Brooke Scale are often used, there is a lack of more speciﬁc
outcome measures to assess UE function and UE capacity and performance in daily
life. Measures such as 3D motion analysis and EMG recordings are recommended
to provide additional insight in UE function. Questionnaires like the Abilhand are
recommended to assess UE capacity and accelerometry to assess UE performance
in daily life.
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3.1 Introduction
Muscular dystrophies encompass a group of more than 30 inherited myopathies that
are characterized by progressive muscle wasting and weakness. Patients with certain
forms of muscular dystrophy become symptomatic in infancy or childhood, whereas
others may not become symptomatic until middle age or later. Although the various
muscular dystrophies vary in their severity and progression, all types are generally
progressive, disabling over time. Upper-extremity (UE) function is often impaired
due to muscle weakness [1], which may result in limitations in daily activities and
fatigability [2]. However, little is known about the severity, course, and impact of UE
impairments and limitations. Facioscapulohumeral dystrophy (FSHD) and limb-girdle
muscular dystrophies (LGMD) are two types of muscular dystrophies in which loss
of UE function is prominently present. Both FSHD and LGMD are slowly progressive
and have a typical age of onset between 10 and 30 years of age[1]. FSHD is an
autosomal-dominant, slowly progressive form of muscular dystrophy and one of the
most common inherited muscular dystrophies with an estimated prevalence in the
general population of 1 : 21,000[3, 4]. It is characterized by initial signs of weakness in
the muscles of the face and shoulder girdle, but the pattern and severity of subsequent
muscle aﬄiction in FSHD are highly variable[5, 6]. LGMD comprises another group
of autosomal muscular dystrophies that primarily involve the pelvic and/or shoulder
girdle muscles. LGMD includes several sub-types with distinct rates of progression
of muscle weakness and patterns of activity limitations. The prevalence of sub-types
of LGMD in the population is highly variable, depending on geographical and ethnic
factors[7].
Currently, there is no cure for muscular dystrophies. However, treatment and man-
agement can consist of medication, surgery and/or rehabilitation services including
strength training, training of aerobic capacity or the use of aids and adaptations such
as arm supports to enable the performance of daily activities[8–10]. For the develop-
ment of eﬀective training programs for the UE, and innovative motion controlled arm
supports, a better understanding of the natural course of UE function and activity in
FSHD and LGMD is needed.
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The aims of this systematic review were 1) to evaluate the natural course of UE
impairments and UE activity limitations associated with FSHD and LGMD and 2) to
provide an overview of the outcome measures used to evaluate the natural course of
UE function and activity in FSHD and LGMD patients.
3.2 Method
Search strategy
A search of the PubMed, MEDLINE (1948 – 2013, week 40), EMBASE (1980 –
2013, week 40), CINAHL and Cochrane databases was performed using the MeSH
terms and free text words “fshd” OR “facioscapulohumeral” OR “limb girdle muscular
dystrophy” in combination with “upper extremity” OR “arm” OR “hand”. Potentially
relevant publications were also identiﬁed by manually searching through the citations
listed in the retrieved articles.
Selection criteria
Articles that contained an abstract and were written in English, Dutch, German or
French were included. Studies were selected when they 1) included participants with
a clinically or genetically conﬁrmed diagnosis of FSHD or LGMD and 2) reported the
natural course of UE functions and/or activities with outcome measures at these levels.
Studies were excluded in case the full-text article was not available or if UE function
was described as part of an intervention such as surgery, that would inﬂuence the
natural course following FSHD and LGMD, or might introduce a selection bias in the
research population due to the aim of the intervention.
Procedure
The ﬁrst author (AB) assessed the titles and abstracts and saved the references that
appeared to be relevant. In the case of doubt, the abstract was assessed by a second
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reviewer (EC) and the results were discussed until consensus was reached. The
two reviewers then decided whether to include or exclude each article based on the
detailed information contained in the full-text article. The ﬁrst author also scanned
the reference lists of the included articles to identify additional articles for potential
inclusion. Additional articles that fulﬁlled the selection criteria were retrieved for a
more detailed evaluation. Final inclusion or exclusion of each article was based on an
independent assessment by two reviewers (AB and EC).
Each study was evaluated on three domains of the International Classiﬁcation of
Functioning, Disability and Health (ICF) relevant to assess the use of the UE in daily
life [11]. These domains were UE functions (ICF b7), UE mobility activities (ICF
d440/d445) and self-care activities and domestic life activities (ICF d5/d6). For each
article, the study’s aim, design, inclusion and exclusion criteria, and the characteristics
of the participants (including age, gender and duration of symptoms) were recorded (if
reported) in addition to the outcome measures, results and conclusions (Tables 1 and
2).
3.3 Results
Selection of studies
Our search of the online databases yielded 247 articles (see Figure 1). After assessing
the titles and abstracts, 215 of these studies were excluded because the type of
participants and/or the outcome measures did not meet our predeﬁned criteria. The
full-text articles of the remaining 32 studies were retrieved and assessed for eligibility.
Of these 32 articles, one could not be accessed, and 19 did not meet the selection
criteria. A manual citation tracking search yielded an additional four articles. Thus,
the ﬁnal selection included a total of 16 articles.
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Figure 1: Flowchart showing the search and the inclusion and exclusion of articles
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FSHD
Studies and patients included In our search, 10 articles were identiﬁed that described
UE functions and/or activities in patients with FSHD, based on the description of eight
study cohorts (Table 1). These studies comprised a total of 272 patients (153 males
and 119 females). The mean ages of the patients in the studies were 36 to 59 years
(with a range from 13 to 80 years). The mean duration of symptoms was 17 to 38
years (with a range from 0 to 54 years), and the mean age at onset was 16 to 18 years
(with a range from 9 to 30 years).
Outcome measures Each study used outcome measures at the level of UE function.
Four of these studies also included measures at the level of UE mobility activities [16,
20, 28, 29], and two studies included outcome measures at all three levels[17, 20].
One study by Stübgen [20] also included follow-up measurements at all levels (Tables
1). To evaluate UE function, six of the studies performed manual muscle testing (MMT)
of 18-36 muscles [13, 14, 16, 18, 20, 28], a clinical evaluation method to grade the
strength of muscle groups [30]. Several studies assessed maximal isometric and
isokinetic muscle strength by measuring maximum voluntary contractions (MVC) force
[12–14, 19] and two studies measured grip strength and pinch strength by handheld
dynamometry [12, 14]. One study measured the passive range of motion in the joints
[28] and one study recorded half-fatigue time (deﬁned as the time interval between
maximum torque and half-maximum torque)[19]. With respect to outcome measures at
the level of activity, ﬁve of the studies used the Brooke scale[14, 16, 17, 20, 28], which
is a scale that ranges from 1 to 6 and is used to classify basic UE mobility activities
(a higher score indicating more severe limitation)[31]. One of the studies measured
the time required to complete a certain task[28]. One study used the Barthel Index
(BI)[32], a general Activities of Daily Living (ADL) score that ranges from 0 to 100 (with
a higher score indicating better ADL)[17], and one study used a modiﬁed BI in which a
higher score indicates poorer ADL performance[20].
UE function According to Brouwer et al.[12], the muscles that are most severely
aﬀected in patients with FSHD are the muscles that abduct the shoulder above 90º
(deltoid), the shoulder anteﬂexors (deltoid, pectoralis major and subscapularis) and
the shoulder extensors (deltoid and latissimus dorsi). The authors also indicated
that the extensor muscles are weaker than the ﬂexors, that the external rotators are
60 Chapter 3 Review on upper limb function and activity in FSHD & LGMD
more severely aﬀected than the internal rotators, and that the forearm muscles are
largely spared. Brouwer et al. [12] found that the wrist extensors and elbow extensors
are relatively strong in women compared to men. Kilmer et al.[28] concluded that,
compared to healthy controls, male patients show more severe muscle weakness than
female patients. On the other hand, the FSH-DY Group[13] reported no signiﬁcant
diﬀerence in the degree of muscle involvement between men and women. Several
studies reported asymmetric muscle strength; some studies indicated that the dominant
arm (or the mostly used arm) is the weaker arm[12, 17, 28]. Tawil et al.[14] found
that the right side of the body was usually weaker than the left side, but they found no
correlation with handedness. No consensus was reached among the various studies
with respect to the relationship between age and strength. For example, the FSH-DY
Group[13] found no signiﬁcant correlation between age and strength; the slow but
signiﬁcant progression of the disease over time was not associated with age, gender,
age at onset or the duration of symptoms. In contrast, Kilmer et al.[28] found a slow but
steady progressive decline in strength per decade of age, with the proximal muscles
being weaker than the distal muscles and the extensor muscles being weaker than the
ﬂexors. Similarly, the FSH-DY Group[13] and Kilmer et al.[28] found that an early age
of onset (under the age of 15 years) was associated with more severe weakness, and
the FSH-DY Group additionally concluded that patients with a relatively long duration
of symptoms (>20 years) tended to be more severely aﬀected.
UE mobility activities In ﬁve of the studies, the Brooke scale was used to evaluate
basic UE activities [14, 16, 17, 20, 28]. Combining the scores from four studies [16,
17, 20, 28] comprising a total of 68 participants, approximately 60% of the patients
scored either a 3 (unable to raise the hands above the head but able to raise a 250-ml
glass of water to the mouth) or a 4 (able to raise each hand separately to the mouth,
but unable to raise a 250-ml glass of water to the mouth). Only two of the participants
scored a 5, while none scored a 6. Kilmer et al. [28] also measured Timed Motor
Performance (TMP) and found that FSHD patients took 2 to 6 times longer to perform
a TMP task than healthy controls, but found no correlation of Brooke scores or TMP
tests with age or disease duration.
Self-care activities and domestic life activities Lue et al. [17] found an average BI
score of 97.8 + 4.7 (range: 85-100) in their patients. In their cohort, 80% (n=16) of the
patients had a maximum score of 100, meaning that they were completely independent.
In the same research group, they found a signiﬁcant correlation between BI and mean
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muscle strength, but no correlation between BI and age or disease duration [17, 18].
Also Stübgen et al. [20] found a correlation of BI with mean muscle strength and not
with age or disease duration.
LGMD
Studies and patients included Nine articles describing UE impairments and/or activity
limitations in patients with LGMD were identiﬁed by our search strategy (Table 3). Each
article described a prospective or cross/sectional cohort study, with a total of 270
patients, including 123 men and 81 women (one study including 66 patients did not
report gender [23]). The mean age of the included patients was 35 to 55 years (with a
range of 12-81 years), and the mean disease duration was 17 to 34 years. The age of
onset also varied widely and was dependent on the type of LGMD [23].
Outcome measures Eight of the studies reported outcome measures at the level of
UE function[16, 19, 21–23, 25–27], eight studies measured UE mobility activities [16,
18, 21–23, 25–27], and ﬁve studies included measures of self-care and domestic
life [18, 21, 25–27]. Four of the studies collected follow-up measurements [22, 23,
26, 27]. To evaluate UE function, seven studies manually tested 18-36 muscles [16,
21–23, 25–27], and two studies assessed maximal isometric and isokinetic muscle
strength by measuring MVC [19, 23]. One study measured grip strength and pinch
strength [23], and another study performed physical examinations to evaluate posture
and stability of the scapula [22]. Another study recorded half-fatigue time, which is
deﬁned as the time spent between maximum torque and half-maximum torque [19].
With respect to measuring outcome at the level of activities, seven studies used the
Brooke scale [16, 18, 21, 23, 25–27] [16, 18, 23, 25, 27-29], and one study used a
self-created six-points scale to measure basic activity [22]. One study measured the
time required to complete a given task [23]. Three studies used the original BI [25–27],
and two studies used a modiﬁed BI in which the scores were distributed among severity
categories [18, 21].
UE function Lue et al. [21] reported that LGMD is characterized by a progressive
symmetrical weakness of the limb girdle musculature. Mahjneh et al. [22] reported that
this weakness often remains mild in the UE, that proximal muscles are weaker than
distal muscles, and that UE muscle involvement typically lags behind the involvement
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of the lower limb girdle by several years (with a delay of approximately seven years).
McDonald et al. [23] found a progressive decline in muscle strength per decade of
disease duration. Stübgen et al. [26] found no changes in strength over a period of
six years, but found a signiﬁcant decline in UE muscle strength after ten years [27].
Because of these ﬁndings, Stübgen [27] concluded that the change in muscle strength
was independent of both patient age and the duration of the disease, but that the
change in muscle strength seemed to progress more rapidly in stronger patients. No
diﬀerences were found between the dominant and non-dominant sides [13, 16].
UE mobility activities Pooling the scores from ﬁve studies [16, 18, 21, 23, 25] with a
combined total of 225 patients revealed that 55% of the participants scored Brooke
scale 1-2, 30% scored a 3, and 15% scored 4-6. An exception is the patient group with
rapidly progressive autosomal recessive muscular dystrophy of childhood (ARMDC),
54% of whom scored Brooke scale 3 and 31% scored Brooke scale 4-6 [23]. Stübgen
et al. [26] found that 53% of the 19 patients in their follow-up study deteriorated by
at least one grade over six years, and this deterioration was not correlated with age,
disease duration or the degree of muscle weakness. In the next follow-up study,
Stübgen et al. [27] reported that eight out of 18 participants with LGMD lost at least
one functional grade over a decade, although none of the participants reached the
worst grade. Mahjneh et al. [22] used a diﬀerent scale to evaluate basic skills based on
six stages (with a higher stage indicating poorer performance). Most of their patients
scored a 3 or 4, meaning that they could ﬂex their arms when carrying a 1-kg weight
and abduct their arms to 90° when lifting a 2- or 1-kg weight (representing stages 3 or
4, respectively), and that they could abduct their arms to 180° when carrying a 1- or
0.5-kg weight, respectively. McDonald et al. [23] found that several of their patients
performed the TMP tests more slowly.
Self-care activities and domestic life activities In both studies by Lue, only one patient
was in the category of being totally dependent, approximately 30% of the patients
were moderately dependent, and 48% were completely independent [18, 21]. In the
follow-up studies conducted by Stübgen [26, 27], the activities of daily living (ADL)
scores did not change signiﬁcantly.
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3.4 Discussion
The aims of this systematic review were to get insight in the natural course of UE
impairments and activity limitations in FSHD and LGMD, and to provide an overview
of the used outcome measures.
In the current review, UE outcome measures were evaluated at two levels of the ICF:
the level of UE functions and UE activities namely mobility, and self-care and domestic
life activities. For the UE activities, capacity and performance can be evaluated.
Capacity describes an individual’s ability to execute a task or an action and performance
describes what an individual does in his or her current environment and [11].
To evaluate UE function in FSHD and LGMD patients, MMT is the most commonly used
method. Some authors argue that MMT is a rather subjective method for assessing
isometric muscle strength [19], whereas others claim that it is a valid and sensitive
measure of disease progression in patients with Duchenne muscular dystrophy [33]. In
current review, it was not possible to compare MMT results between various studies, as
most of the studies reported a composite score of strength instead of reporting scores
for the various UE muscle groups. The studies examined in this review used a variety of
methods, making comparisons diﬃcult and precluding the pooling of data from multiple
studies. Bakhtiary et al. [34], who investigated the eﬀect of motor learning, studied
UE muscle activity and movement patterns by using electromyography (EMG) rather
than MMT. These researchers found that EMG activity during a simulated drinking
task was higher in the FSHD group than in healthy controls. The muscle activity and
movement patterns in the FSHD group included more synergistic muscle activity and
more abduction and ﬂexion of the shoulder and elbow joints.
To evaluate the capacity of UE mobility activities, the Brooke scale is used in most
studies. As it is well standardized, it is more conducive to inter-study comparisons.
Although widely used, the Brooke scale may not be suﬃciently sensitive to measure
diﬀerences in UE capacity in slowly progressive neuromuscular diseases [33]. Indeed,
several studies have reported a decline of only one grade per decade [20, 27]. Rel-
atively few subjects had a Brooke score of 5 or 6, which is consistent with clinical
ﬁndings of problems with the proximal UEs only. Besides, the Brooke scale only
classiﬁes capacity of basic reaching activities of the arm and hand (ICF d4452). In the
64 Chapter 3 Review on upper limb function and activity in FSHD & LGMD
study conducted by Mahjneh [22], a self-created six-stage scale was used to evaluate
capacity of basic UE activities. However, most of the patients in this study were in
stage 3 or 4, which suggests that this modiﬁed scale is probably also not sensitive
enough to detect changes in the course of time. Speciﬁc measures to evaluate UE
capacities such as the Jebsen test [35] or patient reported questionnaires such as the
Abilhand [36, 37] and the Disabilities of Arm Schoulder and Hand (DASH) [38] have
not been used. Also measures to evaluate performance of UE activities in daily life are
lacking. Some studies have used the BI to assess capacity of self-care activities. This
index is, however, very general and does not speciﬁcally assess activity limitations
of the UEs. Stübgen [26] and Lue [18] reported a ceiling eﬀect when using the BI
to evaluate ADL in FSHD and LGMD patients. Measures that assess capacity of
domestic life activities were lacking as well as measures that assess performance of
self-care and domestic life activities.
A better understanding of UE impairments and activity limitations in patients with
muscular dystrophies such as FSHD and LGMD is needed to evaluate rehabilitation
interventions. Such understanding is also important for identifying the requirements for
developing innovative arm-support devices to restore and/or enhance the performance
of daily activities.
Study limitations
In current review, we found that some studies used the same subjects. In FSHD, the
subjects of the study of Tawil et al. [14] were also used in the study of the FSH-DY
group [13]. As for LGMD, the studies of Stübgen et al. [25–27] used the same group of
subjects and also the studies of Lue et al. [17, 18, 21] have included some of the same
subjects. Besides, no intervention studies were included to avoid a possible bias in
describing the natural course of UE functions and activities. Some of these intervention
studies may have included other measures to assess capacity or performance of UE
activities other than the measures that are described in this article.
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Conclusions and recommendations
This is the ﬁrst overview of UE functions and activities in FSHD and LGMD. The clinical
course of UE impairments and activity limitations associated with FSHD and LGMD
is diﬃcult to predict due to its high variability. An early age of disease onset may
be associated with more severe disease progression. However, no clear correlation
between strength, gender, age or duration of symptoms has yet been established.
In general, FSHD and LGMD patients experience diﬃculty elevating their upper ex-
tremities and the execution of tasks takes considerably longer. Hand function largely
remains intact. In the current review outcome measures to assess UE functions and
activities in patients with FSHD and LGMD included MMT to evaluate muscle function
and the Brooke Scale to evaluate UE capacity. There was however, a lack of speciﬁc
outcome measures to assess UE function and UE capacity and performance in daily
life. For additional and speciﬁc assessment of UE function, measures such as 3D
motion analysis and EMG recordings are recommended. Questionnaires like the
Abilhand are recommended to assess UE capacity and accelerometry to assess UE
performance in daily life. Such measures may also be valuable to evaluate the eﬀect
of interventions such as training with or without the use of supportive devices.
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Abstract
Objective: To investigate the upper extremity (UE) at the level of impairments and
related activity limitations and participation restrictions in people with facioscapulo-
humeral muscular dystrophy (FSHD).
Methods: The study was conducted using web-based questionnaires that were dis-
tributed amongst people with FSHD in the Netherlands. Eighty-eight respondents
started the survey, and 71 completed it. The questionnaires covered the dimensions:
Function, Activity and Participation of the International Classiﬁcation of Functioning
Disability and Health.
Results: More than 40% of the respondents experienced pain in one or both arms.
Increased pain and stiﬀness scores and longer disease duration were associated with
increased limitation scores. For basic activities, lifting the arm above shoulder-level
was most frequently reported as most limited, coherent with the clinical picture of FSHD.
Fifty percent of the respondents indicated restrictions at school, 78% at work and
more than 80% indicated restrictions whilst participating in sports, hobbies, household
activities and in romantic relationships.
Conclusions: This study has shown that alongside the well-known problem of lifting
the arms above shoulder-level, UE activities below shoulder height during vocational
and occupational activities are also problematic in patients with FSHD. Alongside
disease duration, pain and stiﬀness are associated with UE activity limitations.
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4.1 Introduction
Facioscapulohumeral dystrophy (FSHD) is an autosomal dominant, slowly progressive
type of muscular dystrophy, with an estimated prevalence of 1:21,000 [1–3]. FSHD is,
thus, one of the most common inherited muscular dystrophies with the ﬁrst signs of
weakness occurring in the muscles of the face and shoulder girdle [4]. Fatty inﬁltration
with loss of muscle ﬁbres gradually results in weakness of nearly all skeletal muscles
[5]. Despite the typical pattern of muscle involvement described in the literature [6],
the upper extremity (UE) impairments are highly variable among people with FSHD
with regard to both proximal and distal muscle weakness [7, 8]. In addition, no clear
correlations have been found between muscle strength and gender, age or duration
of symptoms [9]. Although the clinical picture of muscle weakness is variable, most
persons with FSHD experience activity limitations when elevating the arms above
shoulder-level [10, 11]. It is also known that the execution of many activities of daily
living (ADL) takes considerably longer in persons with FSHD compared to healthy
subjects [8, 11]. Most people with FSHD are unable to raise their hands above their
heads, but are able to bring their hands to their mouths. Hand function itself remains
largely intact [9]. Interestingly, increased muscular co-contraction has been observed
in the UEs of people with FSHD [5, 11], as well as enhanced electromyography activity
in the shoulder muscles during arm elevation movements [11].
To develop tailored training interventions and new supportive aids, it is not only im-
portant to better understand UE impairments and limitations in basic UE activities,
but also to obtain knowledge about limitations in more complex, instrumented UE
activities and restrictions in social participation. Currently, little is known about the
UE capacity and performance of daily activities in people with FSHD [9]. Hence, the
aim of this study was to obtain a better understanding of the UE impairments and
related limitations in activities and restrictions in participation in people with FSHD.
In a previous study of boys and men with Duchenne Muscular Dystrophy (DMD),
a web-based survey that consisted of a set of questionnaires covering all relevant
dimensions of the International Classiﬁcation of Functioning Disability and Health
[12] was used. The same web-based survey was used in this study. Based on the
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clinical picture of people with FSHD, it was hypothesised that especially activities
above shoulder-level would be limited, but also that several participation restrictions
would be present, independent of working above shoulder-level. In addition, it was
hypothesised that UE activity limitations would be associated with disease duration,
pain and stiﬀness.
4.2 Methods
Participants and procedure
A web-based survey (QuestionPro; Survey Analytics LLC, Seattle, USA) was designed.
This survey included questions concerning pain and stiﬀness, as well as items to
assess basic and daily (instrumented) UE activities. The survey was sent via the
Dutch patient organisation, ‘Spierziekten Nederland’, to their Dutch-speaking members
with FSHD in the Netherlands, in December 2011. The recruitment period was from
December 2011 until February 2012. Ethical approval was obtained from the local
Research Ethics Committee (Ethical Committee Arnhem-Nijmegen, 2008/341).
Outcomes
Outcomes were divided into four categories: (1) participant characteristics; (2) impair-
ments; (3) activity limitations; and (4) participation restrictions.
Participant characteristics
The participant characteristics that were assessed were: age, age of diagnosis, disease
duration, hand preference, wheelchair conﬁnement and use of assistive devices for
the arms. For the analyses, the originally-preferred arm was used.
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Impairments
The questions on pain and stiﬀness were adapted from the University of Michigan
Upper Extremity Questionnaire [3, 13]. Both pain and stiﬀness scores were divided into
the aspects frequency (range: 0-6, with the higher the score, the higher the frequency),
severity (range: 0-10, with the higher the score, the more severe) and disablement
due to pain or stiﬀness (range: 0-10; with the higher the score, the more disabling).
Combination scores were calculated for each part of the arm, by taking the sum of the
three aspects (range: 0-26). A similar approach was used previously in the study of
Janssen et al. [12]. Along with the scores for each segment of the arms, total sum
scores for both the right and left UE were calculated (range: 0-182). For each segment,
percentages of respondents that experienced pain and stiﬀness (combination score >
1) in either the right or left UE were determined.
Activity limitations
The Brooke scale [14] was used to classify UE activity, the Capabilities of Upper
Extremity Questionnaire (CUE) [15] was used to assess basic UE activities and the
ABILHAND-plus [16] to assess UE capacity to perform daily activities. The CUE
contains 17 items (of which 15 one-handed, scored on both right and left arm and 2
two-handed), yielding in 32 scores with a seven-point scale (1 = unable to perform, 7 =
can perform without diﬃculty). The CUE questionnaire in this study had 16 items in total,
because the item ‘hold a hammer’ was missing. The ABILHAND-plus questionnaire
contained 26 items (22 items that were described by Vandervelde et al. [16], and four
additional items that were indicated as important by boys with DMD [12] that were
scored on a three-point scale (0 = impossible, 1 = diﬃcult, 2 = easy). Participants
were also asked to select the ﬁve items that were most important to them and to report
the activities in daily life that caused most problems due to UE impairments or activity
limitations.
Participation restrictions
To assess the level of participation, a set of open questions was used. Respondents
were asked if they went to school, had a job, practiced sports, had hobbies, participated
in household activities, performed activities with friends and/or were in a romantic
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relationship. Respondents who reported that they participated in a speciﬁc role, were
asked if they were restricted due to UE impairments or activity limitations.
Statistical analysis
The mean and standard deviation was calculated for age, age of diagnosis and disease
duration. Because not all data were normally distributed, we used non-parametric
statistics. The median and inter-quartile ranges (IQR) of the pain and stiﬀness combi-
nation scores and of the Brooke, CUE total, CUE right/left and ABILHAND-plus scores
were determined. Moreover, the percentages of respondents that reported a CUE
activity to be very, extremely, or totally limited, the percentages of respondents that
reported an ABILHAND-plus activity to be diﬃcult or impossible, and the percentage of
respondents that mentioned an ABILHAND-plus activity as important were calculated.
Answers to the open question “What are the most important problems you encounter
in daily life due to limitations in your arms and/or hands?” were categorised. The
activities that restricted the performance of speciﬁc social roles were determined and
categorised for each of these roles.
Wilcoxon signed rank tests were used to compare diﬀerences in pain, stiﬀness and
CUE scores between the right and left UEs and between the preferred and non-
preferred UEs. Spearman rho correlation coeﬃcients of the pain, stiﬀness, Brooke,
CUE and ABILHAND-plus scores with disease duration and age were calculated, as
well as Spearman rho correlation coeﬃcients of CUE and ABILHAND-plus scores
with the Brooke scale. Finally, backward multivariate linear regression analyses were
performed to determine the eﬀect of disease duration (in years), pain and stiﬀness
on basic arm activities measured with the CUE. All statistical analyses were carried
out using IBM SPSS Statistics Version 20 for Windows (IBM®, Somers, USA). If a
participant did not fully complete the survey, all completed items were included in the
analysis.
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4.3 Results
Participant characteristics A total of 88 respondents began the survey, of whom, 71
(81%) completed it. As a result, the number of respondents varied between the diﬀerent
domains of the questionnaires (see tables). The mean age of all respondents (N=88)
was 51.1±14.8 years, the mean age of diagnosis was 32.0±16.0 years and the mean
disease duration was 19.1±13.1 years. The percentage of participants with FSHD that
were completely wheelchair conﬁned was 17.6%. The same percentage (17.6%) of
participants used some form of arm support.
Impairments
Seventy-one participants (81%) were right-handed. Ten participants (11%) reported
that they switched their preferred arm (nine from right to left, and one from left to
right). The median pain and stiﬀness scores of the right UE were generally higher
than of the left UE. However, these diﬀerences were far from statistically signiﬁcant
for the shoulder and arm (P>0.5). For the wrist (p=0.04), thumb (p=0.06) and ﬁngers
(p=0.08) the diﬀerences were (nearly) signiﬁcant. The overall pain combination score
was signiﬁcantly higher for the right arm (p=0.03). The overall stiﬀness combination
score did not reach statistical signiﬁcance for the left-right-diﬀerence (p=0.06). When
the preferred arm was considered, no signiﬁcant diﬀerences were found between the
summed pain and stiﬀness scores of both arms (respectively p=0.25 and p=0.31). Pain
was most severe in the shoulders and upper arms. The percentage of respondents
that experienced pain (combination score higher > 1) in one or both arms varied
between 43.9% and 89.0% percent for the diﬀerent segments (Table 1). The overall
pain score correlated with disease duration (rs=-0.28, p=0.01), but not with age (rs
=-0.09, p=0.45). Stiﬀness was also most severe in the shoulders and upper arms.
The percentage of respondents that experienced stiﬀness in one or both arms varied
between 40.3% and 66.2% percent for the diﬀerent segments (Table 1). No signiﬁcant
correlations were found between stiﬀness scores and disease duration or age.
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Table 1: Pain and stiﬀness scores (range 0–26) of various upper extremity segments, as
reported by people with FSHD.
Pain N Combination scores(median right arm / median left arm)
Respondents who experienced
paina (%right arm / %left arm)
Shoulders 80 11.0 / 10.0 (p=0.67) 89.0 / 82.9
Upper arms 80 9.0 / 7.5 (p=0.52) 74.4 / 73.2
Elbows 80 1.5 / 0.0 (p=0.78) 51.2 / 43.9
Forearms 80 3.0 / 3.0 (p=0.58) 58.5 / 52.4
Wrists 80 4.0 / 3.0 (p=0.04) 57.3 / 54.9
Thumbs 80 1.5 / 0.0 (p=0.06) 50.0 / 43.9
Fingers 80 2.0 / 0.0 (p=0.08) 51.2 / 46.3
Whole arm 80 39.0 / 31.5 (p=0.03)
Stiﬀness N Combination scores(median right arm / median left arm)
Respondents who experienced
stiﬀnessb (%right arm / %left arm)
Shoulders 75 9.0 / 9.0 (p=0.51) 66.2 / 64.9
Upper arms 75 6.0 / 6.0 (p=0.39) 58.4 / 59.7
Elbows 75 0.0 / 0.0 (p=0.25) 40.3 / 40.3
Forearms 75 0.0 / 1.0 (p=0.60) 45.5 / 45.5
Wrists 75 2.0 / 1.0 (p=0.11) 50.6 / 46.8
Thumbs 75 2.0 / 1.0 (p=0.04) 50.6 / 48.1
Fingers 75 2.0 / 1.0 (p=0.13) 50.6 / 49.4
Whole arm 75 35.0 / 31.0 (p=0.06)
aPain combination score >1
bStiﬀness combination score >1
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Activity limitations
The median Brooke scale was 2 (IQR 2-3). The Brooke scale (rs = 0.43, p<0.01) and
the CUE score (rs=-0.37, p<0.01) correlated with disease duration, but there was no
correlation between disease duration and the ABILHAND-plus sum score (rs=-0.11,
p=0.35). No signiﬁcant correlations between Brooke, CUE and ABILHAND-plus scores
for age were found. The Brooke scale signiﬁcantly correlated with the CUE score
(rs=-0.48, p<0.01) and the ABILHAND-plus score (rs=-0.31, p<0.01).
The median CUE total score was 155.5 (IQR 117.8-176.3), which was 70% of the
maximum possible score. The median of both the CUE right and CUE left score was
75.0 (73% of the maximum possible score). Wilcoxon Signed-Ranks Tests indicated
that the CUE right score was signiﬁcantly lower than the CUE left score (p=0.02) and
that the CUE score of the preferred arm was lower compared to the non-preferred
arm (p=0.03) (Table 2). However, the medians of the CUE right/left scores as well as
the CUE preferred/non-preferred scores were equal, indicating a minimal scale of the
diﬀerence. The percentage of respondents that reported CUE activities being very,
extremely or totally limited was higher for the items considering the right arm as for
the left arm items.
The median ABILHAND-plus sum score was 44.0 (IQR 35.0-50.5), which was 84%
of the maximum possible score. The three activities that were most often indicated
as diﬃcult were ‘buttoning up a shirt’ (56%), ‘taking the cap of a bottle oﬀ’ (47%)
and ‘fastening the zipper of a jacket’ (44%). The three activities that were most often
reported as important were ‘using the keyboard of a computer’ (66%), ‘using a knife
and fork” (52%) and ‘fastening the zipper of a jacket’ (45%) (Table 2).
Multivariate regression analysis for the right arm revealed that the time since diagnosis,
pain and stiﬀness explained 34% of the variance of the CUE. For the left arm these
factors explained 40% of the variance. Table 3 shows that for both arms, pain, stiﬀness,
and disease duration were all independently associated with limitations in basic UE
activities as assessed with the CUE.
The answers to the open questions revealed that reaching for and lifting of objects
above shoulder level caused most problems, followed by personal care and carrying
objects (Table 4).
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Table 2: Upper extremity activity limitations measured with the CUE and ABILHAND-plus, as
reported by people with FSHD.
N Median (IQR)
Brooke scale 76 3 (2-3)
CUE score total (max score = 210) 74 155.5 (117.8-176.3)
CUE score right (max score = 98) 74 75.0 (55.5-84.0)
CUE score left (max score = 98) 74 75.0 (59.5-85.0)
CUE score both (max score = 14) 74 6.0 (3.8-8.3)
ABILHAND-plus score (max score = 52) 73 44.0 (35.0-50.5)
CUE N
% respondents that answered the activity
to be very, extremely or totally limited
(right / left / both arms)
Reach forward at shoulder-level 74 41.9 / 36.5 / *
Arms over head 74 79.7 / 73.0 / *
Reach to the ﬂoor 74 39.2 / 36.5 / *
Raise a ﬁve pound object over the head 74 * / * / 62.2
Slide a light object towards you 74 10.8 / 9.5 / *
Slide a ten pound object towards you 74 40.5 / 37.8 / *
Slide a light object away from you 74 12.2 / 8.1 / *
Slide a ten pound object away from you 74 37.8 / 29.7 / *
Push up in chair 74 * / * / 58.1
Curl wrist upward 74 18.9 / 13.5 / *
Supination 74 14.9 / 8.1 / *
Hold a hammer
Pick up a small object with thumb and ﬁrst two ﬁngers 74 14.9 / 10.8 / *
Hold a small object between thumb and index ﬁnger 74 13.5 / 8.1 / *
Hold/open a two pound object with the tips of the ﬁngers 74 25.7 / 20.3 / *
Manipulate a small object with the ﬁngers 74 17.6 / 12.2 / *
Push a button with tip of the index ﬁnger 74 9.5 / 5.4 / *
ABILHAND-plus N Diﬃcult or impossible (%)a Important (%)b
Take the cap oﬀ a bottle 73 46.6 24.7
Cut nails 73 38.4 21.9
Button up a shirt 73 56.2 38.4
Fasten the zipper of a jacket 73 43.8 45.2
Turn a key in a keyhole 73 21.9 37.0
Fasten a snap e.g. from jacket or bag 73 32.9 16.4
Open a pack of chips 73 31.5 2.7
Open a pack of biscuits 73 31.5 5.5
Insert a key in keyhole 73 20.5 41.1
Turn oﬀ a tap 73 21.9 35.6
Turn on a tap 73 21.9 37.0
Fill a glass with water 73 17.8 19.2
Sharpen a pencil 73 17.8 2.7
Open a lunch box 73 21.9 4.1
Squeeze toothpaste onto a toothbrush 73 15.1 20.5
Spread butter on a slice of bread 73 17.8 37.0
Open a toothpaste tube 73 21.9 12.3
Count banknotes 73 20.5 8.2
Handing out cards 73 28.8 8.2
Unwrap a chocolate bar 73 16.4 4.1
Dry hands 73 15.1 17.8
Wash hands 73 16.4 32.9
Eat with a spoon 73 28.8 27.4
Use knife and fork 73 38.4 52.1
Drink a glass of water without straw 73 24.7 42.5
Use keyboard of a computer 73 27.4 65.8
ABILHAND-plus=measure to assess UE capacity to perform daily activities, Brooke scale=measure to
classify UE activity, CUE=measure to assess basic UE activities, IQR=Inter Quartile Range, *=not applicable.
a Percentage of respondents who answered the activity to be diﬃcult or impossible.
b Percentage of respondents who identiﬁed the activity to be important. Respondents were asked
to identify the ﬁve most important activities.
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Table 3: Variables independently associated with limitations in basic upper extremity activities
as assessed with the CUE based on linear multivariate regression analyses.
Beta Standard error P value 95% CI
CUE Right arma
Duration -0.67 0.15 <0.01 -0.98 – -0.36
Pain right -0.14 0.06 0.03 -0.27 – -0.02
Stiﬀness right -0.10 0.05 0.07 -0.21 – 0.01
CUE Left armb
Duration -0.63 0.13 <0.01 -0.90 – -0.37
Pain left -0.16 0.06 0.01 -0.27 – -0.05
Stiﬀness left -0.09 0.05 0.07 -0.19 – 0.01
aR2=0.34
bR2=0.40
Table 4: Most limited upper extremity activities as reported by people with FSHD (N=73)
%a
Reach / lift objects above shoulder level 45
Personal care activities 32
Carry objects 26
Eat / drink 19
Get dressed 19
Prepare food / household tasks 12
Using the computer / use telephone / write 11
Open cans / bottles 7
Use the toilet 3
Percentages of respondents who mentioned the activity when asking the
open question "What are the most important problems you encounter in
daily life due to limitations in arms and/or hands?"
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Participation restrictions
Table 5 shows the percentage of respondents that reported participation restrictions, as
well as the UE activities they experienced as most limited within diﬀerent participation
domains. Of all respondents, 11% went to school, 51% had a job or did voluntary work,
30% participated in sports, 94% had a hobby, 75% participated in household activities,
and 81% had a romantic relationship. Fifty percent of the respondents indicated
restrictions at school and 78 percent reported restrictions at work. More than 80%
indicated restrictions, whilst participating in sports, hobbies, household activities and
in romantic relationships. Carrying study materials, using a computer and household
activities above shoulder height, (such as cleaning windows and hanging laundry)
were speciﬁc activities that were reported as limited in at least 25% of the participants,
who were involved in respectively school, work and household activities.
4.4 Discussion
To the best of the researchers’ knowledge, this is the ﬁrst study to explore upper
extremity (UE) pain, stiﬀness, activity limitations and related participation restrictions in
people with facioscapulohumeral muscular dystrophy (FSHD) [9]. The most important
result is the frequent presence of pain and stiﬀness in the shoulders and upper arms,
which was associated with UE activity limitations as assessed with the CUE. Besides
pain and stiﬀness, time since diagnosis was independently associated with basic UE
activity limitations. Together, these factors explained a substantial amount of the CUE
variance (34-40%). The top three activities that were most often reported as being
limited were: ‘use of computer keyboard’, ‘use of knife and fork’, and ‘fastening zipper
of jacket’. Half of the respondents indicated restricted participation at school in relation
to UE activity limitations, 78% indicated restrictions at work and more than 80% whilst
participating in other social roles.
With regard to pain and stiﬀness, it is well known that reaching upwards causes
increasing diﬃculty in people with FSHD, when muscle weakness progresses [9, 10].
The most often applied strategy is making a ballistic movement of the arm, by means of
the trunk muscles, through which the arm is ‘thrown upwards’. This rapid compensatory
82 Chapter 4 Upper limb function and activity in people with FSHD: a survey
Table 5: Participation restrictions related to speciﬁc upper extremity activity limitations as
reported by people with FSHD
Participation domain %a %b Activities most often reported as limited N %c
School 11.0 50.0 Carrying study materials 2 25
(N= 73) Typing 1 13
Writing 1 13
Work 50.7 78.4 Using computer 13 35
(N= 73) Writing 8 22
Carrying 6 16
Reaching high 5 14
Other activities 4 11
Sports 30.1 86.4 Cycling 5 23
(N= 73) Swimming 2 9
Physical therapy / ﬁtness 2 9
Other activities 10 45
Hobbies 94.4 80.9 Sports / physical exercise 16 24
(N= 72) Crafts 7 10
Gardening 6 9
Using computer 6 9
Playing piano 5 7
Photographing 5 7
Other activities 9 13
Household 75.0 92.6 Window cleaning / hanging laundry 16 30
(N= 72) Ironing / dish washing 6 11
Vacuuming / mopping 5 9
Carrying 4 7
Other activities 29 54
In romantic relationship 80.6 81.0 Walking 14 24
(N= 72) Shopping 11 19
Entertainment / travel 10 17
Sexuality 4 7
Other activities 20 34
a Percentage of respondents that participated in this social domain,
b Percentage of respondents that suﬀered from upper extremity activity limitations, whilst
participating in this social domain,
c Percentage of the respondents participating in this social domain that experienced upper
extremity activity limitations in speciﬁc items.
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movement may easily lead to overburdening or even micro-damage of structures in
and around the shoulder, which in turn, may explain the pain and/or stiﬀness scores of
this body segments.
A diﬀerence was found between the right and left arm with regard to the prevalence of
pain complaints (medians 39.0 vs 31.5, p=.003). Because the majority of people is
right-handed, this right/left diﬀerence may be explained by slight overuse of the right
arm. When arm preference was however considered, no side diﬀerence between the
pain scores was found when comparing the preferred and non-preferred arm. This
could indicate an asymmetric involvement of the disease that is independent from
arm preference. This would be consistent with the results presented by Rijken et al.,
who demonstrated more fatty inﬁltration on the right body side compared to the left
independent of arm preference, in 70 patients with FSHD, using computed tomography
(CT) scans [6]. The presented results did not show a clear side diﬀerence in limitations
of basic activities (measured with the CUE).
Activities, such as sliding an object over a table and manipulating a light object with
the ﬁngers, were less diﬃcult, probably, because these types of activities make less
use of proximal muscles. However, a striking ﬁnding was the large percentage of
participants that reported diﬃculties with desk-based activities, such as writing or using
a computer. One explanation for this ﬁnding may be that the participants performed
these activities without proper ergonomic positioning, whilst using their weakened arm
and shoulder muscles too much. Another explanation could be that these activities are
often performed over a longer time period, inducing muscle fatigue. Both explanations
would support a rehabilitation strategy, in which the arms are supported by (adaptive)
arm supporting devices during desk-based activities.
Both the Brooke and the CUE score were moderately (rs = 0.43 and rs = -0.37,
respectively) correlated with disease duration. This is to be expected, as both scales
assess the ability to lift the arms, which is a major problem for many persons with
FSHD. In contrast, no correlation was found between the disease duration and the
ABILHAND-plus. This can be explained by the fact that most activities assessed by
the ABILHAND-plus involve a combination of arm and hand use, in which people
can apply compensation strategies in order to succeed. It is also possible that the
ABILHAND-plus is less sensitive to ‘minor’ activity limitations than the CUE, since the
CUE contains questions aiming at basic activities with the arm or hand only. At the
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impairment level, only pain was associated with disease duration, but this association
was only weak (rs = -0.28), suggesting a more indirect relationship between pain and
progression of muscle weakness.
The mean age was 51 years, which clariﬁes that a low percentage of the respondents
indicated going to school (11%) and a higher percentage indicated having work (51%).
The total percentage of respondents who indicated participation in either school or
work was 62%. It is possible that some respondents don’t participate in a given domain
at all due to limitations, although they would like to. In fact, it’s likely that they are
most restricted. The actual percentage of restrictions may therefore be higher than
presented in this study.
Study limitations
81% of all respondents that started the survey, also completed the survey which may
have caused bias. Since the questionnaire was send not only by email, but also via
a link in a public digital newsletter, it is unknown how many persons received the
invitation. This may also have caused bias. Such response bias may have obscured
the experiences of either more severely or less severely aﬀected persons. Moreover,
the results of this study are based on a survey among the Dutch population with FSHD.
Because the standards of care are relatively high in the Netherlands, generalisation of
these results to FSHD patients in other countries requires caution. Another limitation
of this study is that the gender distribution of the respondents remained unknown. The
applied questionnaire was originally designed for people with DMD. Since DMD is
extremely rare in women, gender was not questioned. Erroneously, this adjustment
was not corrected in the current study. The results of this study provide little information
about young persons with FSHD. Both the mean age of the study sample and the
mean age of diagnosis were relatively high compared to other studies (Bergsma, Cup
et al. 2014). Only one participant was younger than 18 years. One explanation could
be that children and teenagers do not yet experience severe UE activity limitations or
do not want to be confronted with these limitations by participating in this survey.
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Recommendations
For future studies in patients with FSHD, a set of measures including the Brooke
classiﬁcation, pain and stiﬀness questionnaires and the CUE are recommended. In
addition, a patient-centred participation scale, such as the Canadian Occupational
Performance Measure (COPM) should be considered, to provide more insight in
patient speciﬁc limitations. To evaluate the eﬀects of individually tailored exercises
and supportive devices, objective measures are recommended, that provide also
quantitative kinematic and electromyography parameters. Such measures include e.g.
3D-kinematic movement analysis [17] and the use of accelerometry to assess actual
motor performance activities in daily life [18].
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Abstract
Objective: The aim of this study was to compare FSHD subjects with healthy controls
during the performance of standardized UE tasks.
Methods: Eleven subjects with FSHD and eight healthy controls were measured.
Kinematic data were recorded using a 3-dimensional motion capturing system. Muscle
activities, recorded using electromyography, were obtained from 6 superﬁcial muscles
around the glenohumeral joint. Shoulder elevation and elbow ﬂexion angles, and max-
imum electromyographic activity during the movements as a percentage of maximum
voluntary contraction (MVC) were calculated.
Results: Kinematic diﬀerences between the FSHD group and the healthy control group
were found in the shoulder elevation angle during single shoulder movements and both
reaching tasks. In general, subjects with FSHD had higher percentages of muscle
activation. The median activity of the trapezius was close to the MVC activity during
the single shoulder movements. Moreover, deltoid and pectoralis muscles were also
highly active.
Conclusions: Higher activation of the trapezius in subjects with FSHD indicates a
mechanism that could help relieve impaired shoulder muscles during arm elevation
around shoulder height. Compared with healthy subjects, persons with FSHD acti-
vated their shoulder muscles to a greater extent during movements that required arm
elevation.
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5.1 Introduction
Muscular dystrophies, although varying in type and severity, are more or less progres-
sive and disabling in time [1]. Some forms of muscular dystrophy become symptomatic
in infancy or childhood, whereas others do not become symptomatic until middle age
or later. Facioscapulohumeral dystrophy (FSHD) is an autosomal dominant, slowly pro-
gressive type of muscular dystrophy. It is one of the most common inherited muscular
dystrophies, with an estimated prevalence of 1:21,000 [2, 3]. In FSHD, the ﬁrst signs
of weakness are in the muscles of the face and shoulder girdle [4, 5]. Weakness of the
shoulder girdle muscles results in impairment of arm function, including movements
above shoulder level [5] and limitations in performing daily activities [6]. When persons
have weakened shoulder girdle muscles and move their arms to carry out daily tasks,
contraction of the relatively spared shoulder girdle muscles results in protraction and
medial rotation of the scapula. The inferior angle of the scapula tends to rotate medially
and the scapula separates from the ribcage. This so-called scapular winging is most
apparent in UE abduction, but can be also found in UE forward ﬂexion [7]. When
healthy subjects achieve full range of shoulder motion, upward rotation and elevation
of the scapula takes place [8, 9]. In contrast to healthy subjects, persons with FSHD
cannot rotate the scapula laterally and are therefore unable to achieve full range of
shoulder motion. Furthermore, because of a decreased acromiohumeral space, there
is an increased risk of impingement.
Persons with FSHD have an increased impingement risk due to the use of compen-
satory movements, such as ballistic movements, in order to lift the upper arm and
overcome the lack of strength of the scapular stabilizing muscles and ultimately to
rotate the scapula. Innovative arm supports may help persons with FSHD to perform
arm activities that would cost considerable eﬀort or possible damage. In order to
develop such support systems, knowledge of UE kinematics and muscle activity in
FSHD is needed.
Several studies have focused on quantifying UE movements with diﬀerent techniques.
Basic arm function in FSHD has often been quantiﬁed using the Brooke scale [10–13],
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which is an observational scale ranging from 1 to 6 (a higher score indicates more
limitation in arm function). More speciﬁc knowledge concerning muscle activity is
conﬁned mainly to manual muscle testing (MMT) of muscle groups during performance
of joint movements such as elbow ﬂexion [6, 10, 12, 13]. Some studies present MMT
scores of muscle groups instead of overall scores only [10]. However, the strength of
an individual muscle can hardly be measured, and using MMT provides very limited
knowledge on the coordination between muscles. Coordination of UE muscles during
reaching tasks has mostly been studied in healthy elderly persons [14, 15] and those
who have experienced a stroke [16, 17]. Only one study to date has described UE
kinematics and muscle activation in FSHD [18]. In that study, the movement and
muscle activity of the biceps brachii, triceps and deltoid of a group of persons with
FSHD were described during a simulated drinking task and were compared with a
group of healthy controls. The pattern of muscle activity and movement in the FSHD
group during the simulated drinking task involved more co-contraction of muscles
and more abduction and ﬂexion of the shoulder and elbow joints compared to the
movement pattern of healthy controls(14). Electromyography (EMG) activity as a
percentage of the maximum voluntary contraction (%MVC) was also higher in the
FSHD group compared to healthy controls. Bakhtiary et al. [18] also hypothesized that
individuals with FSHD have fewer intact muscle ﬁbers and will therefore recruit a higher
percentage of the remaining muscle ﬁbers to perform tasks. The study of Bakhtiary et
al. [18] provided the ﬁrst knowledge of the arm function in FSHD during one daily task.
However, muscles that are responsible for stabilizing the scapula were not investigated.
The aim of the current study is to gain a deeper understanding of shoulder and elbow
movements in FSHD. The purpose is to investigate the kinematics of the UE and the
involvement of speciﬁc proximal muscles during singular joint movements, reaching
tasks and gross motor tasks in persons with FSHD and healthy controls.
5.2 Method
Participants
Eleven persons with FSHD (four male, seven female, mean age 33.9±11.5, 10 right
dominant, one left dominant) and eight healthy volunteers (ﬁve male, three female,
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Table 1: Tasks that were executed by the participants
Movement Instructions Start
position
End
position
Single joint movements
Shoulder
abduction-
adduction
Move the arm sideward/upwards as far as possible and move
the arm back to the start position. Keep the arms straight and
the hand palm facing forward.
Shoulder
ﬂexion-extension
Move the arm forward/upward as far as possible, then bring
the arm back to the start position. Keep the arm straight, with
the hand palm facing inward.
Reaching tasks
Reach up
ipsilateral
• Active protraction
scapula
Reach toward the target at shoulder height on the ipsilateral
side.
Reach up
contralateral
• Active protraction
scapula
Reach toward the target at shoulder height and 1 shoulder
width on the contralateral side.
Gross motor tasks
Bring the hand to
the mouth
• Active ﬂexion
• Active supination
• Passive pronation
Bring the ﬁngers of the hand to the mouth and back to the
start position onthe table top. Wrist about 20cm in front of
abdomen.
Pushing-pulling Push the object as far as possible forward from the starting
position withoutmoving the chest and then pull it back. Use
the lateral edge of the object as reference to follow a line on
the table put at 1 shoulder width from themiddle.
NOTE. Not all participants were wheelchair bound; the ﬁgures are intended only for illustrative purposes.
mean age 49.9±9.8, all right dominant) participated in the study. The dominant side
was tested in all persons. All persons gave written informed consent. None of the
healthy participants had a history of musculoskeletal or neurological problems. Persons
with FSHD were recruited by an invitation letter from the Dutch patient organization
of persons with muscle diseases (Spierziekten Nederland). All persons with FSHD
scored a 2-3 score on the Brooke scale [19], which meant that they were able to raise
a 250 ml glass of water to the mouth. Subjects were excluded if they had suﬀered
from previous upper limb trauma (e.g. bone fractures or surgery). Ethical approval
was obtained for the study (Ethical Committee Arnhem-Nijmegen, NL39024.091.11),
and the study was conducted in accordance with guidelines of the Helsinki protocol.
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Table 2: MVC starting positions and instructions
Muscle Start Position Instruction
Biceps brachii 90°elbow ﬂexion, palm facing upward. Examiner takes
the hand and provides resistance to resist elbow joint ﬂex-
ion.
Flex the elbow as hard as
possible, against the examiner’s
hand.
Deltoid (lateral part) 45°of shoulder abduction and extended elbow. The exam-
iner holds the arm and resists abduction of the shoulder.
Abduct the arm against the
force generated by the
examiner’s hand.
Triceps brachii 90°elbow ﬂexion and 90°abduction. The examiner sup-
ports the elbow and holds the wrist, to resist elbow joint
extension.
Extend the elbow against the
examiner’s hand.
Trapezius (upper part) Arms hanging vertically beside the trunk. The examiner’s
hands are placed on top of the shoulders, to prevent up-
per arm elevation.
Elevate both shoulders, against
the examiner’s hands.
Pectoralis major
(clavicular part)
Upper arm abducted 90°and the elbow ﬂexed in 90°. One
hand of the examiner supports the forearm, while the
other hand is used to resist adduction and ﬂexion of the
shoulder in the horizontal plane.
Flex the upper arm against the
hand of the examiner at the
upper arm.
Latissimus dorsi 90°shoulder abduction, 90°elbow ﬂexion, and external ro-
tation of the upper arm. One hand of the examiner sup-
ports the elbow to resist adduction of the shoulder, while
the other hand is used to keep the wrist in position.
Adduct the upper arm.
Data recording
All assessments were performed using a standardized protocol at a motion analysis
laboratory (Maastricht University, The Netherlands). The movements were recorded
with an eight Vicon MX camera system (Oxford Metrics Group, UK) operating at a
frequency of 200 Hz, and the data were ﬁltered using spline-interpolation (Woltring,
1995). Reﬂective markers were attached on the subject’s body following the guidelines
of the Upper Limb model [20] (Figure 1). Because the scapula rotates underneath the
skin, it is hard to detect rotation and tilting of the scapula with this method.
The movement protocol consisted of two single joint movements (shoulder abduction-
adduction [SAA] and shoulder ﬂexion-extension [SFE]), two forward reaching tasks
at shoulder level (to the ipsilateral side [RFUI] and contralateral side [RFUC]) and
two gross motor tasks (hand to mouth and pulling/pushing of an object on a table).
EMG data from the biceps brachii, deltoid (lateral part), triceps brachii, trapezius
(upper part), pectoralis major (clavicular part) and latissimus dorsi (important during
UE adduction [21]) muscles were collected with Delsys Trigno sensors operating at
2 kHz. The serratus is also important for coordinated UE movements and scapula
stabilization. The serratus muscle, as being composed of several bellies, can however
not be measured reliably using this method of bipolar surface electrodes, and was left
out of this protocol. Sensors were attached following the guidelines by SENIAM [22]
96 Chapter 5 Upper limb kinematics and muscle activity in FSHD
Figure 1: Marker setup for unassisted movements
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and Delagi et al. [23]. The skin was prepared by shaving the skin surface if needed
and cleaning the skin with alcohol. Each task consisted of three repetitions of the same
movement with a common start and endpoint, and at self-selected speed. Each of the
healthy participants was asked to sit on a height-adjustable chair without a backrest.
During the reaching and the gross motor tasks, a table was also placed in front of
the subject. When the table was used, the height of the chair was adjusted until the
elbow angle was 90º with the hand resting on the table and the upper arm in a vertical
position (Figure 1). The target for the reaching tasks was placed at arm length and
one shoulder width on the ipsilateral or contralateral side at shoulder level. In the SAA
and SFE tasks, the subject was instructed to complete the task up to his/her maximum
voluntary active range of motion. The starting point for the hand in the reaching tasks
and the hand to the mouth movement was on the table at the subject’s mid-line and
about 20 cm from the abdomen. Table 1 summarizes the tasks.
Before execution of the set of movements, participants were asked to perform MVCs to
record the maximum EMG activity for each of the six muscles. The EMG activities of
the muscles were recorded during 3 s of isometric MVC, and each test was performed
twice for each muscle. During execution of the MVCs, the subject was encouraged
verbally to produce the maximal contraction. The positions in which the MVC were
performed are summarized in Table 2.
Data processing
Analysis of kinematic parameters
The joint angles were calculated using the Vicon Upper Limb model. For each person
and each task, the mean of the maximum upper-arm elevation and minimum and max-
imum elbow ﬂexion angle of the three repetitions was calculated. Upper-arm elevation
was used, because the clinical terms ‘ﬂexion’ and ‘abduction’ can be confusing. Flexion
followed by abduction would give diﬀerent results than abduction followed by ﬂexion
[24]. Flexion is elevation parallel to the sagittal plane and abduction is elevation in the
frontal plane. For both the control group and the FSHD group, the median values of
maximum upper-arm elevation and minimum and maximum elbow ﬂexion angle were
calculated. The upper-arm elevation and elbow ﬂexion angles were selected since they
are most inﬂuenced by the eﬀects of gravity and would thus require a greater muscle
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Figure 2: Onset time of the muscle activity. The continuous line represents an EMG signal
and the dashed line indicates when the muscle activity was more than 20% of the maximum
EMG value for a period of at least 0.2 s. The circle represents the point that is considered as
onset time of the muscle activity.
activity to compensate for the weight of the arm. In order to avoid a confounding eﬀect
due to the starting and ﬁnishing of the movement, the second repetition of each task
was used for further analysis. The movement of the hand marker was considered as
the starting point. The duration of each movement was compared between the control
group and the FSHD group.
EMG
The recorded EMG data were ﬁltered with a fourth-order Butterworth bandpass ﬁlter
from 20 to 450 Hz and then rectiﬁed. For each person and each muscle, a MVC norm
value was calculated. This was deﬁned as the maximum value of the rectiﬁed signal of
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both MVC contractions. The %MVC of the activities was then expressed as the EMG
signal divided by the MVC norm for the corresponding muscle. For each movement,
muscle and person, the mean of the maximal %MVC of the three repetitions was
calculated. Moreover, the muscle activation patterns were analyzed by comparing the
onset times of the individual muscle contractions. For each task, the onset time of
a muscle was calculated for the second repetition. The onset time was deﬁned as
the percentage of the duration of the movement where the EMG activity was higher
than 20% of the maximum EMG value for a period of at least 0.2 s during that speciﬁc
movement (Figure 2).
Statistics
The data were not normally distributed, so the median and interquartile ranges (IQRs)
were used to describe the data. The non-parametric Wilcoxon rank-sum test was
used to compare the medians between the FSHD group and the healthy control group
for each task; the eﬀect size was also calculated. The signiﬁcance level was set at
α = 0.05.
5.3 Results
Only one person with FSHD was able to elevate the arm above 120º during the
two single joint movements of SAA and SFE. All persons were able to complete the
reaching tasks and the gross motor tasks. Three tasks (SAA, RFUI, RFUC) were
performed signiﬁcantly slower (completion time approximately 25 to 40% slower) by
the FSHD group compared to the healthy control group. Table 3 gives the kinematic
and EMG parameters recorded during execution of diﬀerent tasks, from the FSHD and
the control group.
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Figure 3: The data representing the maximum upper-arm elevation angle of shoulder abduction
(left) and ﬂexion (right). The grey band represents the 95% conﬁdence interval of the control
group, the dashed lines represent the average of the control group and the continuous lines
represent the persons with FSHD.
Arm kinematics
The data depicted in Figure 3 represent the upper-arm elevation angles of the healthy
control group and the FSHD group. Signiﬁcant diﬀerences between the FSHD group
and the healthy control group were found in the upper-arm elevation angle during SAA
and SFE movements and during the two reaching tasks (Table 3). A larger variance
was found in the maximum upper-arm elevation angle of the SAA and SFE movements
in the FSHD group. In addition, the FSHD group showed less extension of the elbow
during the contralateral reaching task (Figure 4 and Table 3). Signiﬁcant diﬀerences
were found in the duration of the shoulder abduction movement, the ipsilateral reaching
task and the hand to the mouth task P=0.02, P=0.04 and P=0.01, respectively).
Muscle activation
On average, the maximum EMG activation as %MVC was signiﬁcantly higher in the
FSHD group than in the control group (Table 4, Figure 5). During the SAA movement,
the trapezius activity in the FSHD group was signiﬁcantly higher than that of the control
group (respectively 115% and 35%). In addition, during the two reaching tasks, the
maximum trapezius activity was also signiﬁcantly higher in the FSHD group (median
59% and 47% of MVC in the FSHD group versus 10% and 13% in the control group).
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Figure 4: Elbow ﬂexion angles during reaching tasks. The grey band represents the 95%
conﬁdence interval of the control group, the dashed lines represent the average of the control
group and the continuous lines represent the persons with FSHD.
Compared to the healthy control group, in the FSHD group the maximum biceps
brachii activity was signiﬁcantly higher during SF movement and both reaching tasks,
which included upper-arm elevation and ﬂexion. Moreover, the maximum activity of
the biceps during these movements was higher than during the hand to the mouth
task. During the SFE movement and the reaching tasks, the maximum triceps activity
was also signiﬁcantly higher in the FSHD group. The maximum activity of the deltoid
muscle was only signiﬁcantly higher in the FSHD group compared to the control group
during the ipsilateral reaching task and the hand to the mouth task. The maximum
activity of the pectoralis was signiﬁcantly higher in the FSHD group during all tasks.
The maximum activity of the latissimus muscle was only signiﬁcantly higher in the
FSHD group during the hand to the mouth task. Visual inspection of the timing of
muscle activation did not reveal any diﬀerence between the control group and the
FSHD group.
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Figure 5: Boxplots of maximum muscle activation as %MVC during performance of predeﬁned
tasks. The red bars represent the IQRs of the muscle activity as %MVC on a logarithmic
scale of the control group; the blue bars represent the IQRs of the FSHD group (bic=biceps
brachii, del=deltoid, tri=triceps brachii, tra=trapezius, pec=pectoralis major, lat=latissimus
dorsi). Plusses represent outliers and asterisks represent comparisons that are signiﬁcantly
diﬀerent.
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5.4 Discussion
The aim of this study was to gain a deeper understanding of shoulder and elbow
movements and the shoulder muscle activation during single joint movements, reach-
ing tasks and gross motor tasks in persons with FSHD. The main diﬀerences in the
kinematics were found in the upper-arm elevation angles, which were smaller in the
FSHD group during shoulder abduction and ﬂexion movements and the two reaching
tasks. Only two FSHD subjects were able to lift their arm to about 90º during shoulder
abduction and ﬂexion. This is in line with the clinical picture of persons with FSHD.
Persons with FSHD also presented much higher muscle activity during task perfor-
mance in all six muscles that were investigated. The highest activity as %MVC was
present in the trapezius.
In order to understand the ﬁndings, it is useful to diﬀerentiate between two phases
occurring during shoulder abduction and/or ﬂexion. A ﬁrst phase includes arm elevation
between 0 to 90º; in a second phase, this occurs from 90º and beyond. During
the ﬁrst phase, the deltoid muscle initiates upper-arm elevation together with other
scapulohumeral muscles [25]. The maximal deltoid activity was shown to be lower
in the FSHD group than in the control group for the SAA and SFE tasks. However,
this result could have been induced by the greater arm elevation achieved by the
healthy controls, although a possible sparing of the deltoid muscle to avoid undesired
movements of the scapula could not be ruled out and should be further investigated.
When axioscapular muscles such as the serratus anterior and trapezius cannot stabilize
the scapula, contraction of the deltoid muscle may not only elevate the humerus but
can also result in undesired movement of the scapula [25, 26].
This study hypothesized that the trapezius is highly active in FSHD in an attempt to
rotate and elevate the scapula. In a healthy situation, the upper trapezius together with
the lower trapezius and serratus anterior are responsible for stabilizing the scapula
to the thoracic cage. The serratus anterior counterbalances the external moment
around the sternoclavicular and acromioclavicular joints induced by the weight of the
arm during UE abduction and ﬂexion [21]. In addition, one of the most important
functions of the trapezius occurs during the second phase of arm elevation from 90º
and beyond when the trapezius is involved in rotating the scapula together with the
serratus anterior [21, 25, 27]. Serratus anterior activity was not recorded in this study.
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Inappropriate functioning of the serratus anterior muscle has however been mentioned
as cause for scapular winging [26, 28, 29], a clinical symptom that is present in FSHD
[26, 30]. Winging of the scapula results in lower acromion elevation, thus leading to
a lower maximal elevation angle of the humerus [8]. The maximum %MVC activity
of the trapezius was higher in FSHD subjects compared to healthy subjects and was
even close to or higher than its activity during MVC during tasks where maximal UE
elevation was required. This may indicate that the trapezius contributed to humeral
elevation by rotating and elevating the scapula.
In the control group, the median biceps activity during movements that required upper-
arm elevation was lower than during the hand to the mouth task. In the FSHD group,
the opposite was observed, indicating that the biceps brachii muscle supports upper-
arm elevation in FSHD. This is consistent with the biomechanical function of this
muscle that, according to Itoi et al. [31], can also function as anterior stabilizer of the
glenohumeral joint and thus assist in forward ﬂexion of the shoulder joint [31]. Bakhtiary
et al. [18] who studied the kinematics and EMG in FSHD during a simulated drinking
task, found similar results. They concluded that the muscles around the shoulder
and rotator cuﬀ are weaker in FSHD and that the biceps is therefore recruited as an
arm ﬂexor. In present study, more tasks were investigated. The complex interaction
between superﬁcial shoulder muscles was evident in muscle-activation patterns that
showed more co-contraction in the muscle activity in FSHD compared to healthy
controls. During the reaching tasks, more co-contraction was present in the deltoid,
trapezius, pectoralis and biceps brachii muscles. No diﬀerence in the starting time
was found.
Study Limitations
Few methodological aspects can be considered as limitations of this study. The MVC
was performed manually, while resistance was provided by one of the researchers. In
some cases, it was diﬃcult to immobilize the joints properly by hand. The maximum
%MVC activity of the upper trapezius muscle during shoulder abduction and ﬂexion
was close to or higher than the EMG activity measured during MVC. It is known that
reduced concentration, motivation and fear for or restrictions in the range of motion
can inﬂuence a person’s voluntary eﬀort during MVC [32, 33]. It is possible that
these factors inﬂuenced the performance of MVC in FSHD subjects and consequently
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resulted in percentages above 100% of MVC during the execution of movements and
tasks. Another explanation could be that diﬀerences exist between the EMG amplitude
of maximal isometric contractions in MVC and the EMG amplitudes during maximal
dynamic contractions. Bobbert et al. [34] have indicated that muscle activity during a
maximal isometric contraction is smaller than during a maximal concentric contraction
and EMG amplitude increases when movement velocity increases. Moreover, force
measurements were not performed in this study. EMG data and 3D kinematics were
recorded to study the movements of the arms in FSHD, and MVC was performed to
indicate relative muscle activity for each of the six individual muscles. The relation
between EMG activity and force produced has been extensively investigated in healthy
subjects [35]. There may be consensus of the opinion that the EMG-force relationship
is linear under isometric conditions and non-linear under isotonic conditions [35],
although force prediction is still approximate at best. In contrast, the relationship
between EMG and force in FSHD still has not been studied. It can be hypothesized
that persons with FSHD have less normal working muscle ﬁbers and that the maximum
force they can produce is therefore reduced compared to healthy persons. To perform
a certain activity, a minimum of force is needed that is comparable for healthy persons
and persons with FSHD (for example to lift the weight of the arm). People with FSHD
need to recruit a higher percentage of available muscle ﬁbers to achieve the required
force, resulting in a higher percentage of MVC. Although activity percentage indicates
the required muscle eﬀort to perform the movements, it provides no information about
the exact forces generated.
Activity of the serratus anterior muscle, which is an important scapula stabilizer, was
not recorded in this study. The reason for this omission is the limited accessibility of
the serratus anterior by surface EMG. Another limitation was the sample size, which
consisted of 11 FSHD subjects. However the study was explorative in nature and,
despite the limited sample size, signiﬁcant diﬀerences between movement patterns and
muscle activities have been shown between healthy controls and FSHD subjects.
In order to further investigate muscle capacities, a combination of external force
measurements, such as dynamometry, is recommended. Together with 3D motion
characteristics and EMG, external force measurements this would provide a more
complete understanding, because then the role of individual muscles can also be better
estimated. The used method with surface EMG is not applicable for muscles that are
not on the surface, like the rotator cuﬀ muscles. The current investigation of six muscles
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provided an initial understanding of the activities of the superﬁcial shoulder muscles.
However, the study was not focused on kinematic analysis of scapular movements and
therefore does not provide a complete representation of the scapulohumeral motions.
Investigating the involvement of rotator cuﬀ muscles and deeper muscles such as
the serratus anterior would require more invasive techniques such as ﬂuoroscopy or
intra-muscular needle EMG. As part of a complementary approach to understanding
rotator cuﬀ muscle contributions, biomechanical musculoskeletal models [21, 36, 37]
could also be used.
As a long-term research perspective, it would be interesting to further evaluate whether
the use of arm supports would result in more eﬃcient movements that require less
eﬀort and would therefore enable the performance of tasks such as eating for longer
periods of time. It could be hypothesized that arm supports would reduce the eﬀort
to perform movements during daily activities. In this study, the FSHD data were
heterogeneous, implying that a one-size-ﬁts-all approach may not be adequate but
that a personalized approach would be needed to customize future arm supports.
Understanding the eﬀect of FSHD on muscle force and arm movements could help
develop more biomechanically oriented assistive arm devices. Ideally, an arm support
would counteract the gravity, thus allowing the users freedom to move their arm with
limited eﬀort. There are two diﬀerent issues: 1) the problem of scapula control and
the role of the serratus anterior and 2) the problem of UE weakness leading to muscle
fatigue and impairments in performing daily tasks. For both problems an arm support
would be helpful to enable persons with FSHD to perform daily tasks better. By
counteracting gravity, less force is needed to lift the arm and thus less activation of the
muscles, resulting in less fatigue. Further research is required in order to determine
what the eﬀect of arm support is on scapula control and fatigability.
Conclusions
This was the ﬁrst study where the involvement of proximal, superﬁcial scapulohumeral
muscles during several standardized movement tasks in FSHD was explored and
described. Compensations were found in FSHD subjects as a consequence of loss of
muscle function; this resulted in increased muscle co-contraction and ultimately an
increased eﬀort and energy needed to accomplish tasks. The trapezius muscle was
highly active in the shoulder abduction and ﬂexion movements, indicating a mechanism
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that compensates for the lack of scapular lateral rotation when the arm is elevated.
Persons with FSHD used higher percentages of MVC in the weakened shoulder
muscles during movements and tasks that required elevation in the shoulder joint.
Further research should be focused on investigating whether existing arm-support
systems reduce these muscular eﬀorts, so that movements or tasks can be performed
longer or more frequently.
110 Chapter 5 Upper limb kinematics and muscle activity in FSHD
References
1. Emery, A. E. H. The muscular dystrophies. Lancet 359, 687–695 (2002).
2. Padberg, G. W., Frants, R. R., Brouwer, O. F., Wijmenga, C., Bakker, E. & Sandkuijl, L. A.
Facioscapulohumeral muscular dystrophy in the Dutch population. Muscle and Nerve 18, S81–
S84 (1995).
3. Emery, A. E. H. Population frequencies of inherited neuromuscular diseases—A world survey.
Neuromuscular Disorders 1, 19–29 (1991).
4. Pandya, S., King, W. M. & Tawil, R. Facioscapulohumeral dystrophy. Physical Therapy 88, 105–13
(2008).
5. Tawil, R. & Van der Maarel, S. M. Facioscapulohumeral muscular dystrophy. Muscle and Nerve
34, 1–15 (2006).
6. Kilmer, D. D., Abresch, R. T., McCrory, M. A., Carter, G. T., Fowler Jr, W. M., Johnson, E. R. &
McDonald, C. M. Proﬁles of neuromuscular diseases. Facioscapulohumeral muscular dystrophy.
American Journal of Physical Medicine & Rehabilitation 74, S131–S139 (1995).
7. Royden, J., De Vivo, D. & Darras, B. Neuromuscular Disorders of Infancy, Childhood, and
Adolescence: A Clinician’s Approach (Elsevier Science, Philadelphia, 2003).
8. Voight, M. L. & Thomson, B. C. The role of the scapula in the rehabilitation of shoulder injuries.
Journal of Athletic Training 35, 364–72 (2000).
9. Reinold, M. M., Escamilla, R. F. & Wilk, K. E. Current concepts in the scientiﬁc and clinical rationale
behind exercises for glenohumeral and scapulothoracic musculature. Journal of Orthopaedic and
Sports Physical Therapy 39, 105–17 (2009).
10. Brouwer, O. F., Padberg, G. W., Van der Ploeg, R. J. O., Ruys, C. J. M. & Brand, R. The inﬂuence
of handedness on the distribution of muscular weakness of the arms in facioscapulohumeral
muscular dystrophy. Brain 115, 1587–1598 (1992).
11. Personius, K. E., Pandya, S., King, W. M., Tawil, R. & McDermott, M. P. Facioscapulohumeral Dys-
trophy Natural History Study: standardization of testing procedures and reliability of measurements.
Physical Therapy 74, 253–263 (1994).
12. FSH-DY-Group. A prospective, quantitative study of the natural history of facioscapulohumeral
muscular dystrophy (FSHD): implications for therapeutic trials. The FSH-DY Group. Neurology
48, 38–46 (1997).
13. Stubgen, J. P. & Stipp, A. Facioscapulohumeral muscular dystrophy: a prospective study of
weakness and functional impairment. Journal of Neurology 257, 1457–64 (2010).
References 111
14. Hughes, A. M., Freeman, C. T., Burridge, J. H., Chappell, P. H., Lewin, P. L., Pickering, R. M.
& Rogers, E. Shoulder and elbow muscle activity during fully supported trajectory tracking in
neurologically intact older people. Journal of Electromyography and Kinesiology 19, 1025–1034
(2009).
15. Prange, G. B., Kallenberg, L. A. C., Jannink, M. J. A., Stienen, A. H. A., van der Kooij, H., Ijzerman,
M. J. & Hermens, H. J. Inﬂuence of gravity compensation on muscle activity during reach and
retrieval in healthy elderly. Journal of Electromyography and Kinesiology 19, e40–e49 (2009).
16. Hughes, A. M., Freeman, C. T., Burridge, J. H., Chappell, P. H., Lewin, P. L. & Rogers, E. Shoulder
and elbow muscle activity during fully supported trajectory tracking in people who have had a
stroke. Journal of Electromyography and Kinesiology 20, 465–76 (2010).
17. Prange, G. B., Jannink, M. J., Stienen, A. H., van der Kooij, H., Ijzerman, M. J. & Hermens, H. J.
Inﬂuence of gravity compensation on muscle activation patterns during diﬀerent temporal phases
of arm movements of stroke patients. Neurorehabilitation and Neural Repair 23, 478–85 (2009).
18. Bakhtiary, A. H., Phoenix, J., Edwards, R. H. T. & Frostick, S. P. The eﬀect of motor learning in
facioscapulohumeral muscular dystrophy patients. European Journal of Applied Physiology 83,
551–558 (2000).
19. Brooke, M. H., Fenichel, G. M., Griggs, R. C., Mendell, J. R., Moxley, R., Miller, J. P. & Province,
M. A. Clinical investigation in Duchenne dystrophy: 2. Determination of the power of therapeutic
trials based on the natural history. Muscle and Nerve 6, 91–103 (1983).
20. Vicon Motion Systems Limited. Upper limb model product guide revision 1.0 2007.
21. Van der Helm, F. C. T. Analysis of the kinematic and dynamic behavior of the shoulder mechanism.
Journal of Biomechanics 27, 527–550 (1994).
22. Hermens, H. J., Freriks, B., Merletti, R., Stegeman, D., Blok, J., Rau, G., Disselhorst-Klug, C. &
Hägg, G. European recommendations for surface electromyography (Roessingh Research and
Development The Netherlands, 1999).
23. Delagi, E. F., Iazzetti, J., Perotto, A. O. & Morrison, D. Anatomical guide for the Electromyographer
5th (Charles C. Thomas, Springﬁeld, Illinois, 2011).
24. Wu, G., van der Helm, F. C., Veeger, H. E., et al. ISB recommendation on deﬁnitions of joint
coordinate systems of various joints for the reporting of human joint motion–Part II: shoulder,
elbow, wrist and hand. Journal of Biomechanics 38, 981–992 (2005).
25. Wattanaprakornkul, D., Halaki, M., Boettcher, C., Cathers, I. & Ginn, K. A. A comprehensive
analysis of muscle recruitment patterns during shoulder ﬂexion: an electromyographic study.
Clinical Anatomy 24, 619–26 (2011).
26. Copeland, S. A., Levy, O., Warner, G. C. & Dodenhoﬀ, R. M. The shoulder in patients with muscular
dystrophy. Clinical Orthopaedics and Related Research, 80–91 (1999).
27. Reed, D., Cathers, I., Halaki, M. & Ginn, K. Does supraspinatus initiate shoulder abduction?
Journal of Electromyography and Kinesiology 23, 425–9 (2013).
28. Martin, R. M. & Fish, D. E. Scapular winging: anatomical review, diagnosis, and treatments.
Current Reviews in Musculoskeletal Medicine 1, 1–11 (2008).
112 Chapter 5 Upper limb kinematics and muscle activity in FSHD
29. Warner, J. J., Micheli, L., Arslanian, L., Kennedy, J. & Kennedy, R. Scapulothoracic motion in
normal shoulders and shoulders with glenohumeral instability and impingement syndrome A study
using Moire topographic analysis. Clinical Orthopaedics and Related Research 285, 191–199
(1992).
30. Demirhan, M., Uysal, O., Atalar, A. C., Kilicoglu, O. & Serdaroglu, P. Scapulothoracic Arthrodesis
in Facioscapulohumeral Dystrophy with Multiﬁlament Cable. Clinical Orthopaedics and Related
Research 467, 2090–2097 (2009).
31. Itoi, E., Kuechle, D. K., Newman, S. R., Morrey, B. F. & An, K. N. Stabilising function of the biceps
in stable and unstable shoulders. The Journal of Bone and Joint Surgery 75, 546–50 (1993).
32. Schillings, M., Kalkman, J., Janssen, H., van Engelen, B., Bleijenberg, G. & Zwarts, M. Experienced
and physiological fatigue in neuromuscular disorders. Clinical neurophysiology : oﬃcial journal of
the International Federation of Clinical Neurophysiology 118, 292–300 (2007).
33. Criswell, E. Cram’s introduction to Surface Electromyography Second edition (Jones and Bartlett
Publishers, 2011).
34. Bobbert, M. F. & Harlaar, J. Evaluation of moment-angle curves in isokinetic knee extension.
Medicine and Science in Sports and Exercise 25, 251–9 (1993).
35. Weir, J. P., Wagner, L. L. & Housh, T. J. Linearity and reliability of the IEMG v torque relationship
for the forearm ﬂexors and leg extensors. American Journal of Physical Medicine & Rehabilitation
71, 283–7 (1992).
36. Essers, J., Murgia, A., Bergsma, A., Verstegen, P. & Meijer, K. An inverse dynamic analysis on the
inﬂuence of upper limb gravity compensation during reaching in IEEE International Conference
on Rehabilitation Robotics (2013).
37. Veeger, H. E. J. & Yu, B. Orientation of axes in the elbow and forearm for biomechanical modelling
in Biomedical Engineering Conference, 1996., Proceedings of the 1996 Fifteenth Southern (1996),
377–380.
References 113

6Effect of forearm gravity
compensation on upper limb
kinematics and muscle
activation in persons with
facioscapulohumeral dystrophy:
A cross-sectional study
Murgia A., Bergsma A., Cup E. H., Groot I. J., Meijer K. Eﬀect of forearm gravity
compensation on upper limb kinematics and muscle activation in persons with fa-
cioscapulohumeral dystrophy: A cross-sectional study. submitted
Abstract
Objective: The aim of this study was to evaluate the eﬀect of forearm gravity compen-
sation, by comparing kinematics and muscle activity of participants with FSHD and
healthy participants during standardized upper extremity tasks.
Methods: Eleven persons with FSHD and eight healthy controls were measured.
Participants performed a series of upper extremity tasks without and with the aid of a
forearm support mechanism (SLING). Kinematic data were recorded using a three-
dimensional motion capture system. Muscle activities of six superﬁcial muscles around
the glenohumeral joint were recorded using surface electromyography. Shoulder
elevation angles, maximum electromyographic activity and electromyographic activity
onset during the movements (reaching tasks only) were calculated.
Results: Shoulder elevation angles diﬀered in single joint tasks in the healthy group due
to the mechanical design of the SLING. The elevation angle waveforms were otherwise
similar between unsupported and SLING conditions within both groups. A decrease
of muscle activity occurred in both groups when the SLING was used. In the FSHD
group, later onsets of biceps and deltoid occurred in both SLING-assisted during ipsi-
and contralateral reaching with the trapezius being also delayed during contralateral
reaching. No temporal shifts were present in activation onsets in the deltoid-trapezius
and deltoid-latissimus pairs between SLING and unsupported conditions.
Conclusions: Reduction of muscle activity can help relieve the load on the shoulder
muscles during arm elevation around shoulder height. Changes in selected muscle
onsets in the FSHD group could have implications for scapular mobility and stability,
both of which should be considered when designing arm support devices for this
group.
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6.1 Introduction
Facioscapulohumeral dystrophy (FSHD) is one of the most common forms of muscular
dystrophy [1–4]. It mainly aﬀects the muscles of the face, the shoulder girdle and the
upper arm. Common symptoms in the upper extremity are weakness of the shoulder
girdle muscles, often associated with scapular instability, and of the upper arm muscles.
This generally results in limitations while performing activities of daily living (ADLs)
and in diﬃculties performing arm elevation [5]. In previous research, the time to
complete daily tasks was often found to become considerably longer [6]. Moreover, in
previous research it was found that persons with FSHD exhibited a higher activity of
their shoulder muscles, especially of the trapezius, during movements that required
humeral elevation at about shoulder level, when compared to healthy persons [7]. Arm
elevation above shoulder height requires upward (lateral) rotation of the scapula [8] by
the simultaneous action of the trapezius and the serratus anterior muscles [9]. Since
the latter is greatly aﬀected by the muscle dystrophy, it was hypothesized in a previous
study that the higher activity of the trapezius could be also an indication of possible
compensatory mechanisms aimed at overcoming limited scapular mobility [7].
An adequate form of arm support could, in principle, enable individuals with FSHD
to overcome the limitations cited above. Support devices that compensate for arm
weight have been extensively employed to assist persons with Upper Extremity (UE)
impairments [10, 11]. Some of the simplest designs include those devices which use
gravity compensation to relieve the weight of the upper extremity. In these devices,
elastic elements, actuators or simple counterweights are used to balance the weight
of the upper extremity. To be able to design more sophisticated arm support mech-
anisms, user-speciﬁc parameters such as muscle capacity and preferred activities,
should be taken into account. The long-term outcome would be a more user-driven
or personalized design process that adapts to the individual characteristics of each
person. The eﬀects of gravity compensation on UE kinematics and muscle activity
have been studied before in healthy elderly [12, 13] and in persons with stroke [14]
during reach and retrieval movements. Prange et al. [12] found that in the presence of
gravity compensation, healthy elderly performed similar movements with a lower level
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of muscle activity compared to the unsupported condition, while muscle activation
patterns in terms of timing remained unchanged. Lower muscle activity was mainly
found in the biceps, deltoid and trapezius muscles. Using the same gravity compen-
sation device as in the study by Prange et al. [12], Coscia et al. [13] also reported
unaltered upper limb kinematic synergies and muscle activation patterns in healthy
persons being assisted during reaching with diﬀerent levels of arm support. Similar
results were also found in stroke persons performing reaching with and without the aid
of a gravity compensation device [15].
Although the eﬀect on UE kinematics and muscle activity resulting from the use of
an arm support are well-investigated in healthy elderly and in persons with stroke,
there is still a lack of evidence on the changes induced by arm supports in person with
neuromuscular dystrophies who have compromised shoulder function, for example
FSHD, and could greatly beneﬁt from this assistive technology. It would be particularly
relevant in order to design adaptive support systems to understand whether kinematics
and electromyography (EMG) activity is changed in persons with FSHD as result
of using an arm weight support system. Such information could be useful when
designing arm support systems which provide an optimal level of support by adapting
to the changing dynamics of the user during a speciﬁc movement. The aim of the
current study was to investigate how UE kinematics and shoulder muscle activities are
inﬂuenced by gravity compensation in persons with FSHD compared to healthy controls.
Changes in shoulder kinematics and muscle activity were quantiﬁed while participants
performed a set of standardized tasks with and without gravity compensation. It was
hypothesized that performing tasks with gravity compensation would result in changes
in individual muscle onset times in FHSD persons, because the mechanism would
compensate for the function of the already weak shoulder muscles.
6.2 Methods
Participants
Eleven persons with FSHD (mean age 49.9 ± 9.8 yrs, four men, seven women, 10
right dominant, one left dominant) and eight healthy persons (mean age 33.9 ± 11.5
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yrs, ﬁve men, three women, all right dominant) were tested on their dominant side.
None of the healthy participants presented musculoskeletal or neurological problems.
FSHD participants were recruited through the Dutch patient organization of persons
with muscle diseases (Spierziekten Nederland).
All FSHD participants had a score of 2 or 3 on the self-assessed Brooke scale [16],
meaning they were able to raise a 250 ml glass of water to the mouth. Participants were
excluded if they had suﬀered from previous upper limb trauma (e.g. bone fractures
or surgery). Ethical approval was obtained for the study (Ethical Committee Arnhem-
Nijmegen, NL39024.091.11) and the study was conducted in accordance with the
guidelines of the Helsinki protocol.
Data recording
Participants were asked to perform a set of standardized movements [7], ﬁrst without
assistance and then while being assisted by a passive gravity support mechanism
(SLING arm support, Focal Meditech BV, The Netherlands). The SLING is constructed
so that counterweights can be added to a slider, which can vertically move inside
a support column (black cylinder Figure 1) and is connected through a cable to the
forearm support. The total cable tension is the sum of the weight of the slider plus
the weight of the counterweight, which can be customized. The total vertical cable
tension was chosen for each person so that he/she experienced a weight-free upper
extremity.
The movement protocol consisted of two shoulder movements: abduction-adduction
(SAA) and ﬂexion-extension (SFE); two reaching tasks at shoulder level: reaching
to the ipsilateral (RFUI) and to the contralateral side (RFUC); two gross motor tasks:
hand to mouth (H2M) and pulling/pushing of an object on a table (PP). The data of the
movements without the SLING were described in a previous study [7]. Movements
were recorded with an 8 camera Vicon MX system sampling at 200 Hz (Vicon Motion
Systems Ltd. UK). Reﬂective markers were attached to the subject’s UE and trunk
(Figure 1), following the guidelines of the upper limb model [17].
Participants were asked to repeat each task three times at self-selected speed in
a cyclic fashion, while they were sitting sit on a height-adjustable chair without a
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Figure 1: Left: marker setup for unassisted movements. Right: marker setup for SLING
assisted movements. Inset bottom right: detail of the counterweights plates that can be
removed or added to change the amount of tension on the cable.
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backrest. During the reaching and the gross motor tasks, a table was placed in front of
the participant. The height of the chair was adjusted so that an elbow angle of 90º was
formed between the upper arm in a vertical position and the forearm when the hand
was placed on the table. For each task, a common start and endpoint was deﬁned and
participants were instructed to complete each task up to his/her maximum possible
active range of motion. The starting position for the shoulder movements was the arm
hanging alongside the body. The starting position for the hand to the mouth movement
and the reaching tasks was with the hand on the table, on the subject’s mid-line and
distant about 20 cm from the abdomen. For the reaching tasks, a target was placed at
shoulder level, at arm length and one shoulder width to the ipsilateral or contralateral
side.
EMG data were collected with Delsys Trigno (Delsys Inc. USA) sensors sampling
at 2 kHz for six muscles that are involved in shoulder and upper arm movements:
biceps brachii, deltoid (lateral part), triceps brachii (long head), trapezius (upper
part), pectoralis major (clavicular part) and latissimus dorsi muscles. Sensors were
attached following international guidelines [18, 19]. In order to normalize the EMG
data, participants were asked to perform isometric maximum voluntary contractions
(MVC) against the manual resistance exerted by one of the investigators to record the
maximum EMG activity for each of the six muscles before the tasks were performed.
For each muscle, the MVC test was performed twice, while the EMG activity was
recorded for 3 s [7]. An alternative normalization to the division by MVC, which used
the z-scores, was also implemented as described below.
Data processing
Marker data were ﬁltered using Woltring spline-interpolation (predicted MSE value=15)
[20] and the Vicon Upper Limb model was used to calculate the joint angles. For each
task and each person, the starting point of a movement (deﬁned as the moment when
the vertical coordinate of the hand marker started moving) was determined visually.
Similarly the end point of the movement was deﬁned as the point when the hand
stopped moving after returning to the common start point once the target was reached.
From the kinematics of each movement, the maximum and minimum shoulder elevation
and elbow ﬂexion angles were determined. The active range of motion (AROM) was
calculated using the diﬀerence between the maximum and minimum angles. For
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both the control and FSHD group, median values for the shoulder elevation and the
elbow ﬂexion angles were calculated for the movements with and without the SLING
support. In order to check whether trunk movements were diﬀerent between healthy
controls and FSHD participants, the maximal Euclidean distance of the marker that
was attached to the top of the sternum on the jugular notch, was calculated between
the start and end of the ﬁrst repetition. EMG data were bandpass ﬁltered (4th order
Butterworth: cutoﬀ 20 - 450 Hz) and rectiﬁed using a root mean square algorithm.
The EMG data were normalized as percentage of MVC (%MVC) per person and
muscle. The MVC norm value was deﬁned as the maximum value of the rectiﬁed
signal from both MVC contractions. Each task was repeated three times and for each
repetition, the %MVC values of the highest amplitude were calculated. The mean of
the maximum %MVC values of the repetitions was then calculated for each task, each
muscle and each person. As an alternative to the normalization approach using MVC,
a normalization analysis was conducted by transforming the rectiﬁed EMG values
to z-scores [21, 22]. The z-score for each trial and each muscle were computed for
each subject, using the EMG mean and standard deviation values of the unsupported
(no-SLING) condition. The normalization to z-scores was performed to reduce the
inﬂuence of potentially unreliable MVC values, among muscles and across subjects,
and to eliminate diﬀerences of tonic EMG values. For the two reaching tasks, the
EMG was selected in the interval between the moment when the hand marker started
moving (0%) and the moment when it stopped moving at the end of the movement
(100%). Within this interval the onset time was deﬁned as the time corresponding
to the muscles exceeding an activity threshold of 5 standard deviations (SD) of the
EMG during a quiet period. In other research [7] a threshold value equal to 20%
of the maximum EMG value has been proposed. This value would be related to a
substantial muscle activation that has a functional eﬀect. However in order to quantify
the exact moment when an EMG signal starts to increase signiﬁcantly from the noise
background level, a 5·SD threshold was used here (Figure 2) [23]. The two reaching
tasks were chosen as being representative of a subject’s abilities, since their execution
requires signiﬁcant active range of motion and values of the shoulder joint moments
near their maximum. These tasks have also been investigated by other researchers
on healthy persons and stroke patients [12–14].
Beside the onset times, the shoulder elevation angle relative increase between the start
of the movement and the time of onset was calculated for each muscle. This outcome
parameter was chosen to quantify at which speciﬁc shoulder elevation angle any given
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Figure 2: Example of how EMG onset and corresponding angles were determined for one
participant of the control group during the RFUC task. The shoulder elevation angle and the
activities of the deltoid and trapezius muscles are shown from top to bottom, respectively.
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muscle became active with respect to the start of the movement. It was chosen as
an additional quantiﬁcation of the muscle onset changes that may be induced by
the SLING. In addition to the onset time and the corresponding increase in shoulder
elevation angle, the relative diﬀerence between onset times of deltoid-latissimus dorsi
and deltoid-trapezius muscles as percentage of normalized time was calculated for
the two conditions with and without the SLING. These muscle groups were considered
because of their involvement during arm elevation (deltoid, trapezius) [9] and their
role in glenohumeral head stabilization through the counteraction of upwards and
downwards forces (deltoid, latissimus dorsi) [24].
Statistics
Non-parametric statics were used to analyze the data since these were not normally
distributed. The median and interquartile ranges (IQR) were used in the descriptive
statistics. Wilcoxon signed-rank tests were used to compare the kinematic data, maxi-
mum and minimum muscle activity, the relative muscle onset times and corresponding
increases in shoulder elevation angle between the start of the movement and the time
of onset between the two conditions with and without the SLING, for both the FSHD
group and the control group. In addition, the shoulder elevation angle waveforms
during the movements with and without the SLING were compared for each subject
and each task. This was done by calculating the coeﬃcient of multiple correlation
(CMC), as described by Kadaba et al. [25], between the shoulder elevation angles
that were normalized in time of a speciﬁc movement performed with and without the
SLING. The CMC was calculated using the between-days formula where the two days
were the conditions with and without the SLING [26]. This provides information on the
similarities in shape of the shoulder elevation angle waveforms. The signiﬁcance level
for all statistics was set at α = 0.05.
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6.3 Results
Kinematics
The kinematic data are summarized in Figure 3. Higher maximum shoulder elevation
angles resulting from SLING-support were found in reaching and H2M movements in
the FSHD group, and in the H2M movements in the healthy persons (P<0.05). The
shoulder elevation angles were lower in SAA and SFE movements when the SLING
was used by healthy persons. The minimal shoulder elevation angle was higher
(P<0.05) in all SLING-assisted movements in the FSHD group compared to the non-
assisted conditions. Moreover, execution time was shorter during the SLING-assisted
shoulder and H2M movements compared to the condition with no SLING (P<0.05 only
for SAA), but longer in the SLING-assisted reaching and PP tasks (P<0.05 only in
RFUC). Movement of the trunk decreased when the SLING was used during the SFE
movement, in both the control and the FSHD group (P<0.05, median reduction 27 mm
in the control group and 25 mm in the FSHD group). For the H2M, the trunk movement
increased (P<0.05, median increment 4 mm in control group and 3 mm in FSHD
group). An increment in trunk movement was found for the FSHD group compared to
the control group for the unsupported SAA, H2M and RFUI and the supported SFE
movement. The maximum diﬀerence was 19 mm. The CMC values for the shoulder
elevation angle waveforms with and without the SLING were above 0.83 for the SAA,
SFE, RFUI, RFUC, PP movements and above 0.54 for the H2M movement.
Muscle activation
In general, muscle activity was lower for all muscles during the SLING-assisted move-
ments compared to the unsupported movements (Figure 4). The results of the analysis
of the EMG data normalized as %MVC were qualitatively the same as those using the
z-scores. In the FSHD group the maximum EMG activity of each of the measured
muscles, except for the latissimus dorsi (MVC and z-score normalization) and the
pectoralis (z-score normalization only), were lower (P<0.05) in the SLING-assisted
shoulder movements (SL SAA and SL SFE) compared to the unsupported movements.
In this same group, the activities of all muscles were also lower during the SLING-
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Figure 3: Boxplots showing maximum and minimum shoulder elevation angles during execu-
tion of various tasks in healthy controls (white boxes) and persons with FSHD (grey boxes)
without and with the SLING (SL). The median value is represented by the horizontal line within
the box.
assisted RFUC task (P<0.05). During the SLING-assisted RFUI task the activities of
all muscles were lower except for the triceps (MVC and z-score normalization) and
the latissimus (z-score normalization). In the SLING-assisted H2M the activity of the
pectoralis was lower (P<0.05; MVC normalization) and during the SLING-assisted PP
movement the activities of the biceps, deltoid and triceps were lower (P<0.05) as well
as that of the pectoralis (P<0.05; z-score normalization only). In the healthy control
group during the SLING-assisted RFUC movement, the biceps and deltoid became
active later (P<0.05) than in the unsupported condition, the biceps also became active
later in SLING RFUI movement (P<0.05). In the FSHD group, the onset of the biceps
and deltoid occurred later (P<0.05) in both SLING-assisted RFUI and RFUC tasks, with
the trapezius’ onset also occurring later in the RFUC movement (P<0.05). The activity
of trapezius and deltoid muscles in relation to the shoulder elevation angle appeared
to show a prominent increase in activity near the maximum reached elevation angle in
selected FSHD cases (see Figure 5). This was visible in both unassisted and assisted
movements.
Concerning the relative increase in shoulder elevation angle between the beginning
of the movement and the moment when a muscle became active: only the deltoid
in the healthy participants became active at a higher angle (P<0.05) during SLING
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Figure 4: Boxplots showing maximum EMG activation as percentage MVC during execution
of various tasks (SAA, SFE, RFUI) in healthy controls (white boxes) and persons with FSHD
(grey boxes) for all muscles without and with the SLING (SL). Bic: biceps; Del: deltoid; Tri:
triceps; Tra: trapezius; Pec: pectoralis; Lat: latissimus dorsi. The median value is represented
by the horizontal line within the box.
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Figure 5: Boxplots showing maximum EMG activation as percentage MVC during execution
of various tasks (RFUC, H2M, PP) in healthy controls (white boxes) and persons with FSHD
(grey boxes) for all muscles without and with the SLING (SL). Bic: biceps; Del: deltoid; Tri:
triceps; Tra: trapezius; Pec: pectoralis; Lat: latissimus dorsi. The median value is represented
by the horizontal line within the box.
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Figure 6: Activity of deltoid and trapezius versus shoulder elevation angle during reaching
tasks for participant C02 (control group) and participant F02 (FSHD group). The ﬁlled circle
and the arrow indicate the beginning of the movement and its direction respectively.
RFUC, while in the FSHD group biceps, deltoid and trapezius became all active at
a higher angle (P<0.05) during SLING RFUC. In addition to the diﬀerences in onset
times between the SLING and unsupported conditions for each individual muscle, the
diﬀerences between the deltoid-trapezius and deltoid-latissimus dorsi muscle pairs
were also considered during the two reaching tasks. None of the relative onsets
(deltoid-trapezius and deltoid-latissimus) changed as result of the SLING in both
reaching tasks (P>0.05).
6.4 Discussion
This is the ﬁrst study that is aimed at quantifying the inﬂuences of arm gravity support
on joint kinematics and muscle activity in persons with FSHD and healthy persons,
when performing a set of standardized tasks encountered in daily life. A reduced
maximal muscle activity in all tasks was generally observed in addition to muscle onset
changes during the reaching tasks in both groups.
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Concerning the kinematic changes resulting from the introduction of the arm support,
or SLING, the angular waveforms for shoulder elevation were in general qualitatively
similar, though some changes in the range of motion were observed. A reduction
in shoulder elevation was measured during the SLING-assisted SFE and SAA tasks
in the control group. This is to be attributed to the limited range of motion of the
mechanism when elevating the arm. In the remaining tasks (H2M, RFUI, RFUC, PP)
the SLING did not limit shoulder elevation, and the increments in shoulder elevation
found in the control group were minimal but consistent in sign. These increments
indicate that the SLING mechanism could have induced a small oﬀset by pulling the
arm upwards. In contrast to the control group, no reduction in shoulder elevation
was found in the FSHD group when the SLING was used during the SFE and SAA
tasks because of the already limited range of motion of this population. Despite the
abovementioned oﬀsets, the CMC values above 0.83 (in SAA, SFE, RFUI, RFUC
and PP) indicate that the shoulder elevation angular waveforms with and without the
SLING were similar in shape and oﬀset, conﬁrming the ﬁndings during reaching of
Prange et al. and Coscia et al. [12, 13] for healthy persons. The angular waveforms
of the H2M movements were less consistent, as indicated by a CMC value of 0.54,
indicating an eﬀect of the SLING on the kinematics. Concerning the way muscle
activity is aﬀected by the arm support, a general scaling of activity was found when
using the arm support in both healthy and FSHD persons, as expected. This ﬁndings
is in agreement with those of Prange, Coscia et al. in healthy and stroke persons.
Concerning the way muscle activity is aﬀected by the arm support, a general scaling
of activity was found when using the arm support in both healthy and FSHD persons,
as expected. The discussion on muscle onset that follows relates to the lifting phase
of the reaching movements (from start to target). In this study it was hypothesized that
performing tasks while using the SLING in FHSD persons would result in changes in
individual muscle onset times. The ﬁndings appear to support this hypothesis only in
some muscles. Additionally in the healthy control group some muscle onsets were
also aﬀected when using the SLING. The biceps’ onset in the healthy group occurred
later in both SLING-assisted reaching tasks, while the deltoid’s onset was delayed
only in the SLING RFUC task. However in the FSHD group, the onsets of biceps,
deltoid were all delayed in both SLING-assisted reaching tasks with the trapezius
being also delayed in the SLING-RFUC task. The biceps accomplishes the function of
an arm forward ﬂexor as well as elbow ﬂexor, while the lateral deltoid serves as an
arm abductor. As the activity of biceps and deltoid was relieved by the SLING, the
later onset also appears to show that healthy controls and FSHD persons chose to
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rely more on the inertia of the SLING to lift the arm, thus resulting in a later muscle
involvement. In previous research of Bakhtiary et al. [7, 27], activation of the biceps
has been found to be higher in persons with FSHD compared to healthy persons
during tasks involving arm elevation. This behaviour is the result of an attempt by
the biceps to compensate for the weakness of other arm elevators. Moreover, as
pointed above, a later onset of the trapezius occurred in the FSHD group, but only
in the SLING RFUC task. Contralateral reaching, compared to ipsilateral reaching,
requires in principle more scapular mobility [28, 29] and dynamic scapular stability
[30], both of which can be diﬃcult to accomplish in people with FSHD [31]. The upper
ﬁbres of the trapezius provide scapular mobility through the upward rotation of the
scapula [9], which increases with arm elevation [31]. A later onset, at a corresponding
higher shoulder elevation angle, of the upper trapezius appears to show that the FSHD
group relied more on the SLING to initiate the movement. The moment generated
by the SLING on the humerus, that induces an abduction movement of the humerus,
might have facilitated upward scapular rotation during the lifting phase, and could
therefore have induced a later onset, as well as reducing the load and subsequent
fatigue of the upper trapezius in the long term. In persons with FSHD the excessive
activity of the trapezius has in fact been hypothesized as part of a compensatory
strategy for the limited scapular rotation [7] and it is therefore relevant to consider
how it is aﬀected by the design of a speciﬁc support device. A common shift in onset
activity however does not necessarily implies a diﬀerent muscle control strategy. In
this study in both healthy and FSHD groups no temporal shifts in activation onsets
were observed between SLING and unsupported conditions in the deltoid-trapezius
and deltoid-latissimus pairs, which appears to provide ﬁrst-time evidence that the
sequential activation of these muscles is unaﬀected by the arm support in persons with
FSHD. The latissimus dorsi plays a role in balancing the abduction moment exerted
by the counterweight, and thus it could be hypothesized that an earlier involvement
of this muscle in the SLING condition would be required to resist the upwards pull of
the mechanism. However the activation onset of the latissimus dorsi did not change
relatively to the deltoid in persons with FSHD when using the SLING. It seems thus that
both the FSHD and control groups were able to exploit the inertia of the mechanism to
their advantage, without an earlier involvement of the latissimus dorsi. In addition, An
abduction moment of the mechanism could also alter the force balance between the
abduction moment of the deltoid and the abduction moment of the latissimus dorsi on
the humerus [24], and thus eventually aﬀect shoulder stability. However this hypothesis
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remains unproved and should be the objective of future research where the synergies
between the superﬁcial shoulder muscle should also be taken into account [32].
Study limitations
Some methodological aspects can be listed as limitations of this study. The movement
order was not randomized, with the unsupported condition always preceding the
supported condition. Although this was done to prevent that the FSHD individuals
would get too fatigued if the supported condition was done ﬁrst and the unsupported
(which required more eﬀort) afterwards, future studies should include a randomization
of conditions. The performance of MVC was carried out while one of the researchers
provided resistance to the subject. This could have induced some variability in the
way MVC was measured at baseline, since in some cases it was diﬃcult to immobilize
the joints properly by hand. In some movements, the maximum activity of the upper
trapezius muscle as %MVC was higher than the EMG activity measured during MVC.
It is possible that factors like reduced concentration or fear of contracting the muscles
inﬂuenced the person’s voluntary eﬀort during MVC [33, 34]. Consequently this could
have resulted in activation percentages above 100% of MVC during the execution of
movements and tasks. Moreover, although the lower trapezius and serratus anterior
muscles are both important scapular stabilizers, their activity were not recorded in
this study. Finally, there was a 16 year mean age diﬀerence between the patient
and control groups. While the FSHD individuals were free from orthopedic problems,
there might have been structural changes in the shoulder aﬀecting for example the
articulation surfaces and tendons, as a result of the aging process.
Conclusions
The biomechanical changes induced by a counterweight arm support mechanism
were described in a group of healthy controls and FSHD persons. An overall reduction
in muscle activity was found, as expected, which conﬁrmed previous research ﬁndings
on healthy individuals. The SLING did not appear to signiﬁcantly aﬀect the shoulder
elevation angle waveforms of healthy controls and FSHD participants, although SFE
and SAA movements were hindered in healthy controls, resulting in lower elevation
angles. However, using the SLING resulted in later activation onsets of biceps and
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deltoid in both reaching tasks in the FSHD group. In addition, a later onset of the
trapezius muscle characterized the use of the support device in FSHD participants
during the reaching task to the contralateral side. This ﬁnding implies that the FSHD
group was more inclined to use the inertia of the mechanism to their advantage when
more scapular mobility was required, thus resulting in a later activation. These ﬁndings
can lead to speculate that scapular function was aided in FSHD persons. However
shoulder stability can also have been inﬂuenced by the introduction of external loads
by the SLING. It is unclear whether these loads can aﬀect shoulder articular structures
or if they can be damaging with a long usage of the device. In future research,
information on muscle activity should be complemented by that on joint moments and
loads to characterize the proﬁle of FHSD users of arm supports more accurately, while
scapular stabilizers such as the lower trapezius and the serratus anterior should also
be measured. This process should eventually lead to a personalized approach aimed
at a customization of support devices in persons with FSHD.
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Abstract
Objective: The aim of this study was to explore upper extremity (UE) impairments,
activity limitations and related participation restrictions in people with four diﬀerent types
of neuromuscular disease (NMD) - FacioScapuloHumeral Dystrophy (FSHD), Limb-
Girdle Muscular Dystrophy (LGMD), Spinal Muscular Atrophy (SMA) and Duchenne
Muscular Dystrophy (DMD) - and to investigate whether there are common proﬁles of
UE function in these types of NMD.
Methods: Web-based administered questionnaires, including the Brooke classiﬁcation
and questionnaires covering UE impairments (pain and stiﬀness), activity limitations
and participation restrictions were distributed amongst people with four types of NMD
in the Netherlands. 267 respondents were included: FSHD (n=88), LGMD (n=65),
SMA (n=64), and DMD (n=50).
Results: The reported problems by the FSHD and LGMD group were characterized
by relatively high scores for pain and stiﬀness and low scores for activity limitations.
Conversely, the experienced problems of the DMD and SMA group were characterized
by relatively low scores for pain and stiﬀness and high scores for activity limitations.
Conclusions: Our results indicate speciﬁc proﬁles of UE function in diﬀerent types of
NMD. While the proﬁle observed in persons with FSHD and LGMD seems to reﬂect
overuse, the proﬁle seen in persons with DMD and SMA is suspicious of disuse, each
requiring a speciﬁc rehabilitation strategy.
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7.1 Introduction
Existing treatments in neuromuscular disease (NMD) mainly focus on symptom relief.
Rehabilitation, including physiotherapy, occupational therapy and speech therapy
are widely used to increase or maintain the ability to participate in daily activities
and society [1–3]. Particularly physiotherapy is widely applied for strength training,
functional training, endurance training, and muscle stretching [1]. A Cochrane review
on strength training and aerobic exercise training for muscle disease has shown
that here are few high quality RCT’s to show the eﬃcacy of exercise training [4].
Recently our group was however able to show that aerobic exercise training can
improve chronic fatigue and physical activity in people with FSHD [5] and that assisted
bicycle training can delay functional deterioration in DMD [6]. In order to develop and
test new treatment approaches in NMD, a thorough insight into the natural proﬁle
of each disease is necessary. Although the natural courses of the most common
NMD have been described in the past [7], these descriptions were mostly focused
on the level of muscle function and structure of the International Classiﬁcation of
Functioning, Disability and Health (ICF) [8], and hardly on the ICF-levels of activities
or participation. In previous studies, we already investigated UE activity limitations
in Duchenne Muscular Dystrophy (DMD) [9] and FacioScapuloHumeral Dystrophy
(FSHD) [10] using a web-based questionnaire. The aim of this study was to document
impairments (pain, stiﬀness), activity limitations and participation restrictions due to UE
involvement also in people with Limb Girdle Muscular Dystrophy (LGMD) and Spinal
muscular dystrophy (SMA) using the same self-report questionnaire that was used for
people with FSHD and DMD, and to investigate whether common proﬁles of UE can
be identiﬁed among these types of NMDs.
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7.2 Methods
Participants and procedure
A web-based survey (QuestionPro; Survey Analytics LLC, Seattle, USA) was designed
which covered the ICF-levels of structure and function, activities and participation.
This survey included questions concerning arm pain and stiﬀness adapted from the
University of Michigan Upper Extremity Questionnaire [11], the Brooke scale [12], the
x (CUE) [13], the Abilhand questionnaire [14] with four added questions (here referred
to as Abilhand-plus [9]) and open questions concerning participation [9]. In 2011, the
survey was sent via the Dutch NMD patient organization ‘Spierziekten Nederland’ to
their Dutch speaking members with DMD, FSHD, LGMD and SMA in the Netherlands
(for DMD also via the Dutch Duchenne Parent Project). The results of the FSHD and
DMD group were described separately before [9, 10]. In this study, the results of the
LGMD and SMA group are described and compared to the results of the FSHD and
DMD group (for persons with DMD only participants of the Netherlands, to make it
comparable with the other groups, and avoid cultural diﬀerences). This procedure
was approved by the medical ethical committee in the Arnhem-Nijmegen region (the
Netherlands). The study has been performed in accordance with the ethical standards
laid down in the Declaration of Helsinki.
Outcomes
Outcomes were divided into four categories (1) participant characteristics, (2) UE
impairments, (3) UE activity limitations and (4) related participation restrictions.
Participant characteristics
The assessed participant characteristics were: age, time since diagnosis, hand prefer-
ence, wheelchair conﬁnement, and use of assistive devices for the UEs. For the anal-
yses, the originally dominant arm was used in case hand preference had changed.
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UE Impairments
The pain and stiﬀness scores were divided into the aspects frequency (range: 0-6,
the higher the score, the higher the frequency), severity (range: 0-10, the higher the
score, the more severe) and disablement due to pain or stiﬀness (range: 0-10; the
higher the score, the more disabling). Combination scores were calculated for each
segment of the dominant and non-dominant arm (shoulder, upper arm, elbow, lower
arm, wrist, ﬁngers, thumb) by taking the sum of the three aspects (range: 0-26). A
similar approach was used before in the study by Janssen et al. [9]. Besides scores
for each arm segment, total sum scores for both the dominant and non-dominant side
of the UE were calculated (range: 0-182).
UE activity limitations
The Brooke scale was used to classify basic UE activities; the higher the score the
more limitations [12]; the CUE was used to assess basic UE capacity [13]; and the
ABILHAND-plus to assess the performance of daily activities [9, 14]. The CUE contains
32 items (30 items right/left arm, 2 items both arms) that can be scored on a 7-point
scale (1 = unable to perform, 7 = can perform without diﬃculty). The CUE questionnaire
in this study had 30 items in total, because the item “Hold a hammer” accidentally
was missing for both the left and right arm. Four CUE dimensions (CUE lift/reach,
CUE pull/push with arms, CUE arm/wrist moving and CUE hand/ﬁngers use) were
determined. These dimensions were based on the original validation of the CUE [13].
The ABILHAND-plus questionnaire contained 26 items (22 items that were described
by Vandervelde et al. [14] and four additional items that were indicated as important
by boys with DMD [9]) that were scored on a 3-point scale (0 = impossible, 1 = diﬃcult,
2 = easy) or could be answered with “I don’t know”.
Participation restriction
Respondents were asked if they went to school, had a job, practiced sports, had
hobbies, participated in household activities and were in a romantic relationship. Sub-
sequently, for each of these social roles, participants were asked if they experienced
restrictions due to UE impairments or activity limitations.
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Statistical analysis
The mean, median and standard deviation were calculated for age, time since diagno-
sis, pain and stiﬀness combination scores, Brooke scale and the four CUE dimensions.
The proportional scores of the CUE dimensions were calculated by dividing the sum of
the associated items by the maximum possible score of these items. The percentage
of respondents was calculated that: 1) experienced pain or stiﬀness in a certain UE
segment (combination score > 1) on either the right or left side; 2) answered a CUE
activity to be very, extremely or totally limited; and 3) answered an ABILHAND-plus
activity to be diﬃcult or impossible. When the participants did not fully complete the
questionnaire, all available items were included in the analysis. To compare the per-
centages of pain and stiﬀness complaints between the four groups, Wilcoxon rank-sum
tests were used. Bonferroni correction was applied to compensate for post-hoc testing.
To compare the CUE dimensions between the four groups, Kruskal-Wallis tests were
used. All statistical analyses were done using IBM SPSS Statistics version 22 for
windows (IBM®, Somers, USA).
7.3 Results
In total 267 respondents were included in this study (FSHD=88, LGMD=65, SMA=64,
DMD=50), of which 222 completed the whole survey (including the questions on
participation). The mean age in de DMD group was 15 years, whereas in the SMA,
LGMD and FSHD group the mean age varied from 39 to 51 years. In the FSHD and
LGMD group, less than 23% of the respondents was wheelchair conﬁned, whereas
more than 64% of the respondents was wheelchair conﬁned in the SMA and DMD
group. The use of arm supports was highest in the SMA group (28.1%) and lowest in
the LGMD group (11.5%). When considering Brooke scores of 2 to 6, representing
people that could beneﬁt from arm supports, respectively 19.4, 20.3, 36.7 and 27.8
percent of the persons with FSHD, LGMD, SMA and DMD reported use of such a
device. The mean Brooke score was highest in the DMD group and lowest in the
LGMD group. The patient characteristics are presented in Table 1.
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Table 1: Tasks that were executed by the participants
FSHD LGMD SMA DMD
N 88 65 64 50
N completed survey 71 49 55 47
Mean age (yrs) 51.1 46.2 39.1 15.2
Mean time since diagnosis (yrs) 19.1 11.7 25.4 10.8
Preferred hand (% right) 81.0 89.0 84.4 84.0
Wheelchair conﬁned (%) 17.6 23.0 71.9 64.0
Use arm support (%)
In total 17.6 11.5 28.1 18.0
Brooke score 2-6 19.4 20.3 36.7 27.8
Brooke score (mean) 2.8±1.0 2.3±1.3 2.9±1.4 3.1±1.9
UE impairments
Pain in the shoulder and upper arm was more often reported in FSHD than in LGMD,
SMA or DMD (all p<0.05). Pain in the lower arm and thumb was reported more often
in FSHD than in LGMD (lower arm: p=0.03 and thumb: p=0.05) (Figure 1). Persons
with FSHD not only reported pain most frequently, they also reported the highest
pain combination scores in the shoulders compared to persons with LGMD, SMA and
DMD (p=0.05, p<0.01 and p<0.01, respectively). The upper arm, wrist, thumb and
ﬁnger pain scores reported by persons with FSHD were signiﬁcant higher compared
to the scores reported by persons with DMD (p<0.01, p=0.02, p=0.02 and p=0.05,
respectively). Finally, the pain score of the upper arm reported by persons with FSHD
was higher compared to the scores reported by persons with SMA (p<0.01) (Figure
2).
Stiﬀness in the shoulders was reported most often by respondents with FSHD and
LGMD (66% and 69%, respectively). Stiﬀness in the shoulders was reported signiﬁ-
cantly more often by persons with FSHD and LGMD compared to persons with DMD
(p=0.04 and p=0.03, respectively). Diﬀerences in the percentages of participants
reporting stiﬀness complaints in other parts of the arm were present, but not signiﬁcant
(Figure 1). The highest stiﬀness combination scores were reported by persons with
FSHD and LGMD in the shoulders and upper arms (Figure 2). The stiﬀness score of the
shoulders reported by respondents with FSHD was signiﬁcantly higher than the score
reported by respondents with DMD (p<0.01) and the upper arm score was signiﬁcantly
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higher in the FSHD group compared to the SMA and DMD group (p=0.02 and p=0.02,
respectively). Between the FSHD and LGMD group, no signiﬁcant diﬀerences were
found between the stiﬀness scores (p>0.05).
UE activity limitations
Items of the CUE that required reaching and lifting were limited in all four types of NMD.
Respondents with SMA and DMD reported in general more activity limitations in all CUE
dimensions than persons with FSHD and LGMD, whereas no signiﬁcant diﬀerences
were found between FSHD and LGMD nor between SMA and DMD (p>0.05) (Figure 3
and Figure 4).
Most UE activity limitations were reported by persons with DMD and SMA, who reported
37 and 24% of the ABILHAND-plus activities being impossible to perform and 32 and
26% diﬃcult to perform, respectively. In FSHD and LGMD, 2 and 5% reported that
activities were impossible and 26 and 17% that activities were diﬃcult to perform,
respectively. On average, 72% of the participants with FSHD reported activities to be
easy to perform and in LGMD this was 78%. In SMA and DMD, this was 44 and 37%,
respectively (Figure 4).
Participation restrictions
Of the respondents with DMD, 73% went to school and 71% experienced UE-related
restrictions at school. For the respondents with FSHD, LGMD and SMA, the corre-
sponding percentages were 11% / 50%, 14% / 71% and 14% / 88%, respectively. About
half of the respondents with FSHD (51%), LGMD (49%) and SMA (55%) participated
in work versus 21% for DMD. More than 60% of all groups experienced UE-related
restrictions at work. Participation in sports varied from 30% in the FSHD, LGMD
and SMA groups to 47% in the DMD group. At least 86% in all groups experienced
UE-related restrictions in sports. The majority of the respondents (DMD 85%, LGMD
and SMA 90%, and FSHD 94%) participated in hobbies. More than 70% (DMD and
SMA) or 80% (FSHD and LGMD) experienced UE-related restrictions in this domain. If
respondents participated in household activities (75% in FSHD and LGMD; and 42% in
SMA. This question was not asked to people with DMD), UE-related restrictions were
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Figure 1: Percentage of participants mentioning having pain (top) and stiﬀness (bottom). (Pain
and stiﬀness scores > 1, *: p<0.05, **: p<0.01)
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Figure 2: Average pain and stiﬀness combination scores for the diﬀerent NMD per body
segment (maximal possible pain and stiﬀness score = 26)
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Figure 3: Capacity of Upper Extremity. Data points represent mean CUE scores as percentage
of the maximal possible score, with standard deviations. The higher the percentage, the more
diﬃculties were experienced. (**: p<0.01; *: p<0.05)
reported by 78% of the SMA group, 89% of the LGMD group and 93% of the FSHD
group. More than 80% of the respondents with FSHD and LGMD were involved in a
romantic relationship, compared to 51% of the SMA group and 0% of the DMD group.
Of those with a romantic relation, 71% reported that they experienced UE-related
restrictions in maintaining this relationship.
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Figure 4: Individual Percentage of participants that mentioned being very, extremely or totally
limited in performing certain CUE activities (item "holding a hammer" is missing).
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7.4 Discussion
The aim of this research was to study impairments (pain, stiﬀness), activity limitations
and participation restrictions due to UE involvement in people with FSHD, LGMD,
SMA and DMD using self-report measures and to investigate whether common or
diﬀerent proﬁles could be identiﬁed. About 20 years ago, a series of proﬁles was
published concerning FSHD, LGMD, SMA and DMD [15–18] that described the general
changes in muscle strength and provided a good understanding of the experienced
impairments in these patient groups. The perspective of the current study aimed not
only at UE impairments, but also at activity limitations and participation restrictions due
to UE involvement using uniform self-reported outcome measures. We found a large
impact of UE impairments on daily activities and societal participation in persons with
NMD, emphasizing the importance of rehabilitation interventions aimed at reducing or
compensating for the activity limitations and participation restrictions related to UE
impairments.
We previously reported UE impairments and activity limitations separately for people
with FSHD and DMD [9, 10]. In current study these populations were compared with
each other as well as with people with LGMD and SMA to investigate whether common
or diﬀerent proﬁles could be identiﬁed among the diﬀerent types of NMD. In general,
the proﬁle of UE activity limitations in SMA was quite similar to that observed in DMD,
while the proﬁle of UE activity limitations in LGMD showed similarity to that of FSHD,
however, major diﬀerences were observed between LGMD and FSHD on the one hand
and SMA and DMD on the other hand. Based, on the ABILHAND-plus, limitations
in UE activities were less often reported by persons with FSHD and LGMD than by
persons with SMA and DMD.
Pain was reported by more than 30% of the respondents in one or more segments
of the UE, and the highest frequencies of pain were reported by people with FSHD
in the shoulder and upper arm. Also in previous studies, it has been shown that
pain is reported frequently in persons with diﬀerent types of NMD, including FSHD,
LGMD, SMA and DMD (frequencies ranging from 54%-96%) [19–22]. In this study,
we found a similar proﬁle for stiﬀness as for pain. Pain and stiﬀness are not always
easily discerned from each other as subjective feelings. This could be explained by
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the relation between pain and stiﬀness (correlation coeﬃcients ranging from 0.44 to
0.83 and p<0.01).
Looking at functional limitations measured with the Abilhand-plus, we found that despite
the high pain and stiﬀness scores in persons with FSHD and LGMD, the limitations in
activities were less prominent than in persons with SMA and DMD. An explanation for
this ﬁnding may be that people with FSHD and LGMD are inclined to overuse their UE,
whereas in people with SMA and DMD there is a decrease in use of the UE due to
higher muscle weakness in the disease course.
The above-mentioned notion can give direction to diﬀerential rehabilitation strategies.
Pain is an important complaint in both FSHD and LGMD and often remains unad-
dressed and untreated in the NMD population [19]. If pain is a sign of overuse in
FSHD and LGMD, education to avoid dysfunctional compensation strategies should
be a key strategy in addition to exercises to improve muscular coordination during
functional movement with or without the use of arm supports. Due to lack of strength
there is a higher risk of inactivity and minimal use of the arms in DMD and SMA. This
results potentially in less pain, but also in decreased use of the upper limb, which
in itself may result in further loss of UE function [6]. New insights have shown that
UE training in DMD is likely to result in the retaining of improved UE function. A
recent study showed that young men with DMD retained signiﬁcantly more UE function
six months after assisted UE training compared to a control group of DMD patients
without such training [6, 23]. In the current study it was remarkable that, despite the
high percentages of severe UE limitations, less than 50% of the persons that could
possibly beneﬁt from an arm supportive device reported the use of such a device. In a
review on the eﬀectiveness of dynamic arm supports, there was already concluded
that the use of such supports in the home situation is often very low [24]. Our results
show that there are diﬀerent proﬁles of UE function in people with NMD that call for a
personalized approach instead of a one-size-ﬁts-all solution.
Study limitations
The questionnaire that we used was originally designed for people with DMD. Since
DMD is extremely rare in women, gender was not asked for in this study. The question-
naire we used was self-reported and, therefore, represented the patients’ perspectives.
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Thus, the pain and stiﬀness scores did not provide insight in the actual impairments of
muscles and/or joints causing the pain and stiﬀness complaints. Some of the items
of ABILHAND-plus questionnaire addressed activities typical of adulthood, such as
cutting nails. These items may have been hard to answer by the younger adolescent
respondents.
Conclusion
This study provides a unique overview of UE function in people with various types of
NMD based on self-reported outcomes. It shows that pain and stiﬀness are highly
prevalent impairments and that many people experience activity limitations and par-
ticipation restrictions due to UE involvement. While persons with FSHD and LGMD
experienced relatively severe pain and relatively few activity limitations, persons with
DMD and SMA showed the opposite pattern. These distinct proﬁles may be related to
predominant ‘overuse’ (FSHD and LGMD) and ‘disuse’ (DMD and SMA), respectively,
and provide clues as to what rehabilitation strategy would be most appropriate from a
personalized healthcare perspective.
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8Summary and general
discussion
8.1 Summary
Upper limb movements play a fundamental role in the performance of daily life activities.
There are various neuromuscular disorders (NMD) that can impair the ability to use the
upper limbs properly, which may inﬂuence people’s quality of life. Typical conditions
that have an impact on the ability to use the upper limbs are Facioscapulohumeral
Dystrophy (FSHD), Limb-girdle Muscular Dystrophy (LGMD), Duchenne Muscular
Dystrophy (DMD) and Spinal Muscular Atrophy (SMA). To improve the quality of life of
people living with NMD who experience severe upper limb impairments, it is important
to facilitate the performance of activities of daily living (ADL). This can, for example,
be achieved by using assistive devices that augment arm function.
The aim of this thesis was to study upper limb function in people with FSHD and
to compare this function between FSHD and other types of NMD that are known to
aﬀect the upper limbs. Several approaches were used: ﬁrst, a literature review was
performed, followed by a survey to explore the inﬂuence of upper limb activity limitations
in FSHD on daily life. These results were compared to other NMD with known upper
limb involvement (LGMD, SMA, and DMD) by means of the same questionnaires.
Finally, laboratory studies were conducted to examine the arm in a 3D-environment
combined with muscle activation patterns with and without arm support.
Upper limb assistive technology for people with DMD
Chapter 2 describes the outcomes of a workshop about the requirements for upper
limb function research and the state-of-the-art assistive devices that can be used to
support upper limb function. This workshop focused speciﬁcally on DMD, because in
this group upper limb function and the use of supportive devices have been investi-
gated before. The primary goal of the workshop was to bring people from diﬀerent
disciplines together and discuss opportunities to accelerate the development of upper
limb assistive technology for enhancing the functional abilities of non- ambulant men
with DMD. Twenty-four participants representing parents, experts in user requirements,
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human-machine research, electrical and mechanical engineering, and clinicians in-
volved in the care of children with DMD from Denmark, the Netherlands, the UK and
the USA participated in the workshop. The workshop addressed the user requirements,
the current methods for the evaluation of arm function, the commercially available arm
supports, the current research projects towards active arm supports, and emerging
technologies that could be useful for the future development of assistive technology
for people with DMD. In order to improve quality of life for those living with Duchenne,
independence and participation must be facilitated. It was stated that individuals with
DMD express an urgent need for privacy, for example during toilet use. Social contacts
and employment are indicated as priorities as well. Current available arm support
devices are still not widespread used at home. There are several initiatives that aim
to develop solutions that better suit the needs of (young) men with DMD. In order
to optimize devices and assess eﬀectiveness of devices, quantitative and objective
evaluation methods are needed as well as clinical validation methods to assess the
value of these new prototypes under operating conditions. Quantitative data comprise
kinematic parameters, such as the range of motion of supported arm movements,
and the muscle eﬀort that is needed for using a particular type of arm support. To
assess upper limb function, among other things, evaluation of reachable workspace
was mentioned. This construct has demonstrated its applicability as a marker of upper
limb function in DMD. Besides the assessment of upper limb functions, there is a need
for outcome measures to evaluate how much the upper limbs are used during the day.
Six clusters of actions were identiﬁed. These were: (a) identifying user and caregiver
needs and acceptance, (b) assess performance of user and caregiver before and after
ﬁtting a device, (c) develop lab and mobile testing metrics and protocols, (d) gather
data on use of devices, (e) develop modular technology, and (f) work on accessibility
and reimbursement in diﬀerent countries.
Review on upper limb function and activity in FSHD and
LGMD
Chapter 3 comprises a literature review of what is known about the natural course of
upper limb functions and capacities in persons with FSHD and LGMD. Both FSHD and
LGMD are slowly progressive diseases that have a typical age of onset between 10
and 30 years of age. This study also gives an overview of outcome measures that are
used to evaluate upper limb function and activities in patients with FSHD and LGMD.
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A search of the PubMed, MEDLINE, EMBASE, CINAHL and Cochrane databases was
performed using the MeSH terms and free text words “fshd” OR “facioscapulohumeral”
OR “limb girdle muscular dystrophy” in combination with “upper extremity” OR “arm”
OR “hand”. This search yielded in 247 articles, and the ﬁnal selection included 16
articles. The included studies comprised a total of 272 patients with FSHD (mean
age ranging from 36 to 59) and 270 patients with LGMD (mean age ranging from
35 to 55). It was concluded that the clinical picture of upper limb impairments and
activity limitations in FSHD and LGMD patients is highly variable. In general, FSHD
and LGMD patients experience diﬃculties while elevating their arms. The execution of
tasks takes a considerably longer time. The clinical course of upper limb functions
and capacities in persons with FSHD and LGMD is hard to predict due to a high
variability. To evaluate upper limb function in FSHD and LGMD patients, manual
muscle testing (MMT) is the most commonly used method. In this review, it was not
possible to compare MMT results between various studies, as most of the studies
reported a composite score of strength instead of scores for the various muscle groups.
Although MMT is considered to be a valid measure to determine disease progression,
MMT is a rather unreliable method for assessing isometric muscle strength. One
study used electromyography (EMG) recordings of several muscles (biceps brachii,
brachioradialis, triceps and deltoid anterior) during a simulated drinking task. The
researchers found that EMG activity during this task was higher in a FSHD group
than in healthy controls. The muscle activity and movement patterns in the FSHD
group included more synergistic muscle activity and more abduction and ﬂexion of
the shoulder and elbow joints. To evaluate people’s capacity to use the arms during
activities, the Brooke scale (scores ranging from 1 to 6) is mostly used. Relatively few
people with FSHD reported, however, a Brooke score of 5 or 6, making the Brooke
scale not sensitive to measure small diﬀerences in upper limb capacity. Besides,
the Brooke scale only classiﬁes the capacity of basic reaching activities of the arm
and hand. More speciﬁc measures to evaluate upper limb capacity and performance
during daily activities have not been used. Although measures like MMT and the
Brooke Scale are often used, this review showed that there is a lack of more speciﬁc
outcome measures to assess upper limb function, capacity and performance. It was
stated that measures such as 3D motion analysis and EMG recordings are needed
to provide additional insight in upper limb function. Moreover, questionnaires like the
Abilhand are recommended to assess upper limb capacity, whereas accelerometry is
recommended to assess upper performance in daily life.
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Upper limb function and activity in FSHD
In chapter 4, the upper limb in people with FSHD was studied by using questionnaires
at the level of impairments, activity limitations and participation restrictions. A web-
based survey was designed, which covered these dimensions of the International
Classiﬁcation of Functioning Disability and Health of the World Health Organization
(ICF). On the dimension of upper limb function, the survey included questions con-
cerning pain and stiﬀness adapted from the University of Michigan Upper Extremity
Questionnaire. To assess the capacity of using the arms during basic activities, the
Brooke scale and the Capabilities of Upper Extremity Questionnaire (CUE) were used.
The Abilhand-plus questionnaire was included to assess the capacity during daily
activities. Moreover, open questions concerning participation were included. Eighty-
eight persons with FSHD answered the questions. Besides the well-known problem of
lifting the arms above shoulder level in FSHD, upper limb activities below shoulder
level during vocational and occupational activities also appeared to be problematic
in patients with FSHD. More than 40% of the respondents with FSHD experienced
pain in one or both arms. The results showed that increased pain and stiﬀness scores
and longer disease duration were associated with increased activity limitation. About
80% of the respondents indicated restrictions at work and while participating in sports,
hobbies, household activities and romantic relationships.
Upper limb kinematics and muscle activation patterns in
people with FSHD
Persons with FSHD have an increased risk of tendon or muscle damage due to com-
pensatory movements that are often used to lift the upper limb and to over- come the
lack of strength of the scapula-stabilizing muscles. Innovative arm supports may help
persons with FSHD to perform arm activities that would cost considerable eﬀort or
might cause possible damage. In order to optimize devices and assess their eﬀective-
ness, quantitative and objective evaluation methods are needed. Quantitative data
comprise kinematic parameters, such as the range of motion of arm movements and
muscle eﬀort that is needed to move the arms. A study of Bakhtiary et al. provided the
ﬁrst knowledge of arm function in FSHD during a simulated drinking task. However,
muscles that are responsible for stabilizing the scapula were not investigated. In chap-
8.1 Summary 163
ter 5, the kinematics of the upper limb and the involvement of speciﬁc proximal muscles
(biceps brachii, deltoid (lateral part), triceps brachii, trapezius (upper part), pectoralis
major (clavicular part) and latissimus dorsi) during singular joint movements, reaching
tasks and gross motor tasks were studied in persons with FSHD and healthy controls.
Eleven persons with FSHD and eight healthy volunteers participated. Participants
were asked to perform a set of six standardized movements (shoulder abduction-
adduction, shoulder ﬂexion-extension, reaching to the ipsilateral and con- tralateral
side at shoulder level, moving the hand to the mouth and pulling-pushing of an object
on a table). For each person and each task, the mean of the maximum upper limb
elevation and minimum and maximum elbow ﬂexion angle was calculated. All persons
were able to complete the two reaching tasks and the two gross motor tasks. We found
kinematic diﬀerences between the FSHD group and a healthy control group, mainly
in the shoulder elevation angle during single shoulder movements and both reaching
tasks. Only one person with FSHD was able to elevate the arm above 120º during
the shoulder abduction-adduction and ﬂexion-extension movements. Compared with
healthy subjects, persons with FSHD activated their shoulder muscles to a greater
extent during movements that required arm elevation. The median activity of the
trapezius during the single shoulder movements was close to the muscle activity dur-
ing maximum voluntary contractions. Moreover, deltoid and pectoralis muscles were
highly active. It was concluded that higher activation of the trapezius in subjects with
FSHD indicates a mechanism that could help to support impaired shoulder muscles
during arm elevation at shoulder height. Visual inspection of the timing of muscle
activations did not show any diﬀerence between the control group and the FSHD
group.
Eﬀect of forearm gravity compensation on upper limb
kinematics and muscle activation in persons with FSHD
Arm supports are developed to compensate for loss of arm function. In chapter 6, the
eﬀect of forearm gravity compensation on kinematics and muscle activity of participants
with FSHD and healthy participants was studied during the performance of standard-
ized upper extremity tasks (shoulder abduction-adduction, shoulder ﬂexion- extension,
reaching to the ipsilateral and contralateral side at shoulder level, moving the hand to
the mouth and pulling-pushing of an object on a table). Eleven persons with FSHD
(Brooke scores 2 to 3) and eight healthy controls were instructed to perform the set of
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movements, ﬁrst with and subsequently without the aid of a SLING forearm support
mechanism. Changes in shoulder kinematics and muscle activity were quantiﬁed while
participants performed a set of standardized tasks with and without the SLING support
mechanism. Shoulder abduction and ﬂexion movements were hindered in healthy
controls, resulting in lower elevation angles. These movements were not hindered
in the persons with FSHD. Execution times were shorter during the SLING- assisted
shoulder and hand to mouth movements compared to the none supported tasks, but
longer in the SLING-assisted reaching and pull/push tasks. Movement of the trunk
decreased when the SLING was used during the shoulder ﬂexion extension movement,
in both the control and the FSHD group. As expected, an overall reduction in muscle
activity was found when the SLING was used, which conﬁrmed previous research
ﬁndings in healthy individuals. Using the SLING resulted in later activation onsets
of biceps and deltoid during both reaching tasks in the FSHD group. In addition, a
later onset of the trapezius muscle was found during the contralateral reaching task in
the FSHD group. This ﬁnding implies that the FSHD group used inertial mechanisms
more to their advantage when more scapular mobility was required, resulting in a
later activation of the trapezius muscle. To characterize the proﬁle of arm support
users more accurately, information about muscle activity should be complemented
by information about joint moments and forces, while scapular stabilizers such as the
lower trapezius and the serratus anterior should also be measured.
Diﬀerent proﬁles of upper limb function in four types of
NMD
The web-based survey that was sent to the FSHD group (chapter 4) was also sent to
a group of people with DMD, LGMD, and SMA. In chapter 7, the impairments, activity
limitations and participation restrictions related to the upper extremity that were reported
by people with FSHD were compared to those reported by people with LGMD, SMA
and DMD in the Netherlands. The aim of this study was to investigate whether diﬀerent
proﬁles of upper limb function can be identiﬁed among these types of NMDs. On the
level of upper limb function, the web-based survey included questions concerning
pain and stiﬀness. To assess the capacity of using the arms during basic activities,
the Brooke scale and the Capabilities of Upper Extremity Questionnaire (CUE) were
used. The Abilhand-plus questionnaire was included to assess the capacity during
daily activities. Moreover, open questions concerning participation were included. In
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total 267 respondents were included (FSHD=88, LGMD=65, SMA=64, DMD=50), of
which 222 completed the whole survey. The mean age of de DMD group was 15
years, whereas in the SMA, LGMD and FSHD groups the mean age varied from 39
to 51 years. In the FSHD and LGMD groups, less than 23% of the respondents was
wheelchair conﬁned, whereas more than 64% of the respondents was wheelchair
conﬁned in the SMA and DMD groups. The use of arm supports was highest in the
SMA group (28.1%) and lowest in the LGMD group (11.5%). When the people that
could beneﬁt from arm supports were selected (Brooke scores 2 to 6), use of arm
support was reported by 19.4%, 20.3%, 36.7% and 27.8% of the persons with FSHD,
LGMD, SMA and DMD, repectively. The mean Brooke score was highest in the DMD
group and lowest in the LGMD group. Pain in one or more segments of the upper
limb was reported by more than 30% of the respondents. The highest frequencies of
pain were reported by people with FSHD in the shoulder and upper arm. The reported
pain scores related strongly to the reported stiﬀness scores, and it was suggested that
pain and stiﬀness may not always easily be discerned from each other as subjective
feelings. Most upper limb activity limitations were reported by persons with DMD and
SMA, who reported 37 and 24% of the ABILHAND-plus activities being impossible to
perform and 32 and 26% diﬃcult to perform, respectively. In FSHD and LGMD, only 2
and 5% reported that activities were impossible and 26 and 17% that activities were
diﬃcult to perform, respectively. Similar to the FSHD group, the reported problems by
persons with LGMD were characterized by relatively high scores for pain and stiﬀness
and low scores for activity limitations. In contrast, the proﬁle of the DMD and SMA
group was characterized by relatively low scores for pain and stiﬀness and high scores
for activity limitations. These results indicate distinct proﬁles of upper limb function in
diﬀerent types of NMD. While the proﬁle observed in persons with FSHD and LGMD
seems to reﬂect overuse, the pattern seen in individuals with DMD and SMA is more
suspicious of decreased use of the upper limb. It is suggested that each pattern
requires a particular rehabilitation strategy.
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8.2 General discussion
Arm and hand movements are essential for proper functioning in everyday life. In
neuromuscular disorders like Facioscapulohumeral Dystrophy (FSHD) the ability to
use the arms and hands is often impaired, which may inﬂuence people’s social partici-
pation and quality of life. Impaired upper limb function during activities of daily living
(ADL) can be supported by technological interventions like dynamic arm supports.
Dynamic arm supports are devices that assist the human arm during movement against
gravity. There are various types of dynamic arm supports available [1, 2] that can be
categorized into non-powered and powered devices [3, 4]. Depending on user require-
ments, these devices may support according to the principle of assist-as-needed or
by completely lifting the arm [5]. While the eﬀectiveness of dynamic arm supports has
been demonstrated under laboratory conditions, the actual use of these devices at
home is often low [1]. The main focus of this thesis was to study arm functioning of
FSHD patients and, subsequently, to evaluate the eﬀect of dynamic arm support on
arm functioning. This thesis was part of the McArm project that intended to develop a
new type of arm support that is motion controlled for which insight in the contributing
factors to arm movement is needed.
The following discussion consists of two parts. First, the studies that are conducted in
this thesis are discussed within the context of recent studies done by others. In the
second part, remaining gaps are identiﬁed and recommendations are made to ﬁll these
gaps. To classify functioning and to structure the measures that were used in this
thesis and those that are recommended for future research, the classiﬁcation of the
International Classiﬁcation of Functioning, Disability and Health (ICF) was used (Figure
4). The ICF was developed by the WHO and provides a framework for classifying
health and disability at both the individual and population levels [6].
Body functions and structures
In this thesis we studied 3D arm movements in relation to standardized EMG, which is
based on the EMG during maximum voluntary contractions as these are used during
manual muscle testing (MMT). MMT is considered as a valid measure to determine
disease progression. It is, however, also argued that MMT is a rather unreliable
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method for assessing isometric muscle strength. This could have inﬂuenced the
standardized EMG outcomes. To determine the mobility of the human arm, passive
range of joint motion (ROM) in the sagittal, horizontal and frontal planes, a standard
method in physiotherapy [7], is often used. In this thesis, we measured active ROM in
the shoulder and elbow joints during a set of single joint movements in a laboratory
setting, combined with electromyography (EMG) of several shoulder muscles. This
was also done by Bakhtiary et al. [8] for one task. The results were well comparable.
We asked participants to execute the activities ﬁrst without and subsequently while
using a SLING arm supportive device. This provided insight in the ROM at the shoulder
and elbow joints. These investigations helped to understand the added value of arm
support at the level of muscles activity and range of joint motion for people with FSHD.
We also looked at changes in muscle activity and shoulder ROM when using a SLING
dynamic arm support. From these studies, we learned that the utilization of a forearm
support mechanism by people with FSHD can increase the shoulder ROM, and reduce
muscle activity. The ﬁnding that forearm support reduces muscle activity in people
with NMD is in line with what other studies have shown. Kooren et al. [9] showed for
example that upward and forward movements were experienced easier to perform
by persons with DMD when they used dynamic arm support. Beside the quantitative
objective measures, we were also interested in subjective impairments that people
report. We asked people about pain and stiﬀness in the diﬀerent parts of the upper
limbs. We found that people with FSHD and LGMD reported relatively higher scores for
pain and stiﬀness compared to people with DMD and SMA. Pain was also mentioned
by others as a common problem among patients with NMDs [10, 11]. The diﬀerence
between various NMDs has however not been studied before.
Activity and participation
In the activity and participation domains, two qualiﬁers are provided by the World
Health Organisation [6], namely capacity and performance. Capacity describes an
individual’s ability to execute a task or an action, and indicates the highest probable level
of functioning of a person in a given domain at a given moment. Performance describes
what an individual does in his or her current environment. To classify capacity limitations
in FSHD and LGMD, the Brooke scale is most often used (see review, chapter 3). The
Brooke scale is, however, not sensitive enough to measure small diﬀerences in upper
limb capacity. Besides, the Brooke scale only classiﬁes the capacity of basic reaching
168 Chapter 8 Summary and general discussion
activities of the upper limb. Therefore, the studies of this thesis included the CUE
and Abilhand questionnaires. These questionnaires were useful to explore at a group
level during which activities people face most limitations. With these measures, we
were able to identify two diﬀerent capacity patterns (overuse and under-use) between
diﬀerent types of NMD. These proﬁles have not been described by others before.
Based on these proﬁles, more group and individual treatment approaches could be
developed. For example in FSHD and LGMD, it could help to make patients more aware
of possible overuse and negative compensatory strategies. Positive compensation
strategies can be stimulated next to using devices and ﬁnding a balance between
physical activity and resting periods. In SMA and DMD, people can be enabled to
move by means of devices to maintain joint mobility and muscle length.
Recommendations
Active ROM at the shoulder and elbow are calculated from the 3D motion capture data
that was recorded in the motion laboratory. Although active ROM in the shoulder and
elbow tells us something about overall arm function, it does not explain well how a
person can move the hand in 3D space to perform activities. Instead of the active ROM
in the shoulder and elbow, the volume in which a person can place the hand(s) can
be useful. This volume is called the reachable workspace of the arm. The concept of
reachable workspace has been used in analyzing mechanical arm supports [12]. The
reachable workspace has also been proposed as a parameter to evaluate shoulder
pathologies [7, 13]. For the use in a clinical setting, it is important to have a pragmatic
approach. The group of Han [13] developed a pragmatic and intuitive approach using a
Kinect camera to assess the upper extremity reachable workspace in people with NMD.
The reachable workspace parameter oﬀers a numerical expression of the shoulder
functions, that is easy to understand by patients and professionals engaged in the
clinical evaluation of the upper limb. The reachable workspace can also be shown
graphically in an easy-to-interpret way (Figure 1).
Such a pragmatic approach may also be useful to assess how fatiguing repetitive
movements are for a person. In case of increasing fatigue, the reachable workspace
decreases. Moreover, the reachable workspace is recommended to assess the eﬀect
of using a dynamic arm support on the arm movement of persons with NMD. The
presence of an arm support may, however, block the view of the camera observing
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Figure 1: Intuitive graphical visualization of 3D reachable workspace. A 7-year-old, healthy con-
trol’s reachable workspace viewed from diﬀerent directions, along with reachable workspaces
of individuals with DMD (ﬁgure used from Han et al. [13]
the person in the system used by Han. This calls for an alternative way to capture 3D
motion data, for example, by using inertial sensors. Such sensors detect forces by
sensing linear acceleration along one or several directions (accelerometer), or angular
motion about one or several axes (gyroscope) [14].
The CUE and Abilhand questionnaires provided insight in the overall ability of a person
to execute certain activities. The CUE and Abilhand questionnaires were useful to
explore limitations in people’s capacity at a group level. More speciﬁc measures to
evaluate upper limb capacities during daily activities were, however, lacking when
this study started. Recently, the Performance of the Upper Limb (PUL) outcome
measure has been developed and validated for the DMD population [15]. Although
the instrument has not been validated yet for adults with NMD, it may be a useful
instrument for future studies. The actual performance of an individual in his or her
current environment is still unknown. Interview-based assessments like the Canadian
Occupational Performance Measure (COPM) are recommended to identify during
which daily activities individuals perceive limitations, and how satisﬁed they are about
performance of these activities. However, to assess a persons’ upper limb performance
and related energy expenditure during the day, questionnaires and interviews are not
the most appropriate measures. To monitor how a person performs activities, video
observation can be used. A disadvantage of video observation is, however, that
somebody needs to assess the video material, which makes it a subjective and very
time consuming approach. Besides, installing a video system in a patient’s home
is a problem and involves privacy issues [16]. To determine a person’s movement
performance during the day, inertial sensors like accelerometers can also be used
[17]. The use of accelerometers has been proposed in diﬀerent research settings
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as a reliable and valid assessment of daily physical activity in various populations.
Studies have been done for example in healthy children [18], healthy adults [19],
young boys with DMD [20] and people with stroke [21]. In most of these studies,
accelerometers were attached to the hip and general levels of physical activity of
persons were reported. There are, however, also examples where the arm-hand
usage in daily life was measured with accelerometers mounted on the wrist [22]. Wrist-
worn accelerometers have also been used in clinical studies, for example to estimate
the use the aﬀected upper limb of patients with stroke in real-life situations [17, 23,
24] or to quantify characteristics of daily arm activities in patients with COPD [25]. To
determine the actual use of the arms during ADL performance, with or without the use
of a dynamic arm support, the use of accelerometers is also recommended.
While body movements can be measured with accelerometers, they provide no in-
formation on the actual energy expenditure of a person. In a study by Meijer et al.
[25], the daily arm activities were assessed using accelerometers in a laboratory envi-
ronment, while the relative eﬀorts of the trapezius, deltoid and biceps muscles were
studied by recording EMG during a set of daily activities. This approach does, how-
ever, not provide insight in the actual performance of daily life activities. A combined
measurement of physical movement activity and muscle activity is recommended,
to estimate how much the arms are moved and how active the muscles are actually
used during daily activities. A pilot has been performed to evaluate the feasibility
of such a combined recording of accelerations and muscle activity. For this pilot, a
six channel mobile system for measuring EMG and accelerations was used (Mobi,
TMSi). First, a person was asked to perform a set of simulated daily tasks, while the
accelerations of the upper arm were recorded in three directions (x, y and z), while in
the meantime the EMG of the trapezius, deltoid, serratus and pectoralis muscles were
recorded [26]. Figure 2 shows that tasks that require certain arm movements can be
clearly recognized. Figure 3 shows the results of a 4-hour and 9-hour recording, while
a person was performing daily activities. Such recordings may be useful to get an
objective impression of a person’s physical arm activity and how actively the muscles
are used.
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While a combined measurement of physical movement activity and muscle activity may
be useful to estimate how much the arms are moved during the day, and how active
the muscles are actually used during performance of daily activities, such a method is
not suitable to look at individual activities that a person is performing. By using motion
tracking sensors that include both accelerometers and gyroscopes, also ROM and
reachable workspace parameters can be determined over a longer period of time. Such
recordings will however generate a huge amount of data that will have little meaning
without any contextual knowledge of the activities that are actually performed. It would
therefore be beneﬁcial to have an automatic approach to structure the recorded data.
A set of tools that was developed to facilitate highly automated, structured recording,
analysis and presentation of data is FusionTools, developed by Roessingh Research
and Development. This tool uses Hidden Markov Models (HMM), a type of stochastic
signal models, that are extensively used in speech classiﬁcation. The FusionTools
have, among other things, been used to classify lifting activities [27]. After a learning
period the software can recognize a movement if it is performed in a similar way during
training. The feasibility of using such an approach based on Hidden Markov Model
techniques to classify arm movements was tested in a group of people with DMD
[28]. Five healthy persons and three persons with DMD were asked to perform an
alternating series of activities (e.g. eating, drinking, working on a laptop and reaching
towards two diﬀerent points), while arm movements were recorded by using 3D motion
tracking sensors (XSens MTx). Although proper calibration was diﬃcult in the persons
with DMD who had very limited arm function, activities could be classiﬁed successfully
[28]. Further development and evaluation of such an approach is recommended in
order to evaluate the quality of actual arm-hand performance when an arm support is
used.
To summarize, measures on the level of upper limb functions and capacities were
studied in this thesis. For future studies, it is recommended to use measures that
provide insight in the reachable workspace of the hand and in the performance of
upper limb movements during daily life. Figure 4 gives an overview of the speciﬁc
instruments that are studied and recommended. More insight is needed to have a
better understanding of upper limb use in daily life and to develop more individualized
treatment interventions like training programs or supportive devices.
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Figure 3: Overview of accelerations of the upper arm and related EMG activity of trapezius,
deltoid, pectoralis and serratus muscles, during daily life activities performed in a time span of
4 (left) and 9 (right) hours.
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Figure 4: Overview of measures that are studied in this thesis, and measures that are
recommended at the diﬀerent levels of the International Classiﬁcation of Functioning, Disability
and Health (ICF) model (World Health Organization (WHO, 2001)[6]
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Armbewegingen spelen een fundamentele rol bij het uitvoeren van dagelijkse ac-
tiviteiten. Er zijn verschillende neuromusculaire aandoeningen (NMA) die de mogelijk-
heid om de armen goed te kunnen gebruiken beperken, waardoor de kwaliteit van
het leven aangetast kan worden. Ziektebeelden die invloed hebben op het kunnen
gebruiken van de armen zijn Facioscapulohumerale dystroﬁe (FSHD), Limb-girdle
spierdystroﬁe (LGMD), Duchenne spierdystroﬁe (DMD) en spinale musculaire atroﬁe
(SMA). Om de kwaliteit van leven te verbeteren van mensen met NMA die ernstig
beperkt worden in het gebruik van de armen, is het belangrijk om het uitvoeren van
dagelijkse activiteiten te vergemakkelijken. Om dit te realiseren kan er bijvoorbeeld
gebruik gemaakt worden van hulpmiddelen die de armfunctie vergroten.
Het doel van dit proefschrift is om de functie van de armen te bestuderen bij mensen
met verschillende vormen van NMA. Er zijn verschillende benaderingen gebruikt. Er is
eerst een literatuurstudie uitgevoerd naar het beloop van de armfunctie, hoe dit wordt
gemeten en welke behandelingen er zijn, gevolgd door een vragenlijstonderzoek om de
invloed van beperkingen in de bovenste ledematen op het dagelijks functioneren van
mensen met FSHD te verkennen. Deze resultaten zijn vergeleken met andere NMA
met beperkingen in de armfunctie (LGMD, SMA en DMD) door middel van dezelfde
vragenlijsten. Tenslotte is een studie uitgevoerd in het bewegingslaboratorium om
bewegingen van de armen in een 3D-omgeving te onderzoeken met en zonder het
gebruik van een armondersteuning, en daarnaast is ook naar spieractivatiepatronen
gekeken.
Technologie om de bovenste ledematen van mensen met
DMD te ondersteunen
Hoofdstuk 2 beschrijft de resultaten van een workshop over de eisen voor armfunctie
onderzoek bij mensen met DMD en de techniek die beschikbaar is om de armen te
ondersteunen. Deze workshop was speciﬁek gericht op DMD, omdat er in die groep
relatief veel onderzoek is gedaan naar de functie van de armen en het gebruik van
hulpmiddelen. De resultaten zijn echter ook relevant voor andere neuromusculaire
aandoeningen (NMD). Het primaire doel van de workshop was om mensen uit ver-
schillende disciplines samen te brengen en om te bespreken hoe de ontwikkeling van
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nieuwe ondersteunende technologie, die de armfunctie van jonge mannen met DMD
kan vergroten, te versnellen. Er waren 24 deelnemers, waaronder ouders, experts
op het gebied van gebruikersbehoeften / mens-machine-onderzoek / elektrotechniek
/ werktuigbouwkunde en clinici die betrokken zijn bij de zorg voor tieners met DMD
uit Denemarken, Nederland, het Verenigd Koninkrijk en de Verenigde Staten, die
deelnamen aan de workshop. Tijdens de workshop is ingegaan op de behoeften van
de gebruikers, de huidige methoden voor de evaluatie van armfunctie, de armsteunen
die nu verkrijgbaar zijn, de lopende onderzoeksprojecten om actieve armsteunen te
ontwikkelen en opkomende technologieën die nuttig kunnen zijn voor de toekomstige
ontwikkeling van ondersteunende technologie voor de DMD doelgroep. Zes clusters
van actiepunten werden geïdentiﬁceerd, namelijk (a) het identiﬁceren van gebruiker en
verzorger behoeften en hun acceptatie, (b) een beoordeling van de prestaties van de
gebruiker en verzorger voor en na het in gebruik nemen van een hulpmiddel, (c) het
ontwikkelen van lab en mobiele uitkomstmaten en protocollen, (d) het verzamelen van
gegevens over het gebruik van een apparaat, (e) het ontwikkelen van modulaire tech-
nologie en (f) het werken aan de toegankelijkheid en de vergoeding in verschillende
landen.
Review over de functie en activiteiten van de bovenste
ledematen in FSHD en LGMD
Hoofdstuk 3 omvat een literatuurreview over wat er bekend is over het natuurlijke
beloop van de functie van de bovenste ledematen en de capaciteit van mensen met
FSHD en LGMD om de armen te kunnen gebruiken. Zowel FSHD en LGMD zijn
langzaam progressieve ziekten, waarbij de eerste problemen meestal ontstaan op
een leeftijd tussen de 10 en 30 jaar oud. Deze studie geeft ook een overzicht van
meetinstrumenten die worden gebruikt om de functie van de bovenste ledematen
en het uitvoeren van activiteiten bij patiënten met FSHD en LGMD te evalueren. In
wetenschappelijke databases (PubMed, MEDLINE, EMBASE, CINAHL en Cochrane)
is gezocht naar wat er in de literatuur bekend is over arm- en handfunctie bij mensen
met FSHD of LGMD. Deze zoektocht heeft in totaal 247 artikelen opgeleverd, waarvan
er uiteindelijk zestien relevant waren voor dit onderzoek. Deze 16 artikelen bevatten
informatie over in totaal 272 patiënten met FSHD (gemiddelde leeftijd tussen de 36
en 59 jaar) en 270 patiënten met LGMD (gemiddelde leeftijd van 35 tot 55 jaar). Op
basis van deze eerdere onderzoeken is geconcludeerd dat het klinische beeld van
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stoornissen betreﬀende de armfunctie en beperkingen in activiteiten waarin de armen
een rol spelen bij mensen met FSHD en LGMD zeer variabel is. Over het algemeen
ervaren mensen met FSHD en LGMD problemen met het heﬀen van hun armen. De
uitvoering van taken duurt ook aanzienlijk langer. Het klinische beloop van de functies
van de bovenste ledematen en de capaciteiten van mensen met FSHD en LGMD is
moeilijk te voorspellen ten gevolge van deze hoge variabiliteit. De meest gebruikte
manier om armfunctie te testen is manueel spieronderzoek. In de review die is gedaan
was het niet mogelijk om de resultaten van deze spieronderzoeken te vergelijken tussen
de verschillende studies, omdat in de meeste studies alleen een samengestelde score
van verschillende spiergroepen is beschreven in plaats van scores voor de individuele
spiergroepen. Hoewel manueel spieronderzoek beschouwd wordt als een goede
methode om het verloop van een ziekte te beschrijven, is het geen betrouwbare
methode om spierkracht kwantitatief te meten. Er is een studie gevonden waarbij de
onderzoekers gebruik gemaakt hebben van elektromyograﬁe (EMG) van verschillende
spieren (biceps brachii, brachioradialis, triceps en deltoideus anterior) tijdens een gesi-
muleerde drinktaak. De onderzoekers die dit onderzoek gedaan hebben, ontdekten
dat de gemeten EMG-activiteit tijdens deze taak hoger was bij mensen met FSHD
dan bij gezonde personen. De spieractiviteit en het bewegingspatroon bij de FSHD
groep omvatte meer synergistische spieractiviteit en meer abductie en ﬂexie in de
schouder- en ellebooggewrichten. Om te evalueren in hoeverre mensen in staat
zijn de armen te gebruiken tijdens activiteiten, wordt de Brooke schaal (score van
1 tot 6, 1=volledige arm en handfunctie, 6=geen nuttige arm en handfunctie) het
meest gebruikt. Mensen met FSHD melden echter niet vaak een score van 5 of 6,
waardoor de Brooke schaal niet gevoelig is voor het meten van kleine verschillen in
de capaciteit van de bovenste ledematen. Daarnaast classiﬁceert de Brooke schaal
alleen de capaciteit van basale reiktaken. Meer speciﬁeke instrumenten om de ca-
paciteit van de bovenste ledematen en de prestaties tijdens dagelijkse activiteiten te
evalueren werden vrijwel niet gebruikt. Hoewel methoden als manueel spieronderzoek
en de Brooke schaal veel gebruikt worden, is er een gebrek aan meer speciﬁeke
uitkomstmaten om de functie, capaciteit en de prestaties van de bovenste ledematen
te beoordelen. Op basis van de review zijn andere instrumenten aanbevolen, zoals 3D
bewegingsanalyses en EMG (spieractiviteit) opnames, om meer inzicht te krijgen in de
functie van de bovenste ledematen. Daarnaast worden vragenlijsten zoals de Abilhand
aangeraden om de capaciteit van de bovenste ledematen te kunnen beoordelen, en
is het gebruik van accelerometers voorgesteld om prestaties in het dagelijks leven te
kunnen evalueren.
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Bovenste ledematen functie en de activiteit in FSHD
In hoofdstuk 4 zijn de armen bij mensen met FSHD onderzocht op de niveaus van
stoornissen in functie, beperkingen in activiteiten en restricties in participatie van de
’International Classiﬁcation of Functioning Disability and Health’ (ICF). Er is een online
enquête ontworpen, met uitkomstmaten op alle drie deze niveaus van de ICF. De
enquête bevat vragen over pijn en stijfheid, de Brooke schaal, een vragenlijst om
de mogelijkheden van de bovenste ledematen te evalueren (CUE), een vragenlijst
om de moeilijkheid van het uitvoeren van bepaalde activiteiten in kaart te brengen
(Abilhand-plus) en open vragen met betrekking tot sociale participatie. Achtentachtig
mensen met FSHD hebben de vragen beantwoord. Naast het bekende probleem van
mensen met FSHD om de armen te heﬀen boven schouderhoogte, is uit de enquête
ook gebleken dat activiteiten waarbij de armen niet hoog opgetild hoeven te worden ook
problematisch zijn bij patiënten met FSHD. Meer dan 40% van de respondenten met
FSHD hebben aangegeven pijn te ervaren in één of beide armen. De resultaten hebben
aangetoond dat hogere pijn en stijfheid scores en een langere ziekteduur geassocieerd
zijn met een verhoogde beperking in het uitvoeren van activiteiten. Ongeveer 80%
van de respondenten heeft aangegeven beperkingen te ervaren bij werk gerelateerde
activiteiten, tijdens het deelnemen aan sport activiteiten, het uitvoeren van hobby’s,
huishoudelijke activiteiten en in intieme relaties.
Bovenste ledematen kinematica en spieractivatiepatronen
bij mensen met FSHD
Mensen met FSHD hebben een verhoogd risico op pees- of spierschade door het
maken van compenserende bewegingen die vaak gebruikt worden om de armen te
heﬀen en om het gebrek aan spierkracht rond het schouderblad te compenseren.
Innovatieve armsteunen kunnen mensen met FSHD helpen bij het uitvoeren van
activiteiten die veel moeite kosten of die mogelijk schade kunnen veroorzaken. Om
dit soort apparaten te optimaliseren en om de eﬀectiviteit ervan te evalueren, zijn
kwantitatieve en objectieve evaluatiemethoden nodig. Kwantitatieve gegevens zijn
bijvoorbeeld parameters zoals het bewegingsbereik van armbewegingen en de hoogte
van de spieractiviteit tijdens het bewegen van de armen. Een eerder onderzoek van
Bakhtiary et al. heeft een eerste indruk gegeven van deze parameters tijdens het
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uitvoeren van een gesimuleerde drink taak. In dat onderzoek is echter niet gekeken
naar spieren die verantwoordelijk zijn voor het stabiliseren van het schouderblad.
Hoofdstuk 5 beschrijft de kinematica van de bovenste ledematen en de betrokkenheid
van een aantal speciﬁeke spieren (biceps brachii, deltoideus, triceps brachii, trapezius
(bovenste deel), grote borstspier (claviculaire deel) en de brede rugspier) van mensen
met FSHD en gezonde personen tijdens het uitvoeren van verschillende soorten
taken. Elf mensen met FSHD en acht gezonde vrijwilligers hebben aan deze studie
deelgenomen. Deelnemers werden gevraagd om een set van zes gestandaardiseerde
bewegingen (schouderabductie-adductie, schouder ﬂexie-extensie, reiken naar beide
kanten op schouderhoogte, het verplaatsen van de hand naar de mond en het duwen-
trekken van een voorwerp op een tafel) uit te voeren. Voor elke persoon en iedere taak
is vervolgens bepaald wat de maximale hoek was tussen de romp en de bovenarm
(geeft aan hoe hoog mensen de bovenarm konden heﬀen) en wat de minimale en
maximale hoek in de elleboog was. We hebben kinematische verschillen gevonden
tussen de FSHD groep en de gezonde controlegroep, vooral in de hoogte van de
schouder elevatiehoek. Slechts één persoon met FSHD was in staat om de arm boven
120º te heﬀen tijdens de schouder abductie-adductie en ﬂexie-extensie bewegingen. In
vergelijking met gezonde personen is in de personen met FSHD tijdens het uitvoeren
van de bewegingen waarbij de bovenarm geheven moest worden meer spieractiviteit
gemeten. De activiteit van de trapezius was tijdens een aantal bewegingen zelfs bijna
net zo hoog als de spieractiviteit die gemeten was tijdens een beweging waarbij mensen
gevraagd werd de spieren maximaal aan te spannen. Ook de deltoïdeus en pectoralis
spieren waren zeer actief. Er is geconcludeerd dat de hogere activatie van de trapezius
bij patiënten met FSHD duiden op een mechanisme om de zwakke schouderspieren
te ondersteunen tijdens het heﬀen van de armen op schouderhoogte.
Eﬀect van onderarm zwaartekrachtcompensatie op de
kinematica en spieractiviteit in de bovenste ledematen bij
mensen met FSHD
Armondersteuningen zijn ontwikkeld ter compensatie van het verlies van armfunctie.
In hoofdstuk 6 wordt het eﬀect gemeten van het compenseren van de zwaartekracht
op de kinematica en spieractiviteit van de armen van mensen met FSHD en gezonde
personen. Dit is gedaan terwijl mensen een aantal gestandaardiseerde armtaken
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(schouderabductie-adductie, schouder ﬂexie- extensie, reiken naar beide kanten op
schouderhoogte, bewegen van de hand naar de mond en het duwen-trekken van een
voorwerp op een tafel) uitvoerden. Aan elf mensen met FSHD (Brooke score 2-3) en
acht gezonde vrijwilligers is gevraagd om een set van bewegingen uit te voeren, eerst
met en daarna zonder de hulp van een arm ondersteuning die de onderarm onder-
steunde (SLING armsteun). Veranderingen in de schouder kinematica en spieractiviteit
werden gekwantiﬁceerd, terwijl de deelnemers een set van gestandaardiseerde taken
uitvoerden met en zonder de SLING onderarmsteun. De gezonde vrijwilligers konden
met de armsteun de armen minder hoog optillen als gevolg van het mechanische
ontwerp van de armsteun. Dit verschil werd niet waargenomen bij mensen met FSHD,
omdat ze de armen niet zo hoog konden optillen dat ze hier last van hadden. Er is in
beide groepen ook aangetoond dat er minder spieractiviteit nodig was om activiteiten
uit te voeren met armsteun in vergelijking met activiteiten die zonder armsteun uit-
gevoerd werden. Het bewegen van de hand naar de mond en het maken van rechte
schouderbewegingen (abductie-adductie, ﬂexie-extensie) ging sneller wanneer de
SLING werd gebruikt. Reiken en het duwen-trekken van een object op tafel ging
daarentegen langzamer met de SLING. De hoeveelheid rompbewegingen werd in
zowel de FSHD groep als in de controle groep minder tijdens de SLING ondersteunde
schouderbewegingen. Zoals verwacht zorgde het ondersteunen van de armen tij-
dens alle bewegingen in alle spieren voor een vermindering van de spieractiviteit, wat
ook de resultaten uit eerdere onderzoeken met gezonde proefpersonen bevestigen.
Het gebruiken van de SLING resulteerde in het later aanspannen van de biceps en
deltoideus-spier tijdens beide reiktaken in de FSHD groep. Daarnaast werd ook een
latere aanspanning van de trapezius spier gevonden tijdens de reiktaak naar de an-
dere kant (met de rechterhand naar links reiken) in de FSHD groep. Deze bevinding
impliceert dat de FSHD groep het zwaartekracht compensatie mechanisme meer in
hun voordeel konden gebruiken wanneer stabiliteit van het schouderblad nodig was.
Om het proﬁel van armsteun gebruikers nog beter te begrijpen, moet de informatie
over de spieractiviteit worden aangevuld met informatie over momenten en krachten in
de gewrichten. Daarnaast is het van belang dat dan ook gekeken wordt naar andere
spieren die het schouderblad stabiliseren, zoals het onderste deel van de trapezius
en de serratus anterior.
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Verschillende proﬁelen van de bovenste ledematen functie
in vier soorten NMD
De vragenlijst die naar de FSHD groep is gestuurd (hoofdstuk 4), is ook voorgelegd
aan een groep mensen met DMD, LGMD en SMA. In hoofdstuk 7 zijn de stoornissen,
beperkingen in activiteiten en restricties in sociale participatie met betrekking tot de
armen die gemeld zijn door mensen met FSHD vergeleken met die van mensen met
LGMD, SMA en DMD in Nederland. Het doel van deze studie was om te onderzoeken
of verschillende proﬁelen van de functie van de armen geïdentiﬁceerd kunnen wor-
den tussen verschillende vormen van neuromusculaire aandoeningen (NMA). Op het
niveau van de armfunctie van de zijn vragen gesteld over pijn en stijfheid in de armen,
handen en vingers. Om de capaciteit van het gebruik van de armen tijdens basisac-
tiviteiten te beoordelen, zijn de Brooke schaal en de CUE vragenlijst (mogelijkheden
van de bovenste ledematen) gebruikt. De Abilhand-plus vragenlijst is gebruikt om
de capaciteit van het kunnen uitvoeren van dagelijkse activiteiten te evalueren. Tot
slot zijn er een aantal open vragen gesteld met betrekking tot sociale participatie. In
totaal hebben 267 mensen deelgenomen aan de studie (FSHD = 88, LGMD = 65,
SMA = 64, DMD = 50), waarvan 222 mensen de complete vragenlijst ingevuld hebben.
De gemiddelde leeftijd van de DMD-groep was 15 jaar. In de SMA, LGMD en FSHD
groepen varieerde de gemiddelde leeftijd tussen de 39 en 51 jaar. In de FSHD en
LGMD groepen was minder dan 23% van de respondenten volledig rolstoel gebonden,
terwijl dit in de SMA en DMD groepen meer dan 64% was. Het gebruik van armsteunen
was het hoogst in de SMA-groep (28,1%) en het laagst in de LGMD groep (11,5%).
Wanneer alleen gekeken werd naar de mensen die mogelijk zouden kunnen proﬁteren
van een armsteun (Brooke scores 2-6), werd het gebruik van een armsteun gemeld
door respectievelijk 19,4%, 20,3%, 36,7% en 27,8% van de mensen met FSHD, LGMD,
SMA en DMD. De gemiddelde Brooke score was het hoogst in de DMD-groep en het
laagst in de LGMD groep. Pijn in een of meer segmenten van de bovenste ledematen
werd gerapporteerd door meer dan 30% van de respondenten. De hoogste frequenties
van pijn werden gemeld door mensen met FSHD in de schouder en bovenarm. De ger-
apporteerde pijnscores waren sterk gerelateerd aan de gerapporteerde stijfheidscores,
en er is gesuggereerd dat pijn en stijfheid niet altijd gemakkelijk te onderscheiden zijn
van elkaar als subjectieve gevoelens. De meeste beperkingen in het uitvoeren van
activiteiten met de armen werden gemeld door personen met DMD en SMA. In deze
twee groepen werd aangegeven dat respectievelijk 37% en 24% van de ABILHAND-
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plus activiteiten onmogelijk uit te voeren waren, en dat respectievelijk 32% en 26%
van deze activiteiten moeilijk zijn om uit te voeren. In FSHD en LGMD werd slechts
van respectievelijk 2% en 5% van de ABILHAND-plus activiteiten gemeld dat deze
onmogelijk uit te voeren waren, en dat respectievelijk 26% en 17% van de activiteiten
moeilijk uit te voeren waren. Net zoals gemeld werd door mensen met FSHD, melden
ook mensen met LGMD relatief hoge scores voor pijn en stijfheid en lage scores voor
beperkingen in het kunnen uitvoeren van activiteiten. Het proﬁel van de DMD en SMA
groep daarentegen werd gekenmerkt door relatief lage scores voor pijn en stijfheid
en hoge scores voor beperkingen in activiteiten. Deze resultaten geven aan dat er
binnen de verschillende soorten NMA verschillende proﬁelen van armfunctie bestaan.
Terwijl het proﬁel dat bij personen met FSHD en LGMD waargenomen werd eerder
duidt op overbelasting, is bij mensen met DMD en SMA juist sprake van verminderd
gebruik van de bovenste ledematen. Er is gesuggereerd dat beide patronen een
andere revalidatie strategie vereisen.
Discussie
In dit proefschrift is de armfunctie onderzocht bij mensen met verschillende neuro-
musculaire aandoeningen (NMA). Dit is onder andere gedaan door onderzoek van
kinematica en spieractiviteit tijdens het uitvoeren van verschillende activiteiten. Deze
onderzoeken hebben geholpen om inzicht te krijgen in de toegevoegde waarde van
een armondersteuning op het niveau van de activiteit van spieren en het bewegings-
bereik in de schouder en elleboog bij mensen met FSHD. Er is ook gekeken naar pijn
en stijfheid die mensen ervaren in de schouders, armen en handen. Tot slot is de
capaciteit om activiteiten met de armen uit te kunnen voeren bekeken door middel
van de Brooke score, de CUE- en ABILHAND-plus vragenlijst en een aantal open
vragen. Deze instrumenten hebben een tweetal proﬁelen opgeleverd (overbelasting
en verminderd gebruik) tussen verschillende typen NMA. Hoewel deze onderzoeken
bij hebben gedragen aan een beter inzicht op het niveau van de functie van de armen
en de beperkingen in het uitvoeren van bewegingen, is het nog onbekend hoe mensen
daadwerkelijk presteren tijdens het uitvoeren van dagelijkse activiteiten. Om te achter-
halen welke beperkingen individuele mensen met NMA ervaren bij de uitvoering van de
dagelijkse activiteiten, en hoe zij deze activiteiten scoren op belangrijkheid, uitvoering
en tevredenheid wordt naast het gebruik van gestandaardiseerde vragenlijsten het
gebruik van een cliëntgerichte maat aanbevolen zoals de Canadian Occupational
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Performance Measure (COPM). Daarnaast is het nog onbekend hoe mensen daad-
werkelijk presteren tijdens het uitvoeren van dagelijkse activiteiten, met en zonder
het gebruik van een armondersteuning. Om dit in kaart te kunnen brengen zijn de
volgende aanbevelingen gedaan:
• Meten van het totale bewegingsbereik van de hand met behulp van een methode
die zowel met als zonder armondersteuning gebruikt kan worden (bijv. met
inertiele sensoren).
• Kwantiﬁceren hoeveel de armen daadwerkelijk gebruikt worden tijdens het uit-
voeren van dagelijkse activiteiten, met of zonder het gebruik van een armonder-
steuning (bijv. met accelerometers).
• Inzicht krijgen in de mate waarin de spieren gebruikt worden gedurende de dag,
door het meten van de activiteit van bepaalde spieren met een mobiel EMG
meetsysteem.
• Verder ontwikkelen en evalueren van methoden om grote hoeveelheden be-
wegingsdata te classiﬁceren, om niet alleen een globaal inzicht te krijgen in het
gebruik van de armen, maar om ook speciﬁeke activiteiten zoals bijvoorbeeld
eten of drinken te kunnen bestuderen.
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Appendices
Dankwoord
De afgelopen vier jaar heb ik met veel plezier aan dit proefschrift gewerkt. Ik wil iedereen
die in de afgelopen jaren bijgedragen heeft aan mijn promotieonderzoek hartelijk bedanken.
Alleen had ik het project niet tot een goed einde kunnen brengen. Ik heb in de afgelopen
jaren op verschillende plekken tijd doorgebracht. Dit heeft er voor gezorgd dat ik mij inmiddels
niet alleen thuis voel binnen het Radboudumc, maar ook bij de Universiteit Maastricht, het
UMCG, het VUmc en de Universiteit Twente. Een aantal mensen wil ik graag in het bijzonder
bedanken. Allereerst alle proefpersonen die vrijwillig hebben meegewerkt aan de metingen in
Maastricht. Bedankt voor jullie geduld en ook voor de mooie gesprekken die ik met jullie heb
gehad.
Sander, Imelda en Edith, ik vond het geweldig dat jullie mijn promotor en co-promotoren waren!
Dankzij jullie support en geduld heb ik mijn artikelen kunnen afronden. Als techneut heb ik
ontzettend veel van jullie klinische expertise kunnen leren. Jullie kritische commentaren heb ik
enorm kunnen waarderen, dit is de kwaliteit van de stukken zeer ten goede gekomen. Ook
wil ik jullie graag bedanken dat jullie me hebben voorgedragen voor de Radboud Da Vinci
Challenge. Jullie waardering heeft mij gesterkt in mijn vertrouwen dat er voor mij als generalist
te midden van specialisten een rol is weggelegd. Imelda, door jouw inzet voor mij heb ik in
Nijmegen kunnen werken. Het budget binnen het McArm project was niet toereikend voor een
promotietraject. Door jouw steun hebben we er echter een mooi traject van weten te maken,
waarin ik als freelancer in deeltijd aan mijn onderzoek heb kunnen werken. Jouw klinische
kennis en hart voor de patiënten hebben mij tijdens de afgelopen jaren enorm geinspireerd.
Tijdens het promotieonderzoek en de vele andere projecten waarin we samen betrokken zijn.
Ik ben altijd opnieuw onder de indruk wanneer jij als enig clinicus aan tafel een heel team van
ingenieurs weer op het goede spoor weet te helpen. Ik hoop dat we nog vele jaren kunnen
samenwerken! Edith, jouw enthousiaste en positieve manier van feedback geven hebben mij
gemotiveerd om mijn artikelen af te ronden. Ik was af en toe onzeker over de kwaliteit van
de stukken, maar na dat met jou besproken te hebben, zag ik het altijd weer positief in. Ik
kijk er naar uit om het project bij de NA groep samen een vervolg te geven. Sander, bedankt
voor jouw uitgebreide en snelle feedback op mijn stukken. Ik heb veel van jouw uitmuntende
manier van schrijven geleerd.
Natuurlijk wil ik ook de leden van de manuscriptcommissie, Prof. dr. ir. N.J.J. Verdonschot, Prof.
dr. B.G.M. van Engelen en Prof. dr. ir. H.F.J.M. Koopman, hartelijk danken voor de kritische
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beoordeling van dit proefschrift en de bereidheid om zitting te nemen in de promotiecommissie.
Professor Koopman, beste Bart, jou wil ik in het bijzonder bedanken voor alle mogelijkheden
die je me al sinds mijn afstuderen binnen jouw groep in Enschede hebt geboden. Ik zal nooit
vergeten hoe we samen de laatste hand hebben gelegd aan de Symbionics STW Perspectief
aanvraag, toen we beide in Sneek waren om te zeilen. Met onze koﬃekoppen op de stapels
papieren, om te voorkomen dat de wind onze aantekeningen het meer in zou blazen, hebben
we de laatste puntjes op de i gezet. Uiteindelijk is dit een succesvolle aanvraag geworden. Ik
hoop dat er nog veel initiatieven zullen volgen waarin we samen betrokken zijn.
Mijn mede-auteurs Alessio, Elizabeth, Joan, Just, Kenneth, Mariska, Pat en Paul, wil ik
bedanken voor hun inzet en prettige samenwerking. Alessio, ik beschouw jou als mijn partner
in crime. Samen hebben we vele uren doorgebracht. Eerst tijdens de metingen in het lab in
Maastricht en later tijdens de vele werkdagen in Groningen en de Skype meetings waarin we
de meetresultaten uitgewerkt hebben in twee artikelen. Ik heb veel geleerd van jouw precieze
manier van werken. Tijdens het analyseren van de data ben ik je daar nog vaak dankbaar
voor geweest. Mariska, met jou heb ik vaak gediscussieerd over meetinstrumenten om naar
armfunctie te kijken, en ik vond het leuk om samen met jou aan de vragenlijst artikelen te
werken. Kenneth, bedankt voor de kans die je me hebt gegeven om een jaar lang twee dagen
in de week binnen jouw groep op de Universiteit Maastricht te kunnen werken. Just, je was al
vanaf het begin betrokken bij mijn afstudeeropdracht en in het kader van Flextension werken
we nog steeds samen. Ik wil jou graag bedanken voor de samenwerking in de laatste fase van
mijn promotieonderzoek waarin we samen aan het artikel over de workshop in London hebben
gewerkt. Joan, thanks for all the nice conversations we have had, at the department in Twente,
but also during all other events where we spent time together. I enjoyed the period where we
turned Elizabeth’s garage into a Flextension laboratory. I admire your enthousiasm and the
passion you have for your work. One day, we will start a project together in Barcelona! Beste
Paul, bedankt voor de discussies die we hebben gehad in het kader van McArm, Flextension en
eNHANCE. Ik vond het leuk om samen een paar dagen in Londen door te brengen. Elizabeth
and Pat: I’m grateful for the funding that you provided from UPPMD to kickstart the Flextension
A-Gear project. Thanks to your initial support, I have been able to develop the questionnaires,
that eventually became part of my thesis. The outcome of the workshop in London last year
has brought great results, thank you for organizing it together. Elizabeth, jou wil ik ook graag
bedanken voor alle inspirerende en gezellige gesprekken. Ik heb veel bewondering voor jouw
enorme gedrevenheid en de hoeveelheid ballen die jij in de lucht weet te houden. Het is altijd
weer een feest om bij jou en Justus in Amsterdam langs te komen.
Collega’s bij de groep revalidatie van het Radboudumc. Ten eerste mijn kamergenoten in
Nijmegen; Chantal, Jilske, Laura, Mariëlle, Mariska en Merel, bedankt voor jullie gezelligheid
en de mooie gesprekken die we hebben gehad. Frank, Geert, Jorik, Roland en Sjoerd, ik heb
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veel plezier beleefd tijdens onze klaverjasavonden. Deze leverden altijd hilarische momenten
op. Geert en Roland, jullie wil ik ook bedanken voor de technische ondersteuning. Roland,
toen ik net in Nijmegen kwam werken voelde ik me als techneut enigszins onwennig tussen
alle clinici, maar jij wist dat perfect in balans te brengen. Ik vond het altijd leuk om even bij jouw
kamer binnen te lopen. Jij was altijd bezig met een of andere nieuwe technische opstelling of je
had weer iets leuks bedacht voor de jonge onderzoekers. Daarnaast hebben we verschillende
keren na werktijd onder het genot van een biertje zitten ﬁlosoferen over uiteenlopende zaken.
Bedankt voor alle leuke gesprekken die we door de jaren heen hebben gehad. Noortje, bedankt
voor je enthousiaste verhalen tijdens koﬃepauzes en thuiswerkdagen. Allan, Annemieke, Bas,
Digna, Hanneke, Jasper, Jolanda, Jos, Joyce, Lotte, Milou, Nens en Renske wil ik bedanken
voor de samenwerking, de gezelligheid tijdens de vele lunchmomenten en de dagen waarop ik
onderdak kwam zoeken bij een van jullie op de kamer.
Hans, Michiel en Pieter, bedankt dat ik af en toe bij jullie op de kamer terecht kon op de dagen
dat ik in Maastricht was. Hans, bedankt voor jouw ondersteuning tijdens de metingen die
we in Maastricht gedaan hebben en de latere studies met de accelerometers, waarbij we in
Nijmegen de algoritmes uit Maastricht gebruikt hebben. Ik vind het leuk dat we nu opnieuw
samenwerken, nu je zelf als PhD werkzaam bent binnen het Symbionics project.
Collega’s van de vakgroep Biomechanical Engineering van de UT: bedankt voor al jullie
collegialiteit en gezelligheid in de afgelopen jaren. Ik kom iedere week weer met veel plezier
naar Enschede en ik vind het leuk om met velen van jullie samen te werken of gewerkt te
hebben.
Bij de vakgroep Biomedical Signals and Systems van de UT wil ik graag professor Peter Veltink
bedanken. Beste Peter, dankzij jou hebben we in een razend tempo het eNHANCE project op
weten te tuigen, én met succes. Ik heb bewondering voor jouw uitmuntende talent om ideeën
concreet en geordend op papier te krijgen en ik werk met plezier met je samen.
Alle medewerkers van de sectie Ontwikkeling van het VUmc. Ook jullie hebben mij in de
afgelopen jaren met enige regelmaat terug zien komen, ik voel me altijd welkom wanneer ik
weer eens dag langskom.
Uiteraard wil ik ook alle studenten bedanken die me in de afgelopen jaren geholpen hebben,
niet alleen tijdens de onderzoeken die in dit proefschrift zijn beschreven, maar ook in een van
de andere projecten. Anneliek, Anne-Marie, Annette, Bob, Carrie, Carry, Elles, Gertilde, Ilse,
Jesper, Jose, Kamiel, Karlijn, Kyra, Pim, Sandra, Stephan en Tomas, bedankt voor al jullie
inzet!
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De hele McArm projectgroep wil ik bedanken voor alle enerverende discussies en jullie
bereidheid om buiten de eigen discipline te kijken en samen stappen te maken.
Dennis, Jeroen, Michiel, Peter, Rocío, Sami, Tom en Tong, bedankt voor de fantastische tijd en
de reizen die we samen hebben gemaakt tijdens de Radboud Da Vinci Challenge. Ik waardeer
de open gesprekken die ik met jullie heb gevoerd en denk er met plezier aan terug.
Flextension: Bart, Ed, Elizabeth, Imelda, Jaap, Just en Micha, samen hebben we in de
afgelopen jaren een heel bijzondere samenwerking tot stand gebracht. Ik wil jullie graag
bedanken voor alle inspiratie die jullie mij gegeven hebben. Ik hoop dat we vanuit Flextension
nog veel mooie initiatieven zullen starten. Micha, jou wil ik in het bijzonder graag bedanken. In
2008 heb je mij de kans gegeven om mijn afstudeeropdracht bij jou en Nina in het VUmc te
doen. Tijdens deze periode kwam ik er al snel achter dat het ontwerpen van producten niet
mijn sterkste kant is en dat ik dat veel beter aan jou over kan laten. Sinds ik ben afgestudeerd
hebben we echter samen veel tot stand gebracht en ik vind dat wij samen een ijzersterk team
vormen. Uren hebben we zitten brainstormen over vervolgstappen voor Flextension. Jouw
drive om nieuwe innovatieve oplossingen te bedenken en jouw geweldige doorzettingskracht
om deze te realiseren, inspireren mij enorm in mijn werk. Daarnaast wil ik je graag bedanken
voor de kans die je me hebt gegeven om een aantal maanden voor Pontes Medical in het
VUmc te werken. Ed, bedankt voor jouw steun en voornamelijk ﬁnancieel advies. Dit heeft er
mede voor gezorgd dat ik als freelancer aan de slag ben gegaan en deze manier van werken
heeft mij de vrijheid geboden die ik als prettig ervaar.
Bob, Edsko, Knut, Liezel and Olle, thanks for your collaboration in the study that we are doing
together to evaluate the MSS in Indonesia. Bob, bedankt voor het werk dat je gedaan hebt
tijdens jouw afstudeerproject, waar ik veel van geleerd heb. Ik vind het leuk dat we samen
dit vervolgproject zijn begonnen. Knut, thank you for the nice discussions that we had during
the preparation of the project and for arranging the sponsorship from Össur to provide the
prosthetic components for the participants. Olle, I appreciate your openness and willingness
to run this study together. There are a few conversations that I will never forget. Thank you for
your support in preparing and running the study in Jakarta and Bali.
MoveAid Foundation: Bob en Wilco, samen met jullie hebben we Stichting MoveAid opgezet,
met het doel om hulpmiddelen te ontwikkelen die afgestemd zijn op de behoeften en mogelijkhe-
den van mensen met een beperking in ontwikkelingslanden. Hoewel MoveAid inmiddels een
andere invulling heeft gekregen, wil ik jullie graag bedanken voor de prettige samenwerking en
de discussies die we als bestuur samen hebben gehad, ik denk daar met plezier aan terug.
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Movendi Foundation: Annelies, Esther en Karin. Bedankt voor de open gesprekken die we
gehad hebben over hoe de doelstellingen van MoveAid en Movendi elkaar zouden kunnen
versterken. Bedankt dat jullie me als nieuweling binnen jullie bestuur verwelkomt hebben en
natuurlijk voor alle inspirerende werk(zater)dagen. Naast dat ik van jullie veel geleerd heb
over het opzetten en runnen van projecten in ontwikkelingslanden, heb ik ook mijn kennis over
baby’s ﬂink bij kunnen spijkeren.
The CoPPers: Anthony, Azah, Bram, Herman and Liezel. Serendipity brought us together.
I ﬁnd it really incredible with how much enthusiasm and passion we work together on the
realization of a global initiative. I’m always looking forward to our next Skype meeting, and the
working week earlier this year was a fantastic experience.
Dan mijn paranimfen Mark Prins en Martin Willemink. Al sinds het allereerste begin van onze
studententijd in Enschede zijn wij vrienden, toen we samen in Villa 65 zijn gaan wonen. Met
z’n drieën hebben we vele avonturen beleefd en hebben we ons als de drie ‘Bikkelfeuten’
onsterfelijk weten te maken. Nog altijd hangt er een foto van ons drieën boven de bank in
ons oude studentenhuis. Ik ben blij dat jullie vandaag als paranimfen naast mij staan! Mark,
we hebben ons heel wat op de hals gehaald. Van het opzetten van een legertenten-verhuur-
onderneming, het ophalen van een oeroud campertje uit Rotterdam dat jaren stil had gestaan,
plannen om een bus naar Dakar te rijden (en daarvoor ons busrijbewijs te halen), tot het maken
van een onvergetelijke rondreis door Iran. Hoe onmogelijk sommige dingen op het eerste
gezicht ook leken, als we samen iets bedachten begonnen we er gewoon aan en keken we
vervolgens wel wat het op ging leveren. Martin, jouw rustige, altijd opgewekte en positieve
houding waardeer ik enorm. Ik ben ook onder de indruk van de natuurlijke manier waarop jij je
werk doet. Bij jouw promotie ging je werkelijk als een speer en het leek alsof iedere keer dat
we elkaar spraken er een nieuw artikel van jou geaccepteerd was of dat je weer een award
in de wacht had gesleept. Dit heeft mij ook enorm geïnspireerd en gemotiveerd en met je
huidige werkzaamheden en mooie Stanford plannen doe je dat nog steeds. Ik wil je ook graag
bedanken dat we samen zijn gaan trainen voor de marathon van Berlijn, die we vervolgens
ook gelopen hebben. Zonder jou was ik daar waarschijnlijk niet aan begonnen.
Villa 65: Jacob, Jan, Jasper, Marieke, Mark, Martin, Paul, Quirina, Thijs en Tjitte-Jelte. Met
regelmaat denk ik terug aan Villa65, wat een fantastische tijd hebben we samen gehad. Ik kijk
altijd weer uit naar ons jaarlijkse weekend weg!
De Vrije KonijnenVogels: Bart-Jan, Bas, Bastiaan, Daan, Ivo, Jason, Jasper, Jeroen, Lourens,
Mark, Michiel, Onno, Rens, Rens, Robin, Thijs, Tjitte-Jelte. Wat ooit begonnen is als een
goed verhaal om gratis biertjes te kunnen drinken op een borrel, is uitgegroeid tot een hecht
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dispuut. Samen hebben we heel wat afgeborreld in Enschede en ik ben blij dat we elkaar nog
regelmatig zien tijdens een van de VKVWest borrels, zeiltochten en weekendjes weg.
Rinse en Rutger, jullie ken ik al sinds de middelbare school en ook in onze studententijd waarin
we alle drie in een andere stad zijn gaan studeren, zijn we elkaar niet uit het oog verloren. Ik
geniet van ons jaarlijkse weekendje weg en ik kijk altijd weer uit naar de volgende trip.
Justus, ik heb jou tijdens mijn afstuderen leren kennen toen jij nog op de middelbare school
zat. Inmiddels ben ik jou en Elizabeth bijna als familie gaan beschouwen en denk ik vaak aan
jullie. Ik heb enorm veel bewondering voor de manier waarop jij je leven inricht in Amsterdam
en Delft. Als jij binnenkort in Delft gaat afstuderen, dan ben ik daar ook graag bij. Ik vind het
ook geweldig om te zien en te horen wat je allemaal ontwerpt. Ik vind het echt een eer dat je
de cover van mijn proefschrift hebt ontworpen. Dankjewel, het is super mooi geworden!
Heit en mem, bedankt voor al jullie liefde en steun. Jullie staan altijd achter mij in de keuzes
die ik maak. Heit, het ondernemende karakter en het zoeken naar mogelijkheden heb ik van
jou. Als ik ergens tegenaan loop, weet jij er altijd vanuit een ander perspectief naar te kijken.
Mem, de gevoeligheid heb ik van jou. Die eigenschap helpt mij ook in het werk wat ik doe.
Bedankt dat je altijd voor ons klaar staat. Tom, Jorien, Esther, Bas, Mirjam en Kees, ook al
zien we elkaar soms wat minder, het is altijd goed. Ik ben ontzettend blij met jullie!
Lieve Sophie, wat ben ik blij dat ik jou heb leren kennen. Ik vind het ontzettend ﬁjn om met
jou samen te zijn en om samen plannen te maken. Een leven zonder jou kan ik me niet meer
voorstellen!
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Arjen Bergsma was born in Donkerbroek on February 10th, 1984. After graduating from
secondary school (CSG Liudger in Drachten), he started studying Biomedical Engineering
at the University of Twente. During an internship at the Roessingh rehabilitation center in
2008, he became interested in technology for people with mobility problems. For his master
thesis, he investigated how arm functions of people with severe muscular dystrophy can be
supported. Arjen graduated in 2009. As a direct result of his masters project, the Flextension
Foundation was founded, with the aim to stimulate development of new supportive technology
to improve quality of life of people with Duchenne (Arjen is involved as board member). In
2009, Arjen started working as freelance biomedical engineer, and he had various research
groups as contractors. He coordinated among others the grant application process (STW)
of the Flextension A-Gear project. In 2011, he started a part-time PhD research at the
Department of Rehabilitation at the Radboudumc under supervision of dr. Imelda de Groot
and dr. Edith Cup. He also collaborated closely with the Department of Movement Sciences
at the Maastricht University Medical Centre under supervision of dr. Kenneth Meijer. In
relation to his PhD activities, he participated in 2013 in the Radboud Da Vinci Challenge, a
program that oﬀers excellent PhD students and post-docs the opportunity to experience broad
personal development. In 2014, Arjen was involved in initiating the Symbionics program (STW
Perspectief) and the eNHANCE project (Horizon2020), with the aim to develop sophisticated
assistive technology that adapts to the users’ needs. Both proposals were successfully granted
in 2014, and Arjen became involved in both projects as coordinator. Arjen is also interested
in rehabilitation technology across borders. In 2010 he volunteered in the $50 prosthesis
project of the Waag Society in Amsterdam, and in 2011 he did a four-weeks ﬁeld study into
low-cost prosthetics in the area of Yogyakarta, Indonesia. He also co-founded the MoveAid
Foundation, with the goal to improve prosthetic solutions adapted to the needs of people with
an amputation living in developing countries. In 2014, MoveAid joined forces with the Movendi
Foundation, where Arjen became one of the board members. In 2015, he was involved in the
start of the Community of Prosthetics Practice (CoPP), which falls under the umbrella of the
GATE initiative of the WHO. Aim of the CoPP is to develop and provide a holistic approach to
prosthetic rehabilitation and service delivery for people with lower limb amputations who live in
rural areas.
Arjen has an entrepreneurial spirit and he likes to support others with converting ideas into
concrete projects. Arjen is very interested in people and rehabilitation technology. His passion
is to bring experts from diﬀerent disciplines together to jointly develop new solutions. Arjen
resides with Sophie Schipper in Utrecht. He likes to be in the sky to ﬂy as private pilot, and
together with Sophie he likes to travel around the world.
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Donders Graduate School for
Cognitive Neurosciences
Series
For a successful research Institute, it is vital to train the next generation of young scientists. To
achieve this goal, the Donders Institute for Brain, Cognition and Behaviour established the
Donders Graduate School for Cognitive Neuroscience (DGCN), which was oﬃcially recognised
as a national graduate school in 2009. The Graduate School covers training at both Master’s
and PhD level and provides an excellent educational context fully aligned with the research
programme of the Donders Institute.
The school successfully attracts highly talented national and international students in biology,
physics, psycholinguistics, psychology, behavioral science, medicine and related disciplines.
Selective admission and assessment centers guarantee the enrolment of the best and most
motivated students.
The DGCN tracks the career of PhD graduates carefully. More than 50% of PhD alumni show
a continuation in academia with postdoc positions at top institutes worldwide, e.g. Stanford
University, University of Oxford, University of Cambridge, UCL London, MPI Leipzig, Hanyang
University in South Korea, NTNU Norway, University of Illinois, North Western University,
Northeastern University in Boston, ETH Zürich, University of Vienna etc.. Positions outside
academia spread among the following sectors: specialists in a medical environment, mainly
in genetics, geriatrics, psychiatry and neurology. Specialists in a psychological environment,
e.g. as specialist in neuropsychology, psychological diagnostics or therapy. Positions in higher
education as coordinators or lecturers. A smaller percentage enters business as research
consultants, analysts or head of research and development. Fewer graduates stay in a research
environment as lab coordinators, technical support or policy advisors. Upcoming possibilities
are positions in the IT sector and management position in pharmaceutical industry. In general,
the PhDs graduates almost invariably continue with high-quality positions that play an important
role in our knowledge economy.
For more information on the DGCN as well as past and upcoming defenses please visit:
http://www.ru.nl/donders/graduate-school/donders-graduate/
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